Polynucleotides for modifying organisms

By introducing recombinant DNA or RNA of RNA replication elements recognized by the split virus RNA-dependent RNA polymerase, the expression of cargo RNA is regulated, and the problem of plant genotype and phenotype improvement in the prior art is solved, and the improvement of plant resistance and Effect of stress resistance.

CN118922549APending Publication Date: 2024-11-08FLAGSHIP PIONEERING INNOVATIONS VII LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380025331.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-10-11
Filing Date
2023-01-20
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The prior art is difficult to effectively improve the genotype and phenotype of plants, especially in the process of improving plants in agricultural applications, and there is a lack of effective methods to improve the resistance of plants to pests and stresses.

Method used

Provides recombinant DNA or RNA molecules containing 5' and 3' RNA replication elements recognized by the different viral RNA dependent RNA polymerase (RDRP) to regulate cargo RNA expression by introducing these molecules into plants, thereby catalyzing the synthetic component body Viral satellite RNA, thereby achieving modification of plant genotypes and phenotypes.

Benefits of technology

By introducing recombinant DNA or RNA molecules, plants can be significantly improved to significantly improve their resistance to pests and stress, and changes in plant genotypes and phenotypes can be achieved, and plants can be enhanced to resist diseases and stress.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118922549A_ABST
    Figure CN118922549A_ABST
Patent Text Reader

Abstract

Synthetic split viral satellite RNA molecules and satellite particles containing the same are disclosed. Also disclosed are methods of using the split virus satellite RNA molecules and satellite particles containing the same to alter the phenotype of a plant, improve stress resistance in a plant, and improve pest and pathogen resistance in a plant.
Need to check novelty before this filing date? Find Prior Art

Description

Inventors: Arjun Devang Khakhar, Barry Andrew Martin, Yajie Niu, Daniel Alexander Sprague, Elizabeth Jane Antonelli Dennis, Mehmet Ali Halac, Yumeng Hao, James Michael Kremer, Jayashree Kumar, Chien-Yuan Lin, Michka GabrielleSharpe, Aditya Sushil Kumar Singh and Phu Tri Tran. CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This international patent application claims the benefit of U.S. Provisional Patent Application No. 63 / 379,056, filed on October 11, 2022, and is incorporated herein by reference in its entirety, and the benefit of U.S. Provisional Patent Application No. 63 / 266,967, filed on January 20, 2022, and is incorporated herein by reference in its entirety. Incorporation of Sequence Listing

[0002] This application includes a sequence table, which has been submitted electronically in XML file format and is hereby incorporated by reference in its entirety. The XML file was created on January 13, 2023, and is named P13757WO00.xml, with a size of 727,335 bytes. The sequence table of U.S. Provisional Patent Application No. 63 / 379,056 filed on October 11, 2022 (named P13757US01.xml, with a size of 603,608 bytes) is incorporated herein by reference in its entirety. The sequence table of U.S. Provisional Patent Application No. 63 / 266,967 filed on January 20, 2022 (named VL70006_ST25, with a size of 441,582 bytes) is incorporated herein by reference in its entirety. Background Art

[0003] There is a need in the art for modified polynucleotides to improve the phenotype and genotype of an organism; particularly for use in agricultural applications to improve plants, such as crops.

[0004] The PV is a dsRNA virus with a bipartite genome that is separately encapsidated. One (PV) genome contains dsRNA encoding an RNA-dependent RNA polymerase, and the other PV genome contains dsRNA encoding a capsid protein (Roossinck, M. doi / 10.1111 / nph.15364). Summary of the invention

[0005] A recombinant DNA molecule comprising a first promoter is provided, the first promoter being operably linked to a DNA encoding an RNA molecule, wherein the RNA molecule comprises, from the 5' end to the 3' end: (a) a 5' RNA replication element recognized by a somatic viral RNA-dependent RNA polymerase (RDRP); (b) a cargo RNA molecule; and (c) a 3' RNA replication element recognized by the RDRP; wherein the 5' RNA replication element, the cargo RNA molecule, and the 3' RNA replication element are operably linked, wherein the promoter and the cargo RNA molecule are heterologous to the 5' RNA replication element and the 3' RNA replication element. Cells, vectors, and agricultural formulations comprising recombinant DNA molecules, vectors, or cells are also provided. An expression system is also provided, which comprises a recombinant DNA molecule and a cell containing the recombinant DNA molecule and a RDRP protein that recognizes 5' and 3' RNA replication elements encoded by the DNA molecule. A method for providing a synthetic somatic viral satellite RNA to a plant is also provided, the method comprising contacting the plant with a recombinant DNA molecule, a cell, a vector, or an agricultural formulation thereof. A method for producing an exogenous polypeptide in a plant or a plant cell is provided, the method comprising providing a plant or a plant cell comprising a recombinant DNA molecule, wherein a cargo RNA molecule encoded by the DNA molecule comprises a translatable messenger RNA encoding the exogenous polypeptide, wherein the plant or the plant cell comprises a RDRP protein that recognizes a 5' RNA replication element and a 3' RNA replication element of the recombinant RNA and catalyzes the synthesis of a synthesized split viral satellite RNA from the recombinant RNA molecule, and wherein the exogenous polypeptide is translated from the translatable messenger.

[0006] Also provided is a recombinant RNA molecule, which comprises from the 5' end to the 3' end: (a) a 5' RNA replication element recognized by a somatic viral RNA-dependent RNA polymerase (RDRP); (b) a cargo RNA molecule; and (c) a 3' RNA replication element recognized by the RDRP, wherein the 5' RNA replication element, the cargo RNA molecule, and the 3' RNA replication element are operably connected, and wherein the cargo RNA molecule is heterologous to the 5' RNA replication element and the 3' RNA replication element. Also provided are agricultural formulations and cells comprising recombinant RNA molecules. Also provided is an expression system, which comprises: (a) an RNA molecule containing the recombinant RNA molecule; and (b) a cell containing the recombinant RNA molecule and a RDRP protein that recognizes the 5' and 3' RNA replication elements of the recombinant RNA molecule. Plant propagules comprising recombinant RNA molecules and somatic viral RDRPs are provided. Plant propagules comprising at least one plant cell containing recombinant RNA molecules and somatic viral RDRPs are provided. A method for producing a modified plant propagule is provided, the plant propagule comprising at least one plant cell containing the recombinant RNA molecule, the method comprising isolating a plant propagule comprising at least one plant cell containing the recombinant RNA molecule and a split virus RNA-dependent RNA polymerase (RDRP) from a mixed population of plant cells comprising plant cells containing the recombinant RNA molecule and plant cells lacking the recombinant RNA molecule. A method for providing a synthetic split virus satellite RNA to a plant is also provided, the method comprising contacting the plant with a recombinant RNA molecule. A method for obtaining a phenotypic change in a plant or plant cell is provided, the method comprising providing a recombinant RNA molecule to a plant or plant cell, wherein the cargo RNA molecule is included in the plant or plant cell compared to a plant or plant cell lacking the recombinant RNA to achieve a phenotypic change, wherein the plant or plant cell comprises an RDRP protein that recognizes the 5' RNA replication element and the 3' RNA replication element and catalyzes the synthesis of the synthesized split virus RNA from the recombinant RNA molecule, and the cargo RNA molecule achieves the phenotypic change. A method for increasing resistance of a plant to a pest or pathogen is provided, the method comprising providing a recombinant RNA molecule to a plant, wherein the cargo RNA molecule effects an increase in resistance of the plant to the pest or pathogen compared to a plant lacking the recombinant RNA molecule, and wherein the plant or plant cell comprises a RDRP protein that recognizes the 5' RNA replication element and the 3' RNA replication element of the recombinant RNA and catalyzes the synthesis of a synthetic split viral satellite RNA from the recombinant RNA molecule.A method for increasing plant resistance to stress is provided, the method comprising providing a recombinant RNA molecule to a plant, wherein the plant comprises a RDRP protein that recognizes the 5' RNA replication element and the 3' RNA replication element of the recombinant RNA and catalyzes the synthesis of a synthetic split virus satellite RNA from the recombinant RNA molecule, and wherein the cargo RNA molecule achieves an increase in the plant's resistance to stress compared to a plant lacking the recombinant RNA molecule. A method for making a synthetic split virus satellite particle is provided, the method comprising: (a) providing at least one of the aforementioned recombinant RNA molecules to a plant cell, wherein the recombinant RNA molecule comprises an encapsidation recognition element (ERE), and wherein the plant cell comprises a RDRP protein and a viral capsid protein, the RDRP protein recognizes the 5' RNA replication element and the 3' RNA replication element and catalyzes the synthesis of a synthetic split virus satellite RNA from the recombinant RNA molecule, wherein the ERE provides encapsidation of the RNA by the viral capsid protein; and optionally (b) isolating the synthetic split virus satellite particle from the plant cell, a plant comprising the plant cell, or from a medium in which the plant cell or the plant is grown. Also provided is a method for making a synthetic split viral satellite particle, the method comprising combining the aforementioned recombinant RNA molecule with a viral capsid protein in a container, wherein the recombinant RNA molecule comprises an encapsidation recognition element (ERE), and wherein the ERE provides encapsidation of the RNA by the viral capsid protein in the container; optionally wherein the method further comprises separating the synthetic split viral satellite particle from uncombined RNA and / or viral capsid protein in the container. A method for providing a synthetic split viral satellite RNA to a plant is provided, the method comprising: grafting a scion onto a rootstock comprising a recombinant RNA molecule, wherein at least one cell in the rootstock and / or the scion comprises a split viral RDRP. A method for producing a plant that transmits a recombinant RNA molecule to a progeny plant or seed is provided, the method comprising obtaining an F from a parent plant comprising the recombinant RNA molecule. 1 The method comprises isolating from a population of plants or seeds at least one cell containing a split viral RNA-dependent RNA polymerase (RDRP) and the recombinant RNA molecule. 1 Progeny plants or seeds. BRIEF DESCRIPTION OF THE DRAWINGS

[0007] Figure 1 A non-limiting example of the structure of a split virus satellite construct is shown. In this example, the 5' RNA replication element is labeled "5UTR split virus", and the 3' RNA replication element is labeled "3UTR split virus". The element labeled "tRNA" is a tRNA-like element, "Cargo" is a cargo RNA, and "MP" is a movement protein.

[0008] Figure 2 Schematic diagram of using Agrobacterium infiltration to generate split virus satellite RNA, isolation of encapsidated satellite RNA, and field application to plants is shown. In this example, the 5' RNA replication element is labeled "5UTR split virus", and the 3' RNA replication element is labeled "3UTR split virus". The element labeled "tRNA" is a tRNA-like element, "Cargo" is a cargo RNA, and "MP" is a mobile protein. The element labeled "Rep" refers to the RDRP coding region.

[0009] Figure 3 A scheme for establishing a replicating synthetic split virus genome in Nicotiana benthamiana using Agrobacterium is shown. "Rep" refers to the RDRP coding region.

[0010] Figure 4 Shows that in accepting Figure 3 Analysis of DNA constructs for the spliceovirus capsid protein RNA produced in Nicotiana benthamiana.

[0011] Figure 5 Shows that in accepting Figure 3 Analysis of DNA constructs for the production of schizont viral RdRP RNA in Nicotiana benthamiana.

[0012] Figure 6 A scheme for establishing replication of a synthetic splice virus genome containing a cargo RNA molecule encoding a viral movement protein (MP) in Bloomsdale spinach containing a splice virus (SCV) is shown. In this example, the 5' RNA replication element is labeled "5UTR splice virus" and the 3' RNA replication element is labeled "3UTR splice virus".

[0013] Figure 7 Shown is the analysis of cargo RNA in system 3 leaves 56 days after Agrobacterium infection in SCV-infected Bloomsdale spinach. The arrow points to the band of the correct size RT-PCR product corresponding to the cargo RNA encoding the viral movement protein (MP).

[0014] Figure 8 A T-DNA vector containing a cassette for expressing PV satellite RNA encoding PCV1 RDRP is shown (SEQ ID NO: 255).

[0015] Fig. 9A T-DNA vector comprising a cassette for expressing PV satellite RNA encoding PCV1 CP is shown (SEQ ID NO: 256).

[0016] Fig.10 A T-DNA vector containing a cassette for expressing PV satellite RNA encoding SCV RDRP is shown (SEQ ID NO: 257).

[0017] Fig.11 A T-DNA vector comprising a cassette for expression of PV satellite RNA encoding TMV MP is shown (SEQ ID NO: 258).

[0018] Fig.12 A T-DNA vector containing a cassette for expressing PV satellite RNA encoding SCV CP is shown (SEQ ID NO: 259).

[0019] Fig.13A , Fig. 13B , Fig. 13C and Fig.13D The 5' and 3' RNA replication elements of pepper latent virus 1 (PCV1) are shown. Fig.13A , Fig. 13B , Fig. 13C and Fig.13D The structural features identified in SEQ ID NO:372-375).

[0020] Fig.14A , Fig. 14B , Fig. 14C and Fig.14D The 5' and 3' RNA replication elements of spinach latent virus 1 (SCV1) are shown. Fig.14A , Fig. 14B , Fig. 14C and Fig.14D Structural features identified in SEQ ID NO:376-379).

[0021] Fig.15A , Fig. 15B The 5' and 3' RNA replication elements of the zygote virus from Zea mays Wu312 are shown ( Fig.15A , Fig. 15B The structural features identified in SEQ ID NO:386 and 387). DETAILED DESCRIPTION definition

[0022] The term "and / or" as used herein will be considered as a specific disclosure of each of two specified features or components with or without the other specified feature or component. Thus, the term "and / or" as used in phrases such as "A and / or B" herein is intended to include "A and B," "A or B," "A" (alone), and "B" (alone). Similarly, the term "and / or" as used in phrases such as "A, B, and / or C" is intended to cover each of the following embodiments: A, B, and C; A, B, or C; A or C; A or B; B or C; A and C; A and B; B and C; A (alone); B (alone); and C (alone).

[0023] As used herein, the term "F 1 ”, “F 2 ” etc. refers to plants or seeds obtained from a parent plant that has been selfed or hybridized with another plant.

[0024] As used herein, the term "heterologous" when used to describe a first element with reference to a second element means that the first element and the second element do not exist in nature in the arrangement as described. For example, a heterologous nucleic acid molecule or sequence is a nucleic acid molecule or sequence that is: (a) not native to the cell expressing it, (b) connected or fused to a nucleic acid molecule or sequence that is not connected or fused to it in nature or is not connected or fused to it in the same manner as in nature, (c) has been artificially changed or mutated relative to its natural state, or (d) has been altered in expression compared to its natural expression level under similar conditions. For example, a "heterologous promoter" is used to drive transcription of a sequence that is not naturally transcribed by the promoter (e.g., a eukaryotic promoter for driving transcription of a DNA molecule encoding a somatic viral RNA sequence); therefore, a "heterologous promoter" sequence can be included in an expression construct by recombinant nucleic acid technology. In other examples, a recombinant polynucleotide (such as those provided by the present disclosure) can include genetic sequences of two or more different somatic viruses that are "heterologous" because they do not naturally occur together. In some embodiments, "heterologous" refers to a molecule or a discrete portion of a molecule; for example, to a cargo RNA molecule (e.g., a nucleic acid, such as a protein-encoding RNA, ssRNA, regulatory RNA, interfering RNA, or guide RNA), which can be part of a larger molecule, or to a structure that is not naturally present in a plant mesomeric virus (e.g., a structure comprising a promoter (e.g., for a DNA-dependent RNA polymerase or an RNA promoter-dependent RNA polymerase), an RNA effector, an RNA cleavage agent recognition site, or a polynucleotide comprising or encoding an expression enhancing element, an encapsidation recognition element (ERE), a selectable or scorable marker, a DNA aptamer, an RNA aptamer, a transcription factor binding site, an internal ribosome entry site (IRES), a DNA spacer, an RNA cleavage agent recognition site, a tRNA-like element, or a transcript stabilizing or transcript destabilizing RNA sequence).

[0025] As used herein, the terms "include, includes and including" should be interpreted as having at least the features they specify without excluding any additional unspecified features. The terms "comprise, includes and comprising" mean "include, include and including", respectively.

[0026] As used herein, the term "internal ribosome entry site" or "IRES" refers to a sequence (e.g., an RNA sequence) that is capable of recruiting ribosomes and translation machinery to initiate translation from an RNA sequence. An IRES element is typically between 100-800 nucleotides. Suitable IRES can be obtained from plant and plant virus IRES sequences, such as encephalomyocarditis virus IRES (ECMV), maize hsp101 IRES 5'UTR, tobacco mosaic virus crTMV CR-CP 148 IRES that infects cruciferous plants, tobacco etch virus (TEV) IRES 5'UTR, and Hibiscus chlorotic ringspot virus (HCRSV) IRES. In addition, in an embodiment, the IRES sequence is derived from a non-plant eukaryotic virus sequence, including but not limited to: acute bee paralysis virus (ABPV), classical swine fever virus (CSFV), coxsackievirus B3 virus (CVB3), encephalomyocarditis virus (ECMV), enterovirus 71 (E71), hepatitis A virus (HAV), human rhinovirus (HRV2), human rhinovirus (HRV2), human lymphotropic virus (HTLV), polyomavirus (PV) and maize (ZmHSP101). Examples of IRES sequences that can be used in the compositions and methods described herein are shown in Table 5.

[0027] As used herein, the phrase "operably linked" refers to a juxtaposition wherein the components so described are in a relationship permitting them to function in their intended manner. For example, a promoter is operably linked to a coding sequence if the promoter provides for transcription or expression of the coding sequence.

[0028] As used herein, the term "percent identity" refers to the percentage (%) of sequence identity relative to a reference polynucleotide or polypeptide sequence after alignment by standard techniques. Alignment for the purpose of determining nucleic acid or amino acid sequence identity percentages can be achieved in various ways within the capabilities of those skilled in the art, for example, using publicly available computer software such as BLAST, BLAST-2, PSI-BLAST or Megalign software. In some embodiments, the software is MUSCLE (Edgar, Nucleic Acids Res. [Nucleic Acids Research], 32 (5): 1792-1797, 2004). Those skilled in the art can determine appropriate parameters for aligning sequences, including any algorithm required to achieve maximum alignment over the full length of the compared sequences. For example, in an embodiment, sequence identity percentage values ​​are generated using the sequence comparison computer program BLAST (Altschul et al. (1990) J. Mol. Biol. [Molecular Biology], 215: 403-410). As an illustration, the percent sequence identity of a given nucleic acid or amino acid sequence A with, compared to, or relative to a given nucleic acid or amino acid sequence B (which can alternatively be expressed as the following phrase: a given nucleic acid or amino acid sequence A having a certain percent sequence identity with, compared to, or relative to a given nucleic acid or amino acid sequence B) is calculated as follows: 100 multiplied by (X / Y score), where X is the number of nucleotides or amino acids scored as identical matches by a sequence alignment program (e.g., BLAST) in the alignment of A and B, and where Y is the total number of nucleotides or amino acids in B.

[0029] As used herein, the term "plant" includes any offspring, cell, tissue or part of the whole plant and the plant. The term "plant part" includes any one or more parts of a plant, including, for example, but not limited to: seeds (including mature seeds and immature seeds); plant cuttings; plant cells; plant cell cultures; or plant organs (e.g., pollen, embryos, flowers, fruits, buds, leaves, roots, stems and explants). Plant tissues or plant organs can be seeds, protoplasts, callus or any other plant cell groups organized into structural or functional units. Plant cells or tissue cultures can be able to regenerate plants with physiological and morphological characteristics of the plants from which the cells or tissues are obtained, and can regenerate plants with genotypes substantially identical to the plants. Regenerable cells in plant cells or tissue cultures can be embryos, protoplasts, meristem cells, callus, pollen, leaves, anthers, roots, root tips, flowers or stalks. In contrast, some plant cells cannot be regenerated to produce plants, and are referred to herein as "non-regenerable" plant cells.

[0030] As used herein, the term "transcriptome" refers to the sum of all RNA molecules expressed in a cell. Such RNA molecules include mRNA, tRNA, ribosomal RNA, miRNA, viral RNA (genomic and subgenomic) and long non-coding RNA.

[0031] To the extent that any of the foregoing definitions are inconsistent with definitions provided in any patent or non-patent reference incorporated herein by reference, any patent or non-patent reference cited herein, or any patent or non-patent reference found elsewhere, it should be understood that the foregoing definitions will control herein.

[0032] Unless otherwise stated, nucleotide sequences as described herein are given in a 5' to 3' direction when reading from left to right. As specified, nucleotide sequences can be provided as DNA or RNA. In addition, due to known codon degeneracy, different nucleotide sequences can encode identical polypeptide sequences, and such modified nucleotide sequences (e.g., for the purpose of codon optimization for a given species) are within the scope of this disclosure. Where a term is provided in the singular, it also encompasses aspects of the present invention described by the plural form of the term.

[0033] The present disclosure provides, inter alia, recombinant polynucleotides (e.g., recombinant DNA, recombinant RNA, recombinant ssRNA, recombinant dsRNA, recombinant vectors, etc.) comprising one or more sequences of a phenotypic virus (PV) or derived from a phenotypic virus; in particular, a 5' or 3' RNA replication element recognized by a phenotypic virus RNA-dependent RNA polymerase (RDRP). The present disclosure further relates to methods of preparing and using such recombinant polynucleotides, for example, by using such recombinant polynucleotides to express heterologous cargo sequences in plants, and optionally thereby modifying the expression of endogenous target sequences and / or the genotype or phenotype of the plant. In an embodiment, the phenotypic virus is a symbiotic phenotypic virus, i.e., a phenotypic virus that is unique or native to a given eukaryotic host (e.g., a host plant) without causing significant negative effects on the host (i.e., being considered non-pathogenic), typically present as a persistent but low population (i.e., low viral titer), and typically vertically transmitted to the host's offspring.

[0034] In one aspect, the disclosure relates to a recombinant DNA molecule comprising a promoter that is functional in a cell and operably linked to a DNA sequence encoding an RNA molecule. The RNA molecule comprises, in 5' to 3' order: (a) a 5' RNA replication element that can be recognized by a somatic viral RNA-dependent RNA polymerase (RDRP); (b) a cargo RNA sequence; and (c) a 3' RNA replication element that can be recognized by a somatic viral RDRP. Figure 1An example of the general structure of a DNA polynucleotide encoding a mereovirus satellite is shown, wherein the 5' RNA replication element corresponds to the 5' untranslated region (UTR) of the mereovirus, and wherein the 3' RNA replication element corresponds to the 3' untranslated region (UTR) of the mereovirus.

[0035] The recombinant DNA molecules provided herein can include a promoter that is functional in a cell (e.g., a bacterial cell, a plant cell, a fungal cell, or an animal cell) and is operably linked to a DNA sequence encoding an RNA molecule (e.g., a 5' RNA replication element, a cargo RNA sequence; a 3' RNA replication element; a ribozyme, an intron, or an RNA encoding a protein (e.g., a capsid protein, a movement protein, a RDRP protein, or a RPDRP protein)).

[0036] In an embodiment, a promoter functional in a plant cell can provide an element for cell-, tissue- or organ-specific gene expression or expression inducible by an external signal or agent (e.g., light, pathogen, wound, stress or hormone-inducible elements or chemical inducers), or capable of cell cycle-regulated gene transcription; such an element can be located in the 5' or 3' region of a native gene or engineered into a polynucleotide.

[0037] Promoters include those from viruses, bacteria, fungi, animals and plants. Suitable promoters can be used to drive the expression of any RNA polymerase (e.g., RNA pol I, pol II or pol III). Examples of promoters include those from cauliflower mosaic virus (e.g., p35S), bacteriophage (e.g., pT7) and plants (e.g., pATUBQ10). In certain embodiments, the promoter is operably linked to a nucleotide sequence encoding a plurality of guide RNAs, wherein the sequences encoding the guide RNAs are separated by cleavage sites (e.g., nucleotide sequences encoding microRNA recognition / cleavage sites or self-cleaving ribozymes) (see, e.g., Ferré-D'Amaréand Scott (2010) Cold Spring Harbor Perspectives Biol. [Cold Spring Harbor Perspectives in Biology], 2: a003574). In certain embodiments, the promoter is a pol II promoter operably linked to a nucleotide sequence encoding RNA. In certain embodiments, the promoter operably linked to one or more polynucleotides encoding elements of a genome editing system is a constitutive promoter that drives DNA expression in plant cells. In certain embodiments, the promoter drives DNA expression in a nucleus or an organelle (e.g., a chloroplast or mitochondria). Examples of constitutive promoters active in plant cells include the CaMV 35S promoter disclosed in U.S. Pat. Nos. 5,858,742 and 5,322,938, the rice actin promoter disclosed in U.S. Pat. No. 5,641,876, the corn chloroplast aldolase promoter disclosed in U.S. Pat. No. 7,151,204, and the nopaline synthase (NOS) and octopine synthase (OCS) promoters from Agrobacterium tumefaciens. In certain embodiments, the promoter operably linked to one or more polynucleotides encoding elements of the genome editing system is a promoter from fig mosaic virus (FMV), a RUBISCO promoter, or a pyruvate phosphokinase (PDK) promoter (which is active in the chloroplasts of mesophyll cells). In some embodiments, the promoter is heterologous to the cell in which it is functional and / or to other elements to which the promoter is operably linked. All patent publications cited in this paragraph are incorporated herein by reference in their entirety.

[0038] The recombinant polynucleotides provided herein may include or encode RNA molecules containing 5' and 3' RNA replication elements identified by a somatic virus RNA-dependent RNA polymerase (RDRP). In certain embodiments, the identification of the somatic virus RDRP can be identified in an in vitro RDRP assay (e.g., adapted from Horiuchi et al. Plant Cell Physiol. [Plant Cell Physiology] 42 (2): 197-203, 2001 assay). In certain embodiments, the identification of the somatic virus RDRP can be identified by an in vivo RDRP assay, wherein the RNA comprising 5' and 3' RNA replication elements is introduced into a cell comprising RDRP, and the replication of RNA is measured (e.g., by RT-PCR assay or assay of a reporter gene encoded by a cargo RNA, the cargo RNA being located at the RNA comprising 5' and 3' RNA replication elements). In certain embodiments, the cell comprising RDRP can be engineered by introducing a gene or RNA molecule encoding RDRP into a cell. In other embodiments, the cell comprising RDRP can be a cell comprising a somatic virus expressing RDRP. In certain embodiments, recombinant polynucleotides (e.g., recombinant DNA or recombinant RNA) include 5'RNA replication elements and 3'RNA replication elements obtained from the same solitary viral genome or obtained from the relevant solitary viral genomes with at least 85%, 90%, 95%, 98% or 99% sequence identity to each other. In certain embodiments, recombinant polynucleotides (e.g., recombinant DNA or recombinant RNA) include 5'RNA replication elements, 3'RNA replication elements and RDRP obtained from the same solitary viral genome or obtained from the solitary viral genomes with at least 85%, 90%, 95%, 98% or 99% sequence identity to each other. Non-limiting examples of 5'RNA replication elements and 3'RNA replication elements from the same solitary viral capsid protein genome include those shown in each row of Table 9. Non-limiting examples of corresponding RDRP proteins from the same solitary viral RDRP genome 5'RNA replication elements and 3'RNA replication elements and 5'RNA replication elements and 3'RNA replication elements can be identified include those shown in each row of Table 10. The RDRPs shown in Table 10 can also recognize corresponding 5' RNA replication elements and 3' RNA replication elements from the mereovirus capsid protein genome corresponding to the same mereovirus (ie, the mereovirus having the capsid protein genome of Table 9 and the RDRP genome of Table 10).In certain embodiments, the recombinant polynucleotide (e.g., recombinant DNA or recombinant RNA) comprises a 5'RNA replication element, a 3'RNA replication element and / or a RDRP coding region obtained from two somatic viral genomes, wherein the 5'RNA replication element, the 3'RNA replication element and the RDRP coding region of the two somatic viral genomes have at least 85%, 90%, 95%, 98% or 99% sequence identity to each other. In certain embodiments, the recombinant polynucleotide (e.g., recombinant DNA or recombinant RNA) comprises a 5'RNA replication element and a 3'RNA replication element obtained from different somatic viral genomes. In certain embodiments, the recombinant polynucleotide (e.g., recombinant DNA or recombinant RNA) comprises a 5'RNA replication element, a 3'RNA replication element and a RDRP obtained from different somatic viral genomes. In certain embodiments, different somatic viral genomes will have less than 85%, 80%, 75% or 70% sequence identity to each other. In certain embodiments, different somatic viral genomes will have any of 50%, 60%, or 65% to 70%, 75%, 80%, or 84% sequence identity to each other.

[0039] In certain embodiments, the combination of 5'RNA replication elements, 3'RNA replication elements and RDRP shown in a single row of Table 10, a variant having at least 85%, 90%, 95%, 98% or 99% sequence identity with 5'RNA replication elements, 3'RNA replication elements and RDRP, or a variant thereof wherein the secondary structure of the RNA replication element is conserved, is used together in an expression system, plant cell, plant propagule, plant or method provided herein. In certain embodiments, the 5'RNA replication element and 3'RNA replication element or its variant in a given row are operably connected to the cargo RNA and are replicated by the corresponding RDRP or its variant in the row. In certain embodiments, the combination of 5'RNA replication elements, 3'RNA replication elements and RDRP shown in any row in rows 1 to 20 or a variant thereof disclosed herein as previously described or otherwise disclosed is used in an expression system based on dicotyledonous plant cells, dicotyledonous plant cells, dicotyledonous plant propagules, dicotyledonous plants or related dicotyledonous plant-based methods provided herein. In certain embodiments, the aforementioned dicot is a member of the genus Brassica, Capsicum, Cucumis, Cucurbita, Hordeum, Gossypium, Nicotiana, Solanum, or Glycine. In certain embodiments, the combination of the 5' RNA replication element, the 3' RNA replication element, and the RDRP shown in row 21 (i.e., SEQ ID NOs: 386, 387, and 390, respectively) or variants thereof disclosed above or otherwise are used in the monocot cell-based expression system, monocot cell, monocot propagule, monocot, or related monocot-based methods provided herein. In certain embodiments, the aforementioned monocot is a member of the genus Avena, Hordeum, Oryza, Secale, Triticum, Sorghum, or Zea.

[0040] Examples of DNA molecules encoding RNA molecules that contain or include 5' and 3' RNA replication elements recognized by the RDRP of the somatic virus are shown in Table 1. DNA molecules encoding RNAs include SEQ ID NO: 1 (PV capsid protein genome 5'UTR consensus sequence), SEQ ID NOs: 2-34, 374, 378 and 380 (PV capsid protein genome 5'UTR), SEQ ID NO: 69 (PV RdRP genome 5'UTR consensus sequence), and SEQ ID NOs: 70-88, 372, 376, 382 and 386 (PV RdRP genome 5'UTR), wherein the RNA contains or includes 5' RNA replication elements recognized by the RDRP of the somatic virus. The DNA molecules encoding RNA include SEQ ID NO: 35 (PV capsid protein genome 3'UTR consensus sequence), SEQ ID NO: 36-68, 375, 379 and 381 (PV capsid protein genome 3'UTR), SEQ ID NO: 89 (PV RdRP genome 3'UTR consensus sequence), and SEQ ID NO: 90-108, 373, 377, 383 and 387 (PV RDRP genome 3'UTR), wherein the RNA contains or contains a 3'RNA replication element recognized by the RDRP of the mitotic virus.

[0041] Structural features identified in the 5' and 3' RNA replication elements of the schizoviruses (e.g., dsRNA hairpins and ssRNA loops) are shown in Table 1 using dot-bracket notation. The dot-bracket notation provided in Table 1 was generated using RNA Fold software for predicting RNA secondary structure based on minimum free energy predictions of base pair probabilities. A dot '.' indicates an unpaired base, and a bracket '(' or ')' indicates a paired base. The dot-bracket notation is further described in Mattei et al., Nucleic Acids Research, 42(10):6146-6157, 2014; Ramlan and Zauner, in International Symposium on Biomolecular Computing, E. Csuhaj-Varju, R. Freund, M. Oswald and K. Salomaa (eds.), 27 August 2008, Wien, Austria, pp. 75–86, in: Austrian Computer Society, 2008; and Hofacker et al., Monatshefte Fur Chemie Chem. Monthly, 125:167–188, 1994. Such structural features can range in size from 20, 30 or 40 to about 500 nucleotides (nt). These structural features can be used to design engineered polynucleotide sequences used as split virus RNA replication elements and / or for constructing variants of the sequences shown in SEQ ID NO:1 to 108, 372 to 382, ​​386 and 387 used as 5' and 3' RNA replication elements. In certain embodiments, one or more residues in the RNA secondary structure shown in Table 1 or in the equivalent RNA are replaced by different nucleotides that maintain the RNA secondary structure (e.g., the presence or absence of base pairing). In certain embodiments, the RNA secondary structure shown in Table 1 or in the equivalent RNA is maintained by: a replacement of a position change of a nucleotide that does not cause base pairing or a non-base pairing nucleotide in the nucleotide sequence. In certain embodiments, the RNA secondary structure shown in Table 1 or in the equivalent RNA is maintained by: replacing the nucleotides that are not base paired in the secondary structure with nucleotides that will not base pair and / or replacing the nucleotides that are base paired in the secondary structure with nucleotides that will base pair. In this article, it should be understood that maintaining the RNA secondary structure does not need to be absolute (e.g., the structure can be partially maintained). In certain embodiments, the dsRNA structure is partially maintained when one, two, three or more nucleotides (particularly at the 5' and / or 3' ends of the hairpin-forming structure) are substituted with non-base-pairing nucleotides, thereby reducing the overall length of the dsRNA in the structure.In certain embodiments, when one, two, three or more nucleotides (particularly at the 5' and / or 3' ends of the loop structure) are replaced by base-paired nucleotides, the unpaired RNA structure is partially maintained, thereby reducing the total length of the ssRNA in the loop structure. Embodiments of the split viral satellite RNA include those in which the 5' RNA replication element includes one or more of these 5' structural features and / or in which the 3' RNA replication element includes one or more of these 3' structural features. In certain embodiments, the 5' RNA replication element comprises an RNA encoded by a DNA having at least 70%, 75%, 80%, 85%, 90%, 95%, 98%, 99% or 100% sequence identity to SEQ ID NO: 1-34, 69-88, 372, 374, 376, 378, 380, 382 or 386, optionally wherein the encoded RNA maintains or partially maintains the corresponding structural features shown in Table 1. In certain embodiments, the 3' RNA replication element comprises an RNA encoded by a DNA having at least 70%, 75%, 80%, 85%, 90%, 95%, 98%, 99% or 100% sequence identity to SEQ ID NO:35-68, 89-108, 373, 375, 377, 379, 381, 383 or 387, wherein the encoded RNA optionally maintains or partially maintains the corresponding structural features shown in Table 1.

[0042] The recombinant polynucleotides provided herein (eg, recombinant DNA, recombinant RNA, recombinant ssRNA, recombinant dsRNA, recombinant vectors, etc.) may also contain or encode additional RNA elements.

[0043] Such aforementioned additional RNA elements may include RNA encoding a somatic virus CP. Examples of DNA sequences encoding somatic virus CP include the corresponding sequences of the PV CP genome shown in Table 1 with the descriptor "NC_XXXXXX" (which refers to the database accession number of the National Center for Biotechnology Information of the United States in the World Wide Web Internet database "ncbi.nlm.nih.gov / nuccore"). Examples of DNA sequences encoding somatic virus CP also include Fig. 9 and the sequence of PCV1 CP disclosed in SEQ ID NO: 256, and DNA sequences having at least 85%, 90%, 95%, 98% or 99% identity thereto. Examples of DNA sequences encoding the CP of the splice virus also include Fig.12and the sequence of the DNA encoding SCV CP disclosed in SEQ ID NO: 259, and DNA sequences having at least 85%, 90%, 95%, 98% or 99% identity thereto. Examples of DNA sequences encoding the somatic virus CP and somatic virus CP sequences also include the sequences shown in Table 7, and DNA and protein sequences having at least 85%, 90%, 95%, 98% or 99% sequence identity thereto.

[0044] Such aforementioned additional RNA elements may include RNA encoding a somatic virus RDRP. Examples of DNA sequences encoding somatic viruses include the corresponding sequences of the PV RDRP genome shown in Table 1 with the descriptor "NC_XXXXXX" (which refers to the U.S. National Center for Biotechnology Information database accession number of the entry in the World Wide Web Internet database "ncbi.nlm.nih.gov / nuccore"). Examples of DNA sequences encoding somatic virus RDRP also include Figure 8 and the DNA sequence encoding PCV1 RDRP disclosed in SEQ ID NO: 255, and DNA sequences having at least 85%, 90%, 95%, 98% or 99% identity thereto. Examples of DNA sequences encoding the RDRP of the splice virus also include Fig.10 and the sequence of the DNA encoding the SCV RDRP disclosed in SEQ ID NO: 257, and DNA sequences having at least 85%, 90%, 95%, 98% or 99% identity thereto. Examples of DNA sequences encoding the somatic virus RDRP and somatic virus RDRP protein sequences also include the sequences shown in Table 8, and DNA and protein sequences having at least 85%, 90%, 95%, 98% or 99% identity thereto.

[0045] Such aforementioned additional RNA elements can include RNA encoding viral mobile proteins (MPs). In certain embodiments, the cargo RNA comprises RNA encoding viral MPs. Without being bound by hypothesis or theory, it is believed that viral mobile proteins bind RNA and help it move throughout the plant (thus helping the movement of cargo RNA), for example, by plasmodesmata. MPs include tobacco mosaic virus (TMV), cowpea mosaic virus, potato leaf roll virus, tomato spotted wilt virus, and tomato mosaic virus MPs. MPs from a variety of viruses are described in Table 3.

[0046] Such aforementioned other RNA elements can include tRNA-like sequences (TLS).TLS can trigger the mobility of originally immobile RNA, which helps to increase the systemic delivery of RNA molecules.TLS includes tRNA and tRNA-like sequences identified from other genetic elements (e.g., mRNA).Isoleucine tRNA encoded by SEQ ID NO:249 is an example of a useful tRNA-like sequence.Other mobile RNAs are described in Table 4, including TLS that can be used to construct polynucleotides identified in Arabidopsis.In Assembly Table 4, mobile mRNA sequences are downloaded from the PLAMOM database of Arabidopsis.The tRNA "seed alignment" in the RFAM database is downloaded in Stockholm format (multiple sequence alignment + secondary structure).The covariance model of tRNA Stockholm alignment is created using INFERNAL.PLAMOM mRNA sequences are scanned for significant similarity with tRNA according to primary and secondary structural features.Then mRNA sequences with significant hits (E-val<1) are saved in fasta files. In one embodiment, such tRNA-like sequences include tRNA-like sequences from Arabidopsis flowering time T (FT) mRNA. In some embodiments, the RNA molecule includes at least one RNA encoding a viral MP, a tRNA-like sequence from Arabidopsis FT mRNA, and an encapsidation recognition element (ERE) including TMV-OAS. In some embodiments, the RNA molecule includes a tRNA-like sequence selected from the group consisting of SEQ ID NO: 184–231. In some embodiments, the RNA molecule includes a modified tRNA-like sequence having at least 90%, 95%, 98% or 99% sequence identity with a scaffold tRNA-like sequence selected from the group consisting of SEQ ID NO: 184–231 and maintaining the secondary structure of the scaffold tRNA-like sequence.

[0047] Such aforementioned other RNA elements can include RNA encoding viral capsid protein (CP). Such capsid protein is sometimes also referred to as coat protein, wherein both capsid protein and coat protein are also referred to as "CP". In certain embodiments, cargo RNA comprises RNA encoding viral CP. CP can be provided, for example, by co-expression of a recombinant construct encoding CP or by natural expression of a virus that is endogenous to a plant cell or a virus introduced into a plant cell. If an RNA molecule contains an encapsidation recognition element (ERE), such as an assembly start sequence (OAS), the encapsidation of the RNA molecule is achieved by CP. Table 2 describes several OAS and CP sequences of viruses from a variety of engineered constructs that can be used to provide RNA encapsidation. In an embodiment, OAS is located near the 3' end of the construct, for example, in the 3' region of the cargo RNA or the 3' of the cargo RNA. For example, in some embodiments, it is found that OAS is located at 5' of a 3' RNA replication element (e.g., the 3' RNA replication element shown in Table 1). In an embodiment, the TMV-OAS located at the 3' end of the RNA molecule is recognized by the TMV capsid protein, resulting in the assembly of the TMV virion around the RNA.

[0048] Also provided herein are embodiments in which the recombinant RNA is complexed with an RNA binding protein (RBP). Such RBPs may comprise RNA recognition motifs (RRMs), such as: (i) Lys / Arg-Gly-Phe / Tyr-Gly / Ala-Phe / Tyr-Val / Ile / Leu-X-Phe / Tyr, wherein X can be any amino acid (SEQ ID NO: 253); (ii) Ile / Val / Leu-Phe / Tyr-Ile / Val / Leu-X-Asn-Leu, wherein X can be any amino acid (SEQ ID NO: 254). Such RBPs and RRMs include those disclosed in Maris et al. 2005, doi.org / 10.1111 / j.1742-4658.2005.04653.x.

[0049] Such aforementioned additional RNA elements may include at least one ribozyme. Ribozymes include self-cleaving ribozymes, ligand-responsive ribozymes (aptazymes), trans-cleaving ribozymes designed to cleave a target sequence (e.g., trans-cleaving hammerhead ribozymes designed to cleave a capsicum phytoene desaturase (PDS) sequence (RNA encoded by SEQ ID NO: 250), hepatitis delta virus (HDV) ribozymes (RNA encoded by SEQ ID NO: 251), or hammerhead ribozymes (RNA encoded by SEQ ID NO: 252). In various embodiments, multiple ribozymes are included in the polynucleotide. In certain embodiments, such ribozymes (e.g., self-cleaving ribozymes) are located 5' to the 5' RNA replication element and / or 3' to the 3' RNA replication element in the recombinant RNA. Fig.10 and the related SEQ ID NO:257 describe the use of ribozymes in vectors encoding recombinant RNA.

[0050] Such aforementioned other RNA elements can include intron sequences included in the engineered constructs. Examples of intron sequences are described in Table 6. In certain embodiments, the intron sequence is placed in the 5'UTR downstream of a promoter (e.g., a promoter active in a plant cell) for driving recombinant RNA expression. In certain embodiments, the intron sequence is placed 5' of a 5' RNA replication element or 3' of a 3' RNA replication element in the cargo RNA.

[0051] Such aforementioned additional RNA elements may include RNA promoters recognized by RNA promoter-dependent RNA polymerase (RPDRP) and / or RNA molecules encoding RNA promoter-dependent RNA polymerase (RPDRP). Examples of such RNA promoters and RPDRP include brome mosaic virus RNA promoter and RPDRP (Siegal et al. 1998, doi: 10.1073 / pnas.95.20.11613). In certain embodiments, such RNA promoters may be placed at 5' and / or 3' of an RNA molecule comprising a 5' replication element, a cargo RNA, and a 3' replication element to allow the production of either or both of the + and - chains of an RNA molecule when providing an RPDRP. In certain embodiments, such RNA promoters may be operably connected to cargo RNA molecules and / or any additional RNA elements to allow the production of corresponding cargo and / or additional RNA when providing an RPDRP.

[0052] Other elements in the recombinant polynucleotides provided herein include: a) a discrete expression cassette comprising a second promoter operably linked to the DNA sequence to be transcribed, and optionally a terminator element (see, e.g., NOS or CaMV35S terminator); (b) an expression enhancing element (e.g., DNA encoding an expression enhancing intron sequence); (c) a DNA or RNA sequence encoding a marker (e.g., a selectable marker, such as a DNA or RNA encoding an antibiotic resistance or herbicide resistance sequence; a DNA encoding a scorable marker or a detectable label (e.g., β-glucuronidase, fluorescent protein, luciferase, etc.); (d) a DNA aptamer; (e) a DNA or RNA sequence encoding an RNA aptamer; (f) a T-DNA left and right border DNA sequence; (g) a spacer DNA sequence; (h) a DNA sequence encoding a transcription factor binding site; (i) a DNA sequence encoding a localization sequence (e.g., a DNA encoding a target peptide, such as a nuclear localization signal (NLS), a mitochondrial localization signal, or a plastid localization signal); or (j) a DNA sequence encoding at least one sequence-specific recombinase recognition site (SSRRS: for example, a pair of sequence-specific recombinase recognition sites recognized by a given recombinase, such as a LOX site recognized by a CRE recombinase); and (k) a DNA sequence encoding a transcript stabilizing or transcript destabilizing sequence (see, e.g., U.S. Published Patent Application 2007 / 0011761, incorporated by reference in its entirety; Geisberg et al. Cell (2014) 156:812-824).

[0053] Provided herein are recombinant polynucleotides comprising cargo RNA molecules or comprising DNA encoding cargo RNA molecules. In some embodiments, the recombinant polynucleotides include a single cargo RNA molecule. In other embodiments, the recombinant polynucleotides include at least two cargo RNA molecules, such as 2, 3, 4, 5, 6, 7, 8, 9, 10 or more than 10 cargo RNA molecules.

[0054] In certain embodiments, the length of the cargo RNA molecule is up to about 3.2 kilobases (kb). The length of the cargo RNA molecule can range from about 20 nucleotides (nt), 100 nt, 200 nt, 300 nt, 400 nt, 500 nt, 600 nt, 700 nt, 800 nt, or 900 nt in length to about 1 kb, 2 kb, 3 kb, or 3.2 kb in length. Other lengths of cargo RNA molecules less than or equal to 100 nucleotides (nt) can range from about 20 nt, 30 nt, or 40 nt in length to about 50 nt, 60 nt, 70 nt, 80 nt, 90 nt, or 100 nt in length. In certain embodiments, a recombinant RNA comprising a cargo RNA up to about 3.2 kb in length can be encapsidated by PV capsid protein. In such embodiments, the length of the cargo RNA can range from about 20 nt, 100 nt, 200 nt, 300 nt, 400 nt, 500 nt, 600 nt, 700 nt, 800 nt, or 900 nt in length to about 1 kb, 2 kb, 3 kb, 3.2 kb, 4 kb, 5 kb, 6 kb, 7 kb, 8 kb, 9 kb, 10 kb, 11 kb, 12 kb, 13 kb, or 14 kb in length. In certain embodiments, a recombinant RNA comprising a cargo RNA up to about 3.2 kb, 4 kb, 5 kb, 6 kb, 7 kb, 8 kb, 9 kb, 10 kb, 11 kb, 12 kb, 13 kb, or 14 kb in length can be encapsidated by a heterologous viral capsid protein as shown in Table 3. In certain embodiments, a recombinant RNA comprising up to about 14 kb of cargo RNA and encapsidated by a heterologous viral capsid protein may comprise an OAS element as shown in Table 2 and encapsidated by a corresponding capsid protein as shown in Table 2. In some embodiments, the cargo RNA molecule is greater than 14 kb, for example, 15 kb, 16 kb, 17 kb, 18 kb, 19 kb or even 20 kb. In an embodiment, the cargo RNA molecule comprises: (a) at least one coding sequence, (b) at least one non-coding sequence, or (c) at least one coding sequence and at least one non-coding sequence. Such cargo RNA molecules include a combination of coding / non-coding sequences; a plurality of non-coding / coding sequences; and aptamers, ribozymes, and other elements described herein.

[0055] In an embodiment, the cargo RNA molecule includes at least one coding sequence (e.g., translatable sequence). In certain embodiments, the coding sequence is therefore a protein or polypeptide. In certain embodiments, the cargo RNA comprises a selectable marker RNA encoding an antibiotic resistance or herbicide resistance polypeptide sequence or a scorable marker RNA encoding a scorable marker protein (e.g., β-glucuronidase, fluorescent protein, luciferase, etc.). The example of a selectable marker / selector combination includes glyphosate resistance EPSPS enzyme and / or glyphosate oxidase / glyphosate, bialaphos resistance (bar) or phosphinothricin acyltransferase (pat) enzyme / phosphinothricin ammonium, or neomycin phosphotransferase (npt) / neomycin or kanamycin. The example of a scorable marker includes β-glucuronidase (GUS), luciferase and fluorescent protein, such as green fluorescent protein (GFP), yellow fluorescent protein (YFP) and cyan fluorescent protein (CFP). In certain embodiments, the cargo RNA includes a selectable or scorable RNA marker, such as an RNA aptamer or a regulatory RNA, such as an siRNA or siRNA precursor (see, e.g., U.S. Pat. Nos. 8,404,927, 8,455,716, 9,777,288, 10,378,012), a miRNA or miRNA precursor (see, e.g., U.S. Pat. Nos. 8,410,334, 8,395,023, 9,708,620), a trans-acting siRNA or a trans-acting siRNA precursor (see, e.g., U.S. Pat. Nos. 8,030,473, 8,476,422, 8,816, 061, 9,018,002), staged sRNA or staged sRNA precursors (see, e.g., U.S. Pat. No. 8,404,928), siRNA or miRNA decoys (see, e.g., U.S. Pat. Nos. 8,946,511, 9,873,888), siRNA or miRNA cleavage blockers (see, e.g., U.S. Pat. No. 9,040,774), siRNA or miRNA recognition and cleavage sequences (see, e.g., U.S. Pat. Nos. 8,334,430, 9,139,838, 9,976,152, 10,793,869, 10,876,126), riboswitches or ribozymes. Suitable RNA aptamers include those that exhibit fluorescence upon binding to the molecule. For example, the fluorescent RNA aptamer can be a broccoli RNA aptamer. Other fluorescent RNA aptamers that can be used include, but are not limited to, Spinach, Spinach 2, Carrot, Radish, Corn, Red Broccoli, Orange Broccoli, and Broccoli Fluorets. Suitable regulatory RNAs can be used to downregulate (i.e., silence) the expression of marker genes. For example, phytoene desaturase (PDS) is widely used as a marker gene,Because the silencing of the gene will produce a photobleaching phenotype. Regulatory RNA, such as bait or cleavage blockers, can also be used to interfere with the pathways regulated by endogenous small RNAs, thereby producing a visible phenotype; see, for example, U.S. Patent Nos. 8,946,511, 9,873,888, 9,040,774). In an embodiment, the cargo RNA sequence encodes at least one protein or polypeptide that provides the desired trait in the plant expressing the protein or polypeptide. Non-limiting examples of polypeptides that can be used for agricultural applications include, for example, bacteriocins, lysins, antimicrobial peptides, root nodule C-rich peptides, and bacterial cell regulatory peptides. Such polypeptides can be used to change the level, activity, or metabolism of target microorganisms to increase the fitness of beneficial insects (e.g., bees and silkworms) or to reduce the fitness of harmful invertebrates (e.g., aphids, caterpillars, beetle larvae, and mites). Examples of agriculturally useful polypeptides include peptide toxins, such as those naturally produced by insect pathogenic bacteria (e.g., Bacillus thuringiensis, Photorhabdus luminescens, Serratia entomophila, or Xenorhabdus nematophila), as known in the art. Examples of agriculturally useful polypeptides include polypeptides (including small peptides, such as cyclic dipeptides or diketopiperazines) for controlling agriculturally important pests or pathogens, such as antimicrobial polypeptides or antifungal polypeptides for controlling plant diseases, or pesticidal polypeptides (e.g., insecticidal polypeptides and / or nematicidal polypeptides) for controlling invertebrate pests (e.g., insecticidal polypeptides and / or nematicidal polypeptides). Examples of antimicrobial polypeptides include cathelicidins, cecropins, beta-defensins, amphibian antimicrobial peptides (e.g., mescaline-like peptides, esculin, gaegurin, brevinin, rugosin, ranatuerin, ranacyclin, uperin, ocellatin, grahamin, nigrocin, dermatostagmin, temporin, bombesin, maximin), enterocins, ponicerins, megourins, apidaecins, abaecins, aggressins, bacteriocins and lantibiotics, dermestins, formaecins, halocidins, lactobacilli, tachystatins, and some insecticidal toxins produced by spiders and scorpions. Examples of agriculturally useful polypeptides include antibodies, nanobodies, and fragments thereof, e.g., antibodies or nanobody fragments that retain at least some (e.g., at least 10%) of the specific binding activity of the intact antibody or nanobody. Examples of agriculturally useful polypeptides include transcription factors, e.g., plant transcription factors; see, e.g.,The "AtTFDB" database lists transcription factor families identified in the model plant Arabidopsis thaliana, which is publicly available at agris-knowledgebase[dot]org / AtTFDB / . Embodiments of agriculturally useful polypeptides include nucleases, such as exonucleases or endonucleases (e.g., Cas nucleases, such as Cas9 or Cas12a). Embodiments of agriculturally useful polypeptides further include cell penetrating peptides, enzymes (e.g., amylases, cellulases, peptidases, lipases, chitinases), peptide pheromones (e.g., yeast or fungal mating pheromones, invertebrate reproduction and larval signaling pheromones, see, e.g., Altstein (2004) Peptides [peptide], 25: 1373-1376). Examples of agriculturally useful polypeptides confer beneficial agronomic traits such as herbicide tolerance, insect control, improved yield, increased fungal or oomycete resistance, increased viral resistance, increased nematode resistance, increased bacterial disease resistance, plant growth and development, improved starch yield, improved oil yield, high oil yield, improved fatty acid content, high protein yield, fruit ripening, increased animal and human nutrition, production of biopolymers, environmental stress resistance, medicinal peptides and secretable peptides, improved processing traits, improved digestibility (e.g., reduced levels of toxins or reduced levels of compounds with "anti-nutritional" properties (such as lignin, lectins, and phytates)), enzyme production, flavor, nitrogen fixation, hybrid seed yield, fiber yield, and biofuel production. Non-limiting examples of agriculturally useful polypeptides include polypeptides that confer: herbicide resistance (U.S. Pat. Nos. 6,803,501; 6,448,476; 6,248,876; 6,225,114; 6,107,549; 5,866,775; 5,804,425; 5,633,435; and 5,463,175), increased yield (U.S. Pat. Nos. RE38,446; 6,716,474; 6,663,906; 6,476,295; 6,441,277; 6,423,828; 6,399,330; 6,372,211; 6,235,971; 6,222,098; and 5,716,837),Insect control (U.S. Pat. Nos. 6,809,078; 6,713,063; 6,686,452; 6,657,046; 6,645,497; 6,642,030; 6,639,054; 6,620,988; 6,593,293; 6,555,655; 6,538,109; 6,537,756; 6,521,442; 6,501,009; 6,468,523; 6,326,351; 6,313,378; 6,284,949; 6,281,016; 6,248,536; 6,242,241; 6,221,649; 6,177, 615; 6,156,573; 6,153,814; 6,110,464; 6,093,695; 6,063,756; 6,063,597; 6,023,013; 5,959,091; 5,942,664; 5,942,658, 5,880,275; 5,763,245; 5,763,241; 10,017,549; 10,233,217; 10,487,123; 10,494,408; 10,494,409; 10,611,806; 10,612,037; 10,669,317; 10,827,755; 11,2 54,950; 11,267,849; 11,130,965; 11,136,593; and 11,180,774), fungal disease resistance (U.S. Pat. Nos. 6,653,280; 6,573,361; 6,506,962; 6,316,407; 6,215,048; 5,516,671; 5,773,696; 6,121,436; 6,316,407; and 6,506,962), viral resistance (U.S. Pat. Nos. 6,617,496; 6,608,241; 6,015,940; 6,013,864; 5,850,023; and 5,304,730 ), nematode resistance (U.S. Patent No. 6,228,992), bacterial disease resistance (U.S. Patent No. 5,516,671), plant growth and development (U.S. Patent Nos. 6,723,897 and 6,518,488), starch yield (U.S. Patent Nos. 6,538,181; 6,538,179; 6,538,178; 5,750,876; 6,476,295), improved oil yield (U.S. Patent Nos. 6,444,876; 6,426,447; and 6,380,462), high oil yield (U.S. Patent Nos. 6,495,739; 5,608,149; 6,483,008; and 6,476,295),Improved fatty acid content (U.S. Pat. Nos. 6,828,475; 6,822,141; 6,770,465; 6,706,950; 6,660,849; 6,596,538; 6,589,767; 6,537,750; 6,489,461; and 6,459,018), high protein yield (U.S. Pat. No. 6,380,466), fruit ripening (U.S. Pat. No. 5,512,466), increased animal and human nutrition (U.S. Pat. Nos. 6,723,837; 6,653,530; 6,5412,59; 5,985,605; and 6,171,640), biopolymers (U.S. Pat. Nos. RE37,543; 6,228,623; 5,958,745; and 6,946,588), environmental stress resistance (U.S. Pat. Nos. 6,0 72,103), pharmaceutical peptides and secretable peptides (U.S. Pat. Nos. 6,812,379; 6,774,283; 6,140,075; and 6,080,560), improved processing traits (U.S. Pat. No. 6,476,295), improved digestibility (U.S. Pat. No. 6,531,648), low raffinose (U.S. Pat. No. 6,166,292), industrial enzyme production (U.S. Pat. No. 5,543,576), improved flavor (U.S. Pat. No. 6,011,199), nitrogen fixation (U.S. Pat. No. 5,229,114), hybrid seed yield (U.S. Pat. No. 5,689,041), fiber yield (U.S. Pat. Nos. 6,576,818; 6,271,443; 5,981,834; and 5,869,720), and biofuel production (U.S. Pat. No. 5,998,700). In some embodiments, the RNA molecule further comprises an internal ribosome entry site (IRES) located 5' and adjacent to at least one coding sequence. In yet other embodiments, the cargo RNA molecule comprises multiple coding sequences, and the RNA molecule further comprises an IRES located 5' and adjacent to each coding sequence (e.g., an open translation reading frame encoding a target protein). Useful IRES sequences include those described in Table 5. ,

[0056] In certain embodiments, the cargo RNA molecule includes a non-coding sequence. Such non-coding sequences include hairpin RNA (hpRNA); RNA that forms multiple stem loops; RNA pseudoknots; RNA sequences that form at least partially double-stranded RNA; small interfering RNA (siRNA) or siRNA precursors; microRNA (miRNA) or miRNA precursors; ribozymes; ligand-responsive ribozymes (aptazymes); RNA aptamers; or long non-coding RNA (lncRNA).

[0057] In some embodiments, the cargo RNA molecule comprises a CRISPR guide RNA. CRISPR-associated nucleases, such as Cas9, Cas12, and Cas13 endonucleases, are used as genome editing tools in different plants; see, for example, Wolter et al. (2019) BMC Plant Biol. [BMC Plant Biology], 19: 176-183); Aman et al. (2018) Genome Biol. [Genome Biology], 19: 1-10. CRISPR / Cas9 requires a two-component crRNA:tracrRNA "guide RNA" ("gRNA") comprising a targeting sequence ("CRISPR RNA" or "crRNA" sequence) and a Cas9 nuclease recruitment sequence (tracrRNA). Efficient Cas9 gene editing has also been achieved using chimeric "single guide RNAs" ("sgRNAs"), an engineered (synthetic) single RNA molecule that mimics the naturally occurring crRNA-tracrRNA complex and contains a tracrRNA (for binding the nuclease) and at least one crRNA (to guide the nuclease to the sequence targeted for editing); see, e.g., Cong et al. (2013) Science, 339:819–823; Xing et al. (2014) BMC Plant Biol., 14:327-340. Chemically modified sgRNAs have been shown to be effective in genome editing; see, e.g., Hendel et al. (2015) Nature Biotechnol., 985-991. Commercial manufacturers of CRISPR nucleases and guide RNAs provide algorithms for designing guide RNA sequences; see, e.g., the guide design tool provided by Integrated DNA Technologies at www[dot]idtdna[dot]com / pages / products / crispr-genome-editing / alt-r-crispr-cas9-system. Some Cas nucleases, including Cas12a and Cas13, do not require tracrRNA.

[0058] For many Cas nucleases, guide sequence design is constrained by the requirement that the DNA target sequence (to which the crRNA is designed to be complementary) must be adjacent to a protospacer adjacent motif ("PAM") sequence recognized by the specific Cas nuclease used. Cas nucleases recognize specific PAM sequences, and there are a variety of nucleases and corresponding PAM sequences; see, e.g., Smakov et al. (2017) Nature Reviews Microbiol., doi: 10.1038 / nrmicro.2016.184. For example, the Cas9 nuclease cleaves dsDNA and requires a GC-rich PAM sequence located 3' of the DNA target sequence to be targeted by the crRNA component of the guide RNA, and cleaves to leave a blunt end. The Cas12a nuclease cleaves dsDNA and requires a T-rich PAM sequence located 5' of the DNA target sequence to be targeted by the crRNA component of the guide RNA, and cleaves to leave a staggered end with a 5' overhang. Cas13 nuclease cuts single-stranded RNA and does not require a PAM sequence; instead, the Cas13 nuclease is guided to its target by a single crRNA with a directional repeat ("DR"). In practice, the crRNA component of the guide RNA is usually designed to be between 17-24 nucleotides in length (usually 19, 20 or 21 nucleotides) and to be precisely complementary (i.e., completely base-paired) to the target gene or nucleic acid sequence adjacent to the PAM motif itself (when the Cas nuclease requires it). A crRNA component with less than 100% complementarity to the target sequence (e.g., a crRNA with a length of 20 nucleotides and 1-4 mismatches with the target sequence) can be used, but this will increase the possibility of off-target effects.

[0059] Non-limiting examples of effective guide design can be found in, for example, U.S. Patent Application Publications US 2019 / 0032131, 2015 / 0082478, and 2019 / 0352655, each of which is incorporated herein by reference in its entirety. For the purpose of gene editing, a CRISPR "array" can be designed to include one or more guide RNA sequences corresponding to one or more desired target DNA sequences; see, for example, Cong et al. (2013) Science, 339: 819–823; Ran et al. (2013) Nature Protocols, 8: 2281-2308.

[0060] In an embodiment, the cargo RNA molecule incorporated into the polynucleotide includes at least one CRISPR guide RNA; the release of the guide RNA is mediated by, for example, flanking DR sequences, ribozyme sequences or other self-cleaving RNAs or trans-cleaving RNAs, or by cleavage by endogenous ribonucleases. The corresponding Cas nuclease can be provided by separate or simultaneous delivery, for example, by co-delivery with a vector or polynucleotide, or by transiently or stably expressing the corresponding Cas nuclease in a cell to which the polynucleotide is delivered.

[0061] In certain embodiments, the 5' RNA replication element comprises a 5'UTR element of a solitary viral genome (e.g., a CP or RDRP PV genome comprising a PV 5'UTR as shown in Table 1). In embodiments, the 5' RNA replication element further comprises a genomic sequence of a solitary virus that is naturally located 3' to the 5'UTR sequence and optionally adjacent to or in close proximity to it. In embodiments, the 3' RNA replication element comprises a 3'UTR sequence of a solitary viral genome (e.g., a CP or RDRP PV genome comprising a PV 3'UTR as shown in Table 1). In embodiments, the 3' RNA replication element further comprises a genomic sequence of a solitary virus that is naturally located 5' to the 3'UTR sequence and optionally adjacent to or in close proximity to it.

[0062] In other embodiments, the RNA molecules further include at least one RNA molecule encoding a viral MP. In certain embodiments, the at least one RNA molecule encoding an MP is located (a) before the cargo RNA molecule, (b) after the cargo RNA molecule, or (c) both before and after the cargo RNA molecule. In embodiments, the at least one RNA sequence encoding an MP includes at least two RNA sequences encoding different MPs or a single RNA sequence encoding multiple copies of an MP.

[0063] In some embodiments, the recombinant DNA molecule further comprises a discrete expression cassette comprising a second promoter functional in the cell and operably linked to a DNA sequence encoding at least one viral movement protein, and optionally a terminator element.

[0064] In some embodiments, the RNA molecule further comprises an ERE, wherein the ERE is located proximal or adjacent to a 3' RNA replication element, and optionally wherein the 3' RNA replication element comprises a 3'UTR sequence of a somatic virus. In an embodiment, the ERE comprises a viral OAS, such as a tobacco mosaic virus OAS (TMV-OAS) or an OAS shown in Table 2.

[0065] In an embodiment, the RNA molecule further comprises at least one tRNA-like sequence (TLS), and wherein the at least one tRNA-like sequence comprises a tRNA-like sequence from Arabidopsis FT mRNA (e.g., the TLS in the Arabidopsis FT mRNA of Table 4). In some embodiments, the RNA molecule comprises a tRNA-like sequence selected from SEQ ID NOs: 184–231. In some embodiments, the RNA molecule comprises a modified tRNA-like sequence having at least 90% sequence identity with a scaffold tRNA-like sequence selected from the group consisting of SEQ ID NOs: 184–231 and maintaining the secondary structure of the scaffold tRNA-like sequence. In still other embodiments, the RNA molecule further comprises at least one RNA encoding a viral MP, a tRNA-like sequence from Arabidopsis FT mRNA, and an encapsidation recognition sequence comprising TMV-OAS.

[0066] In some embodiments, the length of the cargo RNA molecule is up to about 3.2 kb. In an embodiment, the cargo RNA molecule includes: (a) at least one coding sequence, (b) at least one non-coding sequence, or (c) at least one coding sequence and at least one non-coding sequence. In other embodiments, the cargo RNA molecule includes at least one coding sequence, and wherein the RNA molecule further includes an internal ribosome entry site (IRES) located at 5' and adjacent to the at least one coding sequence. In other embodiments, the cargo RNA molecule includes multiple coding sequences, and wherein the RNA molecule further includes an IRES located at 5' and adjacent to each coding sequence.

[0067] In other embodiments, the cargo RNA molecule comprises at least one non-coding sequence, and wherein the at least one non-coding sequence is selected from the group consisting of: a hairpin RNA (hpRNA); an RNA that forms multiple stem-loops; an RNA pseudoknot; an RNA sequence that forms at least partially double-stranded RNA; a small interfering RNA (siRNA) or a siRNA precursor; a microRNA (miRNA) or a miRNA precursor; a ribozyme; a ligand-responsive ribozyme (aptazyme); an RNA aptamer; and a long non-coding RNA (lncRNA).

[0068] In an embodiment, a DNA sequence encoding at least one ribozyme is provided. In an embodiment, at least one ribozyme is located 5' of the 5' RNA replication element or 3' of the 3' RNA replication element. In an embodiment, a DNA sequence encoding at least one ligand-responsive ribozyme (aptazyme) is provided. In an embodiment, at least one ligand-responsive ribozyme is located 5' of the 5' RNA replication element or 3' of the 3' RNA replication element.

[0069] Also provided herein are recombinant RNA molecules comprising 5' RNA replication elements, one or more cargo RNA molecules and 3' RNA replication elements as described above or otherwise disclosed, and other elements as described above or otherwise disclosed. In certain embodiments, the recombinant RNA molecules are produced by recombinant DNA molecules as provided herein. In certain embodiments, the recombinant RNA molecules are produced by in vivo or in vitro (e.g., cell-free) RNA replication processes by the action of RDRP or RNA promoter-dependent RNA polymerase (RPDRP).

[0070] An expression system comprising a recombinant polynucleotide is also provided. Such an expression system includes both a cell-based expression system and a cell-free expression system. In certain embodiments, the cell-free expression system may include (a) an RNA molecule, which comprises in the order of 5' to 3': (i) a 5' RNA replication element; (ii) a cargo RNA molecule; and (iii) a 3' RNA replication element; and optionally, the RNA molecule further comprises at least one additional RNA or other element. Such additional RNA elements may include at least one RNA encoding a viral MP, at least one tRNA-like sequence, an OAS, an RDRP protein recognizing 5' and 3' RNA replication elements, an RNA promoter and / or an RPDRP. In certain embodiments, the RDRP protein is provided by a somatic virus (e.g., a somatic virus that is endogenous to the cell in which expression is required). In certain embodiments, a cell-based expression system may include (a) a recombinant DNA molecule comprising a heterologous promoter functional in a cell and operably linked to a DNA sequence encoding an RNA molecule, the RNA molecule comprising, in 5' to 3' order: (i) a 5' RNA replication element; (ii) a cargo RNA molecule; and (iii) a 3' RNA replication element; and optionally, the RNA molecule further comprises at least one additional RNA or other element. Such additional RNA elements may include at least one RNA encoding a viral MP, at least one tRNA-like sequence, an OAS, a RDRP protein that recognizes 5' and 3' RNA replication elements, an RNA promoter, and / or an RPDRP. In certain embodiments, a cell-based expression system may include (a) a recombinant RNA molecule comprising, in 5' to 3' order: (i) a 5' RNA replication element; (ii) a cargo RNA molecule; and (iii) a 3' RNA replication element; and optionally, the RNA molecule further comprises at least one additional RNA or other element. Such additional RNA elements may include at least one RNA encoding a viral MP, at least one tRNA-like sequence, an OAS, a RDRP protein that recognizes 5' and 3' RNA replication elements, an RNA promoter, and / or an RPDRP. In some embodiments, the RDRP protein is provided by a solitary virus. In still other embodiments, the 5' RNA replication element and the 3' RNA replication element are obtained from the same solitary virus and / or from the same solitary viral genome (e.g., both are obtained from the same PV capsid genome or both are obtained from the same PV RDRP genome) or from related solitary viral genomes that have at least 85%, 90%, 95%, 98% or 99% sequence identity to each other. In some embodiments, the cells used in the expression system are bacterial cells, plant cells, fungal cells, or animal cells (e.g., insect cells).In an embodiment, the cell used in the expression system endogenously contains a somatic virus with a genome encoding RDRP, and the RDRP recognizes 5' and 3' RNA replication elements. In some embodiments, the expression system further includes a viral capsid protein, which is recognized by the encapsidation recognition element and encapsidates the RNA molecule. In some embodiments, the viral capsid protein: (a) is expressed by a recombinant DNA molecule in a cell (for example, wherein the recombinant DNA molecule further includes a discrete expression cassette, the discrete expression cassette comprising a second promoter operably connected to a DNA sequence encoding a viral capsid protein, and an optional terminator element), (b) is co-expressed by a second recombinant DNA molecule in the cell; (c) is exogenously provided to the cell; or (d) is expressed by a virus in the cell. In an embodiment, the RDRP protein is heterologous to the cell. In an embodiment, the RDRP protein is exogenously provided to the cell. In certain embodiments, the RDRP protein that recognizes 5' and 3' RNA replication elements is endogenously expressed in a plant cell by a somatic virus (for example, when the somatic virus is naturally present in a plant cell). In an embodiment, the somatic virus is natural or unique to a plant cell. In embodiments, the plant cell-specific mereovirus is non-pathogenic. In embodiments, the plant cell-specific mereovirus is non-pathogenic and symbiotic. In embodiments, the mereovirus is an exogenously introduced mereovirus (i.e., not specific or native to the host, but artificially introduced). For example, a mereovirus naturally found in one plant species, variety, or germplasm can be introduced into a different plant species, variety, or germplasm with or without a corresponding recombinant mereovirus satellite RNA. In an embodiment, a complete self-replicating mereoviral satellite system is introduced into a plant or plant cell, wherein the self-replicating mereoviral satellite system comprises: (1) a recombinant mereoviral satellite RNA comprising, from the 5' end to the 3' end: (a) a 5' RNA replication element recognized by a mereoviral RNA-dependent RNA polymerase (RDRP); (b) a cargo RNA molecule; and (c) a 3' RNA replication element recognized by the RDRP; wherein the 5' RNA replication element, the cargo RNA molecule, and the 3' RNA replication element are operably linked, and wherein the promoter and the cargo RNA molecule are heterologous to the 5' RNA replication element and the 3' RNA replication element; and (2) an exogenous mereovirus (e.g., a mereovirus that is not unique or native to a plant or plant cell) that is capable of replicating in a plant or plant cell and that encodes a mereoviral RDRP that recognizes the 5' and 3' replicase recognition sequences in the recombinant mereoviral satellite RNA. In embodiments, the partiviral RDRP comprises a protein having at least 85%, 90%, 95%, 97% or 99% sequence identity to SEQ ID NO: 272, 290-384 or 390.In an embodiment, the recombinant DNA molecule or recombinant RNA molecule further comprises at least one RNA encoding a viral MP, a tRNA-like sequence from Arabidopsis FT mRNA, and an encapsidation recognition sequence including TMV-OAS.

[0071] Provided herein are cells comprising any of the foregoing or otherwise disclosed recombinant polynucleotides (e.g., recombinant DNA, recombinant RNA, or vectors comprising or encoding them). Cells comprising recombinant polynucleotides include prokaryotic cells (e.g., bacteria, such as bacteria capable of transforming eukaryotic cells) or eukaryotic cells (e.g., plant cells, fungal cells, or animal cells such as insect cells). In certain embodiments, the cell is a bacterial cell capable of transforming a plant cell (e.g., Agrobacterium species, Sinorhizobium species (Sinorhizobium sp.), Mesorhizobium species (Mesorhizobium sp.), Bradyrhizobium species (Bradyrhizobium sp.), Rhizobium species (Rhizobium sp.), or Ensifer species (Ensifer sp.) cells). Bacterial cells capable of transforming plant cells suitable for use with the recombinant polynucleotides provided herein include Agrobacterium species, Sinorhizobium species, Mesorhizobium species, Bradyrhizobium species, Rhizobium species, or Xiphium species cells, which are disclosed in U.S. Patent Application Publications US20170369898 and US20180312854 (each of which is incorporated herein by reference in its entirety).

[0072] Also provided herein is a vector suitable for maintaining, propagating and / or expressing recombinant polynucleotides in the aforementioned prokaryotic or eukaryotic cells. Such a vector may include any of the aforementioned or otherwise disclosed recombinant polynucleotides, recombinant DNA molecules and recombinant RNA molecules and those polynucleotide molecules described in the examples. In some embodiments, the bacteria mediating plant transformation are Agrobacterium species, Sinorhizobium species, Mesorhizobium species, Bradyrhizobium species, Rhizobium species or Sword Pseudomonas species. In embodiments where Agrobacterium species are used, the vector includes a T-DNA (e.g., as described in U.S. Patent Application Publications US20170369898 and US20180312854, each incorporated herein by reference in its entirety) flanking a recombinant DNA molecule encoding a recombinant RNA molecule. In some embodiments, the vector is contained in a plant cell or a bacterial cell (Agrobacterium species, Sinorhizobium species, Mesorhizobium species, Bradyrhizobium species, Rhizobium species or Sword Pseudomonas species).

[0073] Also provided are viral particles comprising any of the foregoing or otherwise disclosed recombinant RNA molecules. In one embodiment, Figure 2The use of Agrobacterium-mediated transformation to infiltrate a host or production plant with a polynucleotide comprising (5' to 3'): (i) a promoter operably linked to a viral MP coding sequence and a TLS element flanked by a partiviral 5' and 3' replication element; (ii) a promoter operably linked to a cargo RNA molecule and a TLS element flanked by a partiviral 5' and 3' replication element; (iii) a promoter operably linked to a Rep (RDRP) coding sequence; and (iv) a promoter operably linked to a CP coding sequence. As described, heterologous promoters independently drive expression of capsid proteins and cargo. RNA expressed by the polynucleotide includes OAS. The host plant is transformed to produce synthetic partiviral satellite RNA and satellite particles containing encapsidated RNA. The expressed and encapsidated mesoviral satellite RNA is then isolated from the leaf material or other tissue of the host plant, purified (and if necessary formulated) for high pressure spraying onto plants endogenously containing the corresponding mesoviral or recombinantly derived PV RDRP for subsequent expression and replication of the mesoviral satellite RNA and satellite particles containing it in encapsidated form. In certain embodiments, the encapsidated satellite particles sprayed with certain cargo RNA molecules can be used to modify plants as desired. The presence of mobile proteins and t-RNA-like sequences facilitates systemic movement throughout plants that receive high pressure sprayed satellite particles containing the desired recombinant RNA molecules containing the encoded MP and cargo RNA. Figure 2 The protocols described in can be applied to any other embodiments disclosed herein. In certain embodiments, a plant that does not have a systemic mesovirus that provides a PV RDRP can further comprise a recombinant DNA or RNA molecule that encodes and provides a RDRP.

[0074] Target plants and plant cells used as hosts for synthetic somatic viral satellite RNAs (e.g., recombinant RNAs) provided herein include both monocots and dicots and plant cells that can support somatic viral replication, which can include row crops, fruit-producing plants and trees, vegetables, trees, and ornamental plants, including ornamental flowers, shrubs, trees, ground cover plants, and lawn grasses. In certain embodiments, target plants and plant cell hosts for synthetic somatic viral satellite RNAs include alfalfa, beets, Brassica species (e.g., canola), Cannabis species, carrots, citrus, clover, curry, dill, radish, figs, strawberry, hops, corn, melon, persimmon, peppers, Primula species, Sinapsis, spinach, tomatoes, and Vicia plants and plant cells. In certain embodiments, target plants and plant cells used as hosts for the synthetic, split viral satellite RNAs (e.g., recombinant RNAs) provided herein include alfalfa, beet, Brassica species (e.g., canola), Cannabis species, carrot, citrus, clover, curry, dill, radish, fig, strawberry, hop, corn, melon, persimmon, pepper, primula species, Sinapsis, spinach, tomato, and Vicia plants and plant cells. In certain embodiments, the dicot or plant cell is a member of the genus Brassica, Capsicum, Cucumis, Cucurbita, Hordeum, Cotton, Nicotiana, Solanum, or Glycine max.In certain embodiments, dicotyledonous target plants and plant cell hosts for synthetic split viral satellite RNA (e.g., recombinant RNA) include avocado (Persea americana), broad bean (Vicia faba), canola (Brassicana pus), calabash (Lagenaria siceraria), common bean (Phaseolus vulgaris), cotton (Gossypium hirsutum), cucumber (Cucumber (Cucumis sativus), guar (Cyamopsis tetragonoloba), Malabar spinach (Basella alba), melon (Cucumis melo), pepper (Capsicum frutescens), jalapeno (Capsicum frutescens), annuum), potato (Solanum tuberosum), pumpkin (Cucurbita pepo), soybean (Glycinemax), tomato (Solanum lycopersicum), wax gourd (Benincasahispida), winged bean (Psophocarpus tetragonolobus), and yerba mate (Ilex paraguariensis) plants and plant cells. In certain embodiments, the monocotyledonous plant or plant cell is a member of the genus Avena, Hordeum, Oryza, Secale, Triticum, Sorghum, or Zea. In certain embodiments, monocotyledonous target plants and plant cells used as hosts for the synthetic split viral satellite RNAs (e.g., recombinant RNAs) provided herein include oat (Avena sativa), barley (Hordeum vulgare), rice (Oryza sativa, Oryza rufipogon), rye (Secale cereale), wheat (Triticum aestivum), sorghum (sorghum, Sorghum bicolor), and corn (Zea mays) plants and plant cells.

[0075] Also provided are methods of using any of the foregoing or otherwise disclosed recombinant polynucleotides, expression systems, cells and / or vectors or methods of using any of the foregoing or otherwise disclosed recombinant polynucleotides, expression systems, cells and / or vectors for: (i) providing a synthetic split virus satellite RNA to a plant cell, (ii) obtaining a phenotypic change in a plant or plant cell; (ii) increasing plant resistance to a pest or pathogen, (iii) increasing plant resistance to stress, (iv) expressing a polypeptide in a plant or plant cell, and / or (v) producing a synthetic split virus viral particle. In certain embodiments of the methods, the recombinant RNA molecule or its formulation is provided by contacting a plant or plant cell with an RNA or its formulation. In other embodiments, the recombinant RNA molecule is provided by expressing a DNA molecule or formulation encoding the recombinant RNA molecule in a plant or plant cell. In other embodiments, the recombinant RNA molecule is provided by contacting a plant or plant cell with a cell comprising a DNA molecule encoding the recombinant RNA molecule and capable of transforming the plant or plant cell. In other embodiments, the recombinant RNA molecule is provided by contacting the plant or plant cell with a satellite particle or a formulation thereof containing an encapsidated recombinant RNA molecule. In an embodiment, the 5' RNA replication element has a nucleotide sequence obtained or derived from a genomic sequence of a solitary virus; and / or the 3' RNA replication element has a nucleotide sequence obtained or derived from a genomic sequence of a solitary virus. In certain embodiments, the plant cell contains a solitary virus, and the RDRP protein is provided to the plant cell by the solitary virus. In an embodiment, the solitary virus is specific to the plant cell. In an embodiment, the solitary virus specific to the plant cell is non-pathogenic and / or symbiotic to the plant cell. In other embodiments, the solitary virus is provided to the plant cell exogenously. In some embodiments, the RDRP protein is provided to the plant cell exogenously. In an embodiment, the recombinant RNA molecule is produced in a fermentation system. In an embodiment, the recombinant RNA molecule is provided to the plant cell by transcribing a recombinant DNA construct in a plant cell, the recombinant DNA construct comprising a promoter functional in the plant cell and operably connected to a DNA sequence encoding the recombinant RNA molecule. In an embodiment, the recombinant RNA molecule further comprises an encapsidation recognition element, and the plant cell further comprises a viral capsid protein capable of encapsidating the synthesized split viral satellite RNA. In an embodiment, the viral capsid protein is provided to the plant cell exogenously. In other embodiments, the recombinant DNA construct further comprises a DNA sequence encoding the viral capsid protein. In yet other embodiments, the recombinant DNA construct further comprises a second promoter that is functional in the plant cell and operably connected to the DNA sequence encoding the viral capsid protein. In an embodiment, the viral capsid protein is expressed in the plant cell and encapsidates the synthesized split viral satellite RNA.In yet other embodiments, the plant cell includes a split virus, and the split virus provides the plant cell with: (a) RDRP protein, (b) viral capsid protein, or (c) both RDRP protein and viral capsid protein. In certain embodiments, the method may further include the following first step: providing a plant population comprising plant cells, the plant cells comprising: (i) a split virus providing RDRP; or (ii) a recombinant polynucleotide molecule encoding RDRP; and then providing a recombinant RNA molecule to the plant comprising the plant cell. In certain embodiments, the method may further include the step of determining whether the plant cell comprises a split virus that can provide RDRP. In embodiments in which it is determined that the plant cell comprises a split virus that can provide RDRP, the split virus, RDRP protein, and / or the recombinant polynucleotide encoding RDRP are optionally not provided to the plant cell exogenously. In other embodiments in which it is determined that the plant cell does not comprise a split virus that can provide RDRP and the split virus is provided to the cell exogenously, the RDRP protein or the recombinant polynucleotide encoding RDRP is provided to the plant cell exogenously, or a combination of split viruses, RDRP proteins, or polynucleotides encoding RDRP is provided to the plant cell exogenously. In an embodiment, a complete self-replicating mereoviral satellite system is introduced into a plant or plant cell, wherein the self-replicating mereoviral satellite system comprises: (1) a recombinant mereoviral satellite RNA comprising, from the 5' end to the 3' end: (a) a 5' RNA replication element recognized by a mereoviral RNA-dependent RNA polymerase (RDRP); (b) a cargo RNA molecule; and (c) a 3' RNA replication element recognized by the RDRP; wherein the 5' RNA replication element, the cargo RNA molecule, and the 3' RNA replication element are operably linked, and wherein the promoter and the cargo RNA molecule are heterologous to the 5' RNA replication element and the 3' RNA replication element; and (2) an exogenous mereovirus (e.g., a mereovirus that is not unique or native to a plant or plant cell) that is capable of replicating in a plant or plant cell and that encodes a mereoviral RDRP that recognizes the 5' and 3' replicase recognition sequences in the recombinant mereoviral satellite RNA. In embodiments, the mereovirus RDRP comprises a protein having at least 85%, 90%, 95%, 97% or 99% sequence identity to SEQ ID NO: 272, 290-384 or 390. The presence or absence of the mereovirus in the target plant can be determined by an RNA detection assay (e.g., an RT-PCR assay) using nucleic acid probes and / or primers that can detect any portion of the mereovirus genome, including the 5' RNA replication element, the CP and / or RDRP coding region, and / or the 3' RNA replication element.Such probes and primers include probes and primers that detect any 5' or 3' RNA replication element shown in Table 1 or have significant sequence identity thereto (e.g., at least about 80%, 85%, 90%, 95%, 98% or 99% of a length of at least about 18, 20, 30, 40 or 50 nt). The presence of a mitogen-activated virus in a target plant can be determined by a protein detection assay (e.g., an immunoassay) for a PV CP or RDRP (e.g., a CP or RDRP encoded by a PV genome disclosed in Table 1 or a CP or RDRP homologous thereto). The target plants and plant cells used in the methods include all of the aforementioned target plants and plant cell hosts for synthetic mitogen-activated virus satellite RNAs (e.g., recombinant RNAs). In certain embodiments, target plants and plant cell hosts used in the methods include alfalfa, beet, Brassica (e.g., canola), cannabis, carrot, citrus, clover, curry, dill, radish, fig, strawberry, hops, corn, melon, persimmon, pepper, primula, sinica, spinach, tomato, and broad bean.

[0076] In certain embodiments of any of the foregoing or otherwise disclosed methods, the recombinant RNA achieves: (i) a phenotypic change in a plant or plant cell; (ii) increased resistance of a plant to a pest or pathogen; or (iii) increased resistance of a plant to stress, the recombinant RNA may include RNA that modulates target gene expression relative to target gene expression in a control plant or plant cell to which the recombinant RNA molecule is not provided, and the phenotypic change, increased resistance to a pest or pathogen, or increased resistance to stress is the result of modulation. In embodiments, the modulation is (a) an increase in target gene expression; or (b) a decrease in target gene expression. In some embodiments, expression of the target gene is increased by up to about 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, %, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 100% or more. In certain embodiments, expression of the target gene is increased by up to about 2-fold, 3-fold, 4-fold, 5-fold, 6-fold, 8-fold, 9-fold, 10-fold or more relative to a reference level (e.g., the level found in a control plant or plant cell lacking the recombinant RNA molecule).In some embodiments, the expression of the target gene is reduced by at least about 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, %, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 100% or more. In certain embodiments, the expression of the target gene is reduced by up to about 2-fold, 3-fold, 4-fold, 5-fold, 6-fold, 8-fold, 9-fold, 10-fold or more relative to a reference level (e.g., a level found in a control plant or plant cell lacking a recombinant RNA molecule). Regulation of target gene expression can be achieved by one or more of the RNAs used to modify the genome, epigenome, and / or transcriptome of a plant or plant cell. The RNA used to modify the genome can include a gRNA recognized by a CAS nuclease, an RNA encoding a TALEN or an artificial zinc finger protein (aZFN). The RNA used to modify the epigenome can include an RNA that provides RNA-guided DNA methylation, such as DNA methylation in the promoter region of a target gene (Matzke and Mosher (2014). doi: 10.1038 / nrg3683). The RNA used to modify the transcriptome can include hairpin RNA (hpRNA); RNA that forms multiple stem-loops; RNA pseudoknots; RNA molecules that form at least partially double-stranded RNA; small interfering RNA (siRNA) or siRNA precursors; microRNA (miRNA) or miRNA precursors; phased siRNA or phased siRNA precursors; ribozymes; ligand-responsive ribozymes (aptazymes); RNA aptamers; or long noncoding RNA (lncRNA).

[0077] In any of the foregoing or otherwise disclosed methods for obtaining or realizing phenotypic changes in plants or plant cells, cargo RNA molecules may be included in the plants or plant cells to realize phenotypic changes compared to plants or plant cells lacking recombinant RNA. In certain embodiments, the phenotypes of the changes include development rate, growth rate, size, yield (e.g., intrinsic yield), vigor, photosynthetic capacity, flavor, starch yield, protein content, carbohydrate content, oil content, fatty acid content, lipid content, digestibility, biomass, bud length, root length, root structure, fruiting rate, seed weight, seed quality (e.g., nutrients), germination rate, fruit setting rate, fruit maturity rate, biopolymer yield, fiber yield, biofuel yield, medicinal peptide yield, secretable peptide yield, enzyme yield, improved processing traits, or the amount of harvested products. In certain embodiments, the phenotypes of the changes include the taste, appearance, or shelf life of the products harvested from the plants. In other embodiments, the altered phenotype comprises flower size, flower color, flower pattern, flower morphology including the presence or absence of stamens, flower number, flower longevity, flower scent, leaf size, leaf color, leaf pattern, leaf morphology, plant height, or plant architecture.

[0078] In any of the foregoing or otherwise disclosed methods in which plant resistance to pests or pathogens is increased, the recombinant RNA may comprise RNA that inhibits gene expression of the pest or pathogen and / or inhibits genomic replication of the pest or pathogen. In certain embodiments, the pest or pathogen is selected from the group comprising bacteria, viruses other than mereoviruses, fungi, oomycetes, and invertebrates (e.g., arthropods or nematodes). Target viruses other than mereoviruses include: (i) positive-strand RNA viruses in the Bromoviridae, Closteroviridae, Flavoviridae, or Potyviridae; (ii) negative-strand RNA viruses in the Benyanviridae and Rhabdoviridae; (iii) dsDNA viruses in the Cauliflower Mosaic Viridae; and (iii) ssDNA viruses in the Conjoint Viridae. Target arthropod pests include insects of the orders Coleoptera and Lepidoptera. Target fungal pathogens include Magnaporthe spp., Botrytis spp., Puccinia spp.; Fusarium spp., Blumeria spp., Mycosphaerella spp., Colletotrichum spp., Ustilago spp., Melampsora spp., Phakopsora spp., Phytophthora spp., and Rhizoctonia spp. In an embodiment, the cargo RNA molecule achieves an increase in resistance of the plant to a pest or pathogen relative to a plant to which the recombinant RNA molecule is not provided.

[0079] In any of the foregoing or otherwise disclosed methods in which plant resistance to stress is increased, the recombinant RNA may include RNA targeting a plant gene that provides such resistance. In an embodiment, the RNA that achieves increased resistance to stress in a plant or plant cell includes RNA that regulates target gene expression relative to target gene expression in a control plant or plant cell that does not provide a recombinant RNA molecule, and wherein increasing stress resistance is the result of regulation. In an embodiment, regulation is (a) an increase in target gene expression; or (b) target gene expression is reduced. In still other embodiments, the RNA that achieves increased resistance to stress in a plant or plant cell includes a messenger RNA encoding a protein that confers stress resistance. In still other embodiments, the messenger RNA includes an RNA sequence that is not present in the transcriptome of a plant or plant cell lacking a recombinant RNA. In an embodiment, stress includes at least one abiotic stress selected from the group consisting of: nutrient stress, light stress, drought stress, heat stress, and cold stress. In other embodiments, the stress comprises at least one biotic stress selected from the group consisting of crowding, shading, and allelopathic effects (eg, caused by allelopathic chemicals including juglone produced by walnut trees).

[0080] In any of the foregoing or otherwise disclosed methods in which an exogenous polypeptide (e.g., an exogenous polypeptide) is expressed in a plant or plant cell, the cargo RNA can encode the exogenous polypeptide. In an embodiment, the polypeptide is separated (e.g., separated from at least one other cellular component (e.g., a carbohydrate, a lipid, or another protein)) or the polypeptide is purified.

[0081] In any of the foregoing or otherwise disclosed methods in which synthetic split viral satellite particles are produced, such production can occur in a cell-based system or a cell-free system. A cell-based method for producing synthetic split viral satellite particles can include: (a) providing the recombinant RNA molecule to a plant cell, wherein the recombinant RNA molecule comprises an encapsidation recognition element (ERE), and wherein the plant cell comprises a RDRP protein and a viral capsid protein, the RDRP protein recognizing the 5' RNA replication element and the 3' RNA replication element and catalyzing the synthesis of a synthetic split viral satellite RNA from the recombinant RNA molecule, wherein the ERE provides encapsidation of the RNA by the viral capsid protein; and optionally (b) isolating the synthetic split viral satellite particle from the plant cell, a plant comprising the plant cell, or from a culture medium in which the plant cell or the plant is grown. Cell-free methods for making synthetic split viral satellite particles include methods in which a recombinant RNA molecule is combined with a viral capsid protein in a container, wherein the recombinant RNA molecule comprises an encapsidation recognition element (ERE), and wherein the ERE provides encapsidation of the RNA by the viral capsid protein in the container; optionally wherein the method further comprises separating the synthetic split viral satellite particles from the uncombined RNA and / or viral capsid protein in the container. In certain embodiments of cell-based or cell-free methods, the synthetic satellite particles are isolated (e.g., separated from at least one other cellular component (e.g., an organelle, a membrane, a carbohydrate, a lipid, or another protein)) or purified. In certain embodiments, the method may further comprise formulating the synthetic split viral satellite particles.

[0082] Also provided are synthetic, split viral satellite particles comprising recombinant RNA, including those prepared by the aforementioned methods. Also provided are methods of providing any of the aforementioned synthetic split viral satellite particles to a plant, the method comprising contacting the plant with the synthetic split viral satellite particle or a formulation thereof (e.g., spraying, dusting, injecting, soaking, etc.).

[0083] The recombinant polynucleotides described herein, cells containing the same, and synthetic split viral satellite particles can be formulated in pure form (e.g., the composition contains only the recombinant polynucleotide) or formulated with one or more additional formulation components to facilitate the application or delivery of the composition. In embodiments, additional formulation components include, for example, carriers (i.e., components that have an active role in delivering the active agent (e.g., recombinant polynucleotide); for example, the carrier can encapsulate, covalently or non-covalently modify the active agent or otherwise associate with the active agent in a manner that improves the delivery of the active agent) or excipients (e.g., delivery vehicles, adjuvants, diluents, surfactants, stabilizers, or tonicity agents). In some embodiments, the composition is formulated for delivery to a plant.

[0084] In some aspects, the disclosure provides a formulation comprising any of the compositions described herein. In some embodiments, the formulation is a liquid, a gel, or a powder. In some embodiments, the formulation is configured to be sprayed on a plant, injected into a plant (e.g., the vascular system of a plant), rubbed on a leaf, soaked in a plant, coated on a plant, or coated on a seed, or delivered by root uptake (e.g., in a hydroponic system or through soil).

[0085] Depend on the purpose of expectation and environment at that time, composition can be formulated as emulsifiable concentrate, suspension concentrate, solution that can directly spray or dilutable solution, paste that can be coated, dilute emulsion, spray powder, soluble powder, dispersible powder, wettable powder, dust, granule, encapsulation in polymeric substance, microcapsule, foam, aerosol, carbon dioxide gas preparation, tablet, resin preparation, paper preparation, nonwoven fabric preparation or knitted fabric preparation or woven fabric preparation.In some cases, composition is liquid.In some cases, composition is solid.In some cases, composition is aerosol, as in pressurized aerosol can.

[0086] In some cases, the recombinant polynucleotides account for about 0.1% to about 100% of the composition, such as any of the following: about 0.01% to about 100%, about 1% to about 99.9%, about 0.1% to about 10%, about 1% to about 25%, about 10% to about 50%, about 50% to about 99%, or about 0.1% to about 90% of the active ingredient (e.g., recombinant polynucleotides). In some cases, the composition comprises at least any one of 0.1%, 0.5%, 1%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95% or more of the active ingredient (e.g., recombinant polynucleotides). In some cases, concentrates are preferred as commercial products, and end users typically use dilute medicaments (active ingredients with significantly lower concentrations).

[0087] In some embodiments, the composition is formulated for topical delivery to plants. In some embodiments, topical delivery is spraying, leaf rubbing, soaking, coating (e.g., using microparticles or nanoparticles for coating), or delivery by root uptake (e.g., delivery in a hydroponic system).

[0088] In some embodiments, the composition further comprises a carrier and / or an excipient. In other embodiments, the composition does not comprise a carrier or an excipient, for example, comprises naked polynucleotides (e.g., naked RNA).

[0089] In some embodiments, the recombinant polynucleotide is delivered at a concentration of at least 0.1 grams per acre, such as at least 0.1, 1, 2, 5, 10, 15, 20, 25, 30, 35, 40, 45, or 50 grams per acre. In some embodiments, less than 120 liters are delivered per acre, such as less than 110, 100, 90, 80, 70, 60, 50, 40, 30, 20, 15, 10, 5, or 2 liters per acre or less than 1 liter per acre.

[0090] In some aspects, formulations include carriers. In certain embodiments, formulations are emulsions or inverse emulsions, liquids or gels. In embodiments, formulations include carriers (e.g., solid or semisolid surfaces or substrates, powders, or particles or nanoparticles) used as physical supports. In embodiments, active agents are encapsulated or encapsulated in or attached to or compounded in carriers, including liposomes, vesicles, micelles or other fluid compartments. In embodiments, active agents are encapsulated or encapsulated in or attached to or compounded in carriers, and carriers include naturally occurring or synthetic, branched or linear polymers (e.g., pectin, agarose, chitin, chitosan, DEAE-dextran, polyvinylpyrrolidone ("PVP") or polyethyleneimine ("PEI")). In embodiments, carriers include cations or cationic charges, such as cationic liposomes or cationic polymers such as polyamines (e.g., spermine, spermidine, putrescine). In embodiments, the carrier comprises a polypeptide, such as an enzyme (eg, cellulase, pectolyase, maceroenzyme, pectinase), a cell penetrating peptide, or a pore-forming peptide (eg, a polylysine, polyarginine, or polyhomoarginine peptide).

[0091] Non-limiting examples of carriers include cationic liposomes and polymer nanoparticles reviewed in Zhang et al. (2007) J. Controlled Release, 123: 1-10, and cross-linked multilamellar liposomes described in U.S. Patent Application Publication 2014 / 0356414A1, which is incorporated herein by reference in its entirety. In an embodiment, the carrier includes a nanomaterial, such as carbon or silica nanoparticles, carbon nanotubes, carbon nanofibers, or carbon quantum dots. Non-limiting examples of carriers include particles or nanoparticles of various size ranges and shapes (e.g., particles or nanoparticles made of materials such as carbon, silicon, silicon carbide, gold, tungsten, polymers, or ceramics), magnetic particles or nanoparticles (e.g., silence Magnetotransfection TM reagents, OZ Bioscience (San Diego, CA), abrasives or scratching agents, needles or microneedles, matrices, and grids.

[0092] In certain embodiments, microparticles and nanoparticles can be used to deliver polynucleotide compositions or nucleases or both. Useful microparticles and nanoparticles include those prepared from metals (e.g., gold, silver, tungsten, iron, cerium), ceramics (e.g., aluminum oxide, silicon carbide, silicon nitride, tungsten carbide), polymers (e.g., polystyrene, polydiacetylene, and poly(3,4-ethylenedioxythiophene) hydrate), semiconductors (e.g., quantum dots), silicon (e.g., silicon carbide), carbon (e.g., graphite, graphene, graphene oxide, or carbon nanosheets, nanocomposites, or nanotubes), and composites (e.g., polyvinylcarbazole / graphene, polystyrene / graphene, platinum / graphene, palladium / graphene nanocomposites). In certain embodiments, such microparticles and nanoparticles are further covalently or non-covalently functionalized, or further include modifiers or cross-linking materials, such as polymers (e.g., linear or branched polyethyleneimine, polylysine), polynucleotides (e.g., DNA or RNA), polysaccharides, lipids, polyglycols (e.g., polyethylene glycol, thiolated polyethylene glycol), polypeptides or proteins, and detectable labels (e.g., fluorophores, antigens, antibodies, or quantum dots). In various embodiments, such microparticles and nanoparticles are neutral, positively charged, or negatively charged.

[0093] Embodiments of compositions comprising microparticles include those formulated as, for example, liquids, colloids, dispersions, suspensions, aerosols, gels, and solids. Embodiments include nanoparticles fixed to a surface or support, for example, vertically aligned carbon nanotube arrays on a silicon or copper wafer substrate. Embodiments include polynucleotide compositions comprising microparticles (e.g., gold or tungsten or magnetic particles) delivered by biolistic type techniques or using magnetic forces. The particle sizes used in biolistics are typically in the "microparticle" range, for example, gold microcarriers in the 0.6, 1.0, and 1.6 micron size range (see, e.g., Manual for the Gene Gun System, Bio-Rad, Hercules, CA; Randolph-Anderson et al. (2015) “Submicron gold particles are superior to larger particles for efficient Submicron gold particles outperform larger particles and are effective for transformation of organelles and some cell types Transformation]", Bio-Rad US / EG Report 2015), but successful biolistic delivery has been reported using larger (40-48-nm) nanoparticles in cultured animal cells; see O'Brian and Lummis (2011) BMC Biotechnol. [BMC Biotechnology], 11: 66-71.

[0094] Other examples of useful particles are nanoparticles, which are generally in the nanometer (nm) size range or less than 1 micron, for example, having a diameter less than about 1 nm, less than about 3 nm, less than about 5 nm, less than about 10 nm, less than about 20 nm, less than about 40 nm, less than about 60 nm, less than about 80 nm, and less than about 100 nm. Specific, non-limiting examples of commercially available nanoparticles (all from Sigma-Aldrich Corp., St. Louis, MO) include gold nanoparticles having a diameter of 5, 10, or 15 nm; silver nanoparticles having a particle size of 10, 20, 40, 60, or 100 nm; palladium "nanopowders" having a particle size of less than 25 nm; single-walled, double-walled, and multi-walled carbon nanotubes, e.g., having a diameter of 0.7-1.1, 1.3-2.3, 0.7-0.9, or 0.7-1.3 nm, or nanotube bundles having a size of 2-10 nm x 1-5 microns, 6-9 nm x 5 microns, 7-15 nm x 0.5-10 microns, 7-12 nm x 0.5-10 microns, 110-170 nm x 5-9 microns, 6-13 nm x 2.5-20 microns. Embodiments include polynucleotide compositions comprising materials such as gold, silicon, cerium or carbon (e.g., gold or gold-coated nanoparticles), silicon carbide whiskers, corundum, porous silica nanoparticles, gelatin / silicon dioxide nanoparticles, cerium dioxide nanoparticles (nanoceria) or cerium oxide nanoparticles (CNPs), carbon nanotubes (CNTs) (e.g., single-, double- or multi-walled carbon nanotubes and chemically functionalized forms thereof (e.g., carbon nanotubes functionalized with amide, amino, carboxylic acid, sulfonic acid or polyethylene glycol moieties)), and graphene or graphene oxide or graphene composites; see, e.g., Wong et al. (2016) Nano Lett., 16:1161-1172; Giraldo et al. (2014) Nature Materials, 13:400-409; Shen et al. (2012) Theranostics, 2:283-294; Kim et al. (2011) Bioconjugate Chem. [Bioconjugate Chemistry], 22: 2558-2567; Wang et al. (2010) J. Am. Chem. Soc. Comm. [Journal of the American Chemical Society Communications], 132: 9274-9276; Zhao et al. (2016) Nanoscale Res. Lett. [Nanoscale Research Letters], 11: 195-203; and Choi et al. (2016) J. Controlled Release [Journal of Controlled Release], 235: 222-235.See also, for example, various types of particles and nanoparticles, their preparation and methods of use thereof (e.g., in delivering polynucleotides and polypeptides to cells) disclosed in U.S. Patent Application Publications 2010 / 0311168, 2012 / 0023619, 2012 / 0244569, 2013 / 0145488, 2013 / 0185823, 2014 / 0096284, 2015 / 0040268, 2015 / 0047074 and 2015 / 0208663, all of which are incorporated herein by reference in their entirety.

[0095] In some aspects, the composition includes an excipient, such as a delivery vehicle, an adjuvant, a diluent, a surfactant, a stabilizer or a tension agent or a combination thereof. In certain embodiments, the excipient is a crop oil concentrate, a vegetable oil concentrate, a modified vegetable oil, a nitrogen source, a deposition (drift control) and / or a retention aid (with or without ammonium sulfate and / or a defoamer), a compatibility agent, a buffer and / or an acidulant, a water regulator, an alkaline mixture, a sticking agent and / or an extender, an adjuvant plus foliar fertilizer, a defoamer, a foam marker, an odorant or a tank cleaner and / or a neutralizer. In certain embodiments, the excipient is an adjuvant described in Compendium of Herbicide Adjuvants [herbicide adjuvant compendium] (Young et al. (2016). Compendium of Herbicide Adjuvants [herbicide adjuvant compendium] (13th edition), Purdue University [Purdue University]).

[0096] The example of delivery vehicle and diluent includes but is not limited to: lactose, dextrose, sucrose, sorbitol, mannitol, starch, gum arabic, calcium phosphate, alginate, tragacanth, gelatin, calcium silicate, microcrystalline cellulose, polyvinyl pyrrolidone, cellulose, water, saline solution, syrup, methylcellulose, methyl hydroxybenzoate and propyl hydroxybenzoate, talc, magnesium stearate and mineral oil. Other examples of delivery vehicle include but are not limited to: solid or liquid excipient material, solvent, stabilizer, sustained release excipient, pigment and surfactant (surfactant). In some cases, excipient (for example, delivery vehicle) is a stabilizing vehicle. In an embodiment, stabilizing vehicle includes, for example, epoxidized vegetable oil, defoamer (for example silicone oil), preservative, viscosity modifier, adhesive or tackifier. In some cases, stabilizing vehicle is a buffer suitable for recombinant polynucleotides. In some cases, the composition microcapsule is encapsulated in a polymer bead delivery vehicle. In some cases, the stabilizing agent protects the recombinant polynucleotide from UV and / or acidic conditions. In some cases, the delivery vehicle contains a pH buffer. In some cases, the composition is formulated to have a pH in the range of about 4.5 to about 9.0, including, for example, a pH in the range of 5.0 to about 8.0, about 6.5 to about 7.5, or about 6.5 to about 7.0.

[0097] In some cases, compositions provided herein include adjuvants. An adjuvant is an agent that does not have polynucleotide activity but imparts beneficial properties to a formulation. For example, an adjuvant is premixed in a formulation or added to a spray tank to improve mixing or improve application or enhance performance. They are widely used in products designed for leaf application. Adjuvants can be used to customize formulations for specific needs and compensate for local conditions. Adjuvants can be designed to perform specific functions, including wetting, smearing, adhesion, reduced evaporation, reduced volatility, buffering, emulsification, dispersion, reduced spray drift, and reduced foaming. No single adjuvant can perform all of these functions, but compatible adjuvants can usually be combined to perform multiple functions simultaneously.

[0098] Non-limiting examples of adjuvants included in the formulation are: binders, dispersants and stabilizers, in particular, for example, casein, gelatin, polysaccharides (e.g., starch, gum arabic, cellulose derivatives, alginic acid, etc.), lignin derivatives, bentonite, sugars, synthetic water-soluble polymers (e.g., polyvinyl alcohol, polyvinyl pyrrolidone, polyacrylic acid, etc.), PAP (acid isopropyl phosphate), BHT (2,6-di-tert-butyl-4-methylphenol), BHA (a mixture of 2-tert-butyl-4-methoxyphenol and 3-tert-butyl-4-methoxyphenol), vegetable oils, mineral oils, fatty acids and fatty acid esters.

[0099] In an embodiment, the composition provided herein is a liquid formulation. Liquid formulations are usually mixed with water, but in some cases are used as excipients with crop oils, diesel fuel, kerosene or other light oils. The amount of active ingredient (e.g., recombinant polynucleotide) generally ranges from about 0.5% to about 80% by weight.

[0100] In an embodiment, an emulsifiable concentrate formulation contains a liquid active ingredient, one or more petroleum-based solvents, and a medicament that allows the formulation to be mixed with water to form an emulsion. Such concentrates can be used for agriculture, ornamental plants and lawns, forestry, construction, food processing, animal husbandry, and public health pest formulations. In an embodiment, these can be applied to application equipment from small portable sprayers to hydraulic sprayers, small-capacity ground sprayers, misters, and small-capacity aircraft sprayers. Some active ingredients are soluble in liquid excipients. When mixed with excipients, they form solutions that will not precipitate or separate, such as homogeneous solutions. In an embodiment, these types of formulations include active ingredients, carriers and / or excipients, and one or more other ingredients. The solution can be used for indoor and outdoor sprayers of any type.

[0101] In some cases, the composition is formulated as an invert emulsion. An invert emulsion is a water-soluble active ingredient dispersed in an oil excipient. Invert emulsions require an emulsifier that allows the active ingredient to be mixed with a large amount of petroleum-based excipients (usually fuel oil). Invert emulsions help reduce drift. For other formulations, some spray drift occurs when water droplets begin to evaporate before reaching the target surface; as a result, the droplets become very small and lightweight. Since oil evaporates more slowly than water, invert emulsion droplets shrink less and more active ingredients reach the target. Oil further helps reduce runoff and improve rain resistance. It also acts as a spreader by improving surface coverage and absorption. Because the droplets are relatively large and heavy, it is difficult to thoroughly cover the underside of the leaf. Invert emulsions, which are most often used along rights-of-way (where drift to susceptible non-target areas), can be a problem.

[0102] Flowable or liquid formulations combine many features of emulsifiable concentrates and wettable powders. Manufacturers use these formulations when the active ingredient is a solid that is not soluble in water or oil. The active ingredient, which is impregnated on a substance such as clay, is ground into a very fine powder. The powder is then suspended in a small amount of liquid. The resulting liquid product is very thick. Flowables and liquids have many features of emulsifiable concentrates, and they have similar disadvantages. They require moderate agitation to keep them suspended and leave visible residues, similar to those in wettable powders.

[0103] Flowables / liquids are easy to handle and apply. Because they are liquids, they are subject to spills and splashes. They contain solid particles, thus causing wear and tear on nozzles and pumps. Flowables and liquid suspensions settle in their containers. Because flowables and liquid formulations tend to settle, packaging in containers of five gallons or less makes remixing easier.

[0104] Aerosol formulations contain one or more active ingredients and a solvent. Most aerosols contain a low percentage of active ingredient. There are two types of aerosol formulations - ready-to-use types that are usually available in pressurized sealed containers, and those products that are used in electric or gasoline powered aerosol generators (which release the formulation as smoke or mist).

[0105] Ready-to-use aerosol formulations are typically small, self-contained units that release the formulation when the nozzle valve is triggered. The formulation is driven through a fine orifice by an inert gas under pressure, producing fine droplets. These products are used in greenhouses, small areas within buildings, or small outdoor areas. Commercial models with five to 5 pounds of active ingredient are usually refillable.

[0106] Smoke or mist aerosol formulations are not under pressure. They are used in machines that use rapidly spinning disks or heated surfaces to break up liquid formulations into a fine mist or fog (aerosol).

[0107] In some embodiments, the composition comprises a liquid excipient. In embodiments, the liquid excipient includes, for example, aromatic or aliphatic hydrocarbons (e.g., xylene, toluene, alkylnaphthalene, phenylxylene ethane, kerosene, gas oil, hexane, cyclohexane, etc.), halogenated hydrocarbons (e.g., chlorobenzene, dichloromethane, dichloroethane, trichloroethane, etc.), alcohols (e.g., methanol, ethanol, isopropanol, butanol, hexanol, benzyl alcohol, ethylene glycol, etc.), ethers (e.g., ethyl ether, ethylene glycol dimethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, propylene glycol monomethyl ether, tetrahydrofuran, dioxane, etc.), esters (e.g., For example, ethyl acetate, butyl acetate, etc.), ketones (for example, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, etc.), nitriles (for example, acetonitrile, isobutyronitrile, etc.), sulfoxides (for example, dimethyl sulfoxide, etc.), amides (for example, N,N-dimethylformamide, N,N-dimethylacetamide), cyclic imines (for example, N-methylpyrrolidone), alkylene carbonates (for example, propylene carbonate, etc.), vegetable oils (for example, soybean oil, cottonseed oil, etc.), plant essential oils (for example, orange oil, hyssop oil, lemon oil, etc.), or water.

[0108] In some embodiments, the composition comprises a gaseous excipient. Gaseous excipients include, for example, butane gas, freon gas, liquefied petroleum gas (LPG), dimethyl ether and carbon dioxide gas.

[0109] In some embodiments, the composition is provided as a dry formulation. Dry formulations can be divided into two types: ready-to-use and concentrates that must be mixed with water to be applied as a spray. Most dust formulations are ready to use and contain a low percentage of active ingredient (less than about 10% by weight) plus very fine dry inert excipients (e.g., talc, chalk, clay, nut shells, or volcanic ash). The size of individual dust particles varies. Some dust formulations are concentrates and contain a high percentage of active ingredient. In some embodiments, these dust formulations are mixed with dry inert excipients prior to application. In some embodiments, dusts are used dry and can easily drift to non-target sites.

[0110] In some cases, the composition is formulated as a dust. In some cases, the composition is formulated as a wettable powder. Wettable powders are dry, finely ground formulations that look like dusts. They usually have to be mixed with water for application as a spray. However, some products can be applied as dusts or wettable powders - the choice depends on the application device. Wettable powders contain from about 1% to about 95% active ingredient by weight; in some cases more than about 50%. These particles are insoluble in water. They settle quickly unless they are frequently stirred to keep them suspended. They can be used for most pest problems and can also be used in most spray equipment that can be stirred. Wettable powders have excellent residual activity. Due to their physical properties, most formulations remain on the surface of treated porous materials (such as concrete), gypsum, and untreated wood. In such cases, only water penetrates the material.

[0111] In some cases, the composition is formulated as a soluble powder. Soluble powder formulations look like wettable powders. However, when mixed with water, soluble powders dissolve easily and form true solutions. After they are thoroughly mixed, no additional stirring is required. The amount of active ingredient in soluble powders ranges from about 15% to about 95% by weight; in some cases more than about 50%. Soluble powders have all the advantages of wettable powders and none of the disadvantages of wettable powders except for the inhalation hazard during mixing.

[0112] In some cases, the composition is formulated as water dispersible granules. Water dispersible granules, also known as dry flowables, are like wettable powders (except that they are not dust-like) in that they are formulated as small, easily measured granules. Water dispersible granules must be mixed with water before they can be applied. Once in the water, the granules break down into fine particles similar to wettable powders. The formulation requires constant stirring to keep it suspended in the water. The percentage of active ingredient is high, usually up to 90% by weight. Water dispersible granules (except that they are easier to measure and mix) have many of the same advantages and disadvantages as wettable powders. Because there is less dust, there is less inhalation hazard to coating equipment during handling.

[0113] In some embodiments, the composition comprises a solid excipient. Solid excipients include fine powders or granules of clays (e.g., kaolin, diatomaceous earth, bentonite, Fubasami clay, acid clay, etc.), synthetic hydrated silica, talc, ceramics, other inorganic minerals (e.g., sericite, quartz, sulfur, activated carbon, calcium carbonate, hydrated silica, etc.), substances that can sublime and are in solid form at room temperature (e.g., 2,4,6-triisopropyl-1,3,5-trioxane, naphthalene, p-dichlorobenzene, camphor, adamantane, etc.); wool; silk; cotton; hemp; pulp; synthetic resins (e.g., polyethylene resins such as low-density polyethylene, straight low-density polyethylene, and high-density polyethylene; ethylene-vinyl ester copolymers such as ethylene-vinyl acetate copolymers; ethylene-methacrylate copolymers such as ethylene-methyl methacrylate copolymers and ethylene-ethyl methacrylate copolymers; ethylene-acrylate copolymers such as ethylene-methyl acrylate copolymers and ethylene-ethyl acrylate copolymers; ethylene-vinyl carboxylic acid copolymers such as ethylene-acrylic acid copolymers; ethylene polypropylene resins, such as propylene homopolymers and propylene-ethylene copolymers; poly-4-methylpentene-1, polybutene-1, polybutadiene, polystyrene; acrylonitrile-styrene resins; styrene elastomers, such as acrylonitrile-butadiene-styrene resins, styrene-conjugated diene block copolymers, and styrene-conjugated diene block copolymer hydrogenates; fluororesins; acrylic resins, such as poly(methyl methacrylate); polyamide resins, such as nylon 6 and nylon 66; polyester resins, such as polyethylene terephthalate; dicarboxylic acid esters, polyethylene naphthalate, polybutylene terephthalate, and polycyclohexylene dimethylene terephthalate; polycarbonate, polyacetal, polyacryl sulfone, polyarylate, polyacrylate, hydroxybenzoic acid polyester, polyetherimide, polyester carbonate, polyphenylene ether resin, polyvinyl chloride, polyvinylidene chloride, polyurethane, and porous resin (such as foamed polyurethane, foamed polypropylene, or foamed ethylene, etc.), glass, metal, ceramic, fiber, cloth, knitted fabric, sheet, paper, yarn, foam, porous material and multifilament.

[0114] In some cases, the composition is provided in a microencapsulated formulation (e.g., nanocapsules). The microencapsulated formulation is mixed with water and sprayed in the same manner as other sprayable formulations. After spraying, the plastic coating ruptures and slowly releases the active ingredient.

[0115] In some cases, the composition is provided in the form of liposomes. In some cases, the composition is provided in a vesicle.

[0116] In some cases, compositions provided herein include surfactants. Surfactants, also referred to as wetting agents and coating agents, physically change the surface tension of spray droplets. In order for the formulation to function properly, the spray droplets must be able to wet the leaves and evenly spread on the leaves. Surfactants expand the coverage area of ​​the formulation, thereby increasing exposure to the active agent. Surfactants are particularly important when the formulation is applied to waxy or hairy leaves. Without proper wetting and coating, the spray droplets will usually run off or fail to fully cover the leaf surface. However, too much surfactant can cause excessive runoff and reduce efficacy.

[0117] Surfactants are classified by the way they ionize or break apart into charged atoms or molecules called ions. Surfactants with a negative charge are anionic. Surfactants with a positive charge are cationic, while surfactants without a charge are nonionic. The activity of a formulation in the presence of a nonionic surfactant can be completely different from the activity in the presence of a cationic or anionic surfactant. Choosing the wrong surfactant can reduce the efficacy of the product and harm the target plant. Anionic surfactants are most effective when used with contact pesticides (pesticides that control pests through direct contact rather than systemic absorption). Cationic surfactants should never be used as stand-alone surfactants because they are often phytotoxic.

[0118] The nonionic surfactants commonly used with systemic pesticides help the spray penetrate the plant cuticle. Nonionic surfactants are compatible with most pesticides, and most EPA-registered pesticides that require surfactants recommend the use of nonionic types. Adjuvants include, but are not limited to, tackifiers, extenders, plant penetrants, compatibilizers, buffers or pH modifiers, drift control additives, defoamers, and thickeners.

[0119] Non-limiting examples of surfactants included in the compositions described herein include alkyl sulfates, alkyl sulfonates, alkyl aryl sulfonates, alkyl aryl ethers and polyoxyethylene products thereof, polyethylene glycol ethers, polyol esters and sugar alcohol derivatives. In some embodiments, the surfactant is a nonionic surfactant, a surfactant plus nitrogen source, a silicone surfactant or a high surfactant oil concentrate.

[0120] In formulations and use forms prepared from these formulations, in embodiments, the recombinant polynucleotides may be in a mixture containing other active compounds, such as pesticides (e.g., insecticides, bactericides, miticides, nematicides, molluscicides or fungicides, attractants, growth regulators or herbicides). As used herein, the term "pesticide" refers to any substance or mixture of substances intended for use in preventing, destroying, resisting or mitigating any harmful organism. A pesticide may be a chemical or biological agent used to combat harmful organisms, including insects, mollusks, pathogens, weeds, nematodes, and microorganisms that compete with humans for food, destroy property, spread disease, or are annoying. The term "pesticide" further encompasses other biologically active molecules, such as antibiotics, antiviral pesticides, antifungals, anthelmintics, nutrients, pollen, sucrose and / or agents that weaken or slow insect movement.

[0121] In the case of applying the recombinant polynucleotide to plants, a mixture containing other known compounds (eg, herbicides, fertilizers, growth regulators, safeners, semiochemicals) or agents for improving plant properties may also be used.

[0122] On the other hand, the present disclosure relates to a method for producing a modified plant propagule, the modified plant propagule comprising at least one plant cell containing a recombinant RNA molecule. The method generally comprises the following steps: separating a plant propagule comprising at least one plant cell containing the recombinant RNA molecule and a somatic virus RNA-dependent RNA polymerase (RDRP) from a mixed population of plant cells comprising plant cells containing the recombinant RNA molecule and plant cells lacking the recombinant RNA molecule, wherein the recombinant RNA molecule comprises a 5' replication element capable of being recognized by the somatic virus RDRP in the order of 5' to 3'; a cargo RNA sequence; and a 3' replication element capable of being recognized by the somatic virus RDRP. In certain embodiments, the isolated plant propagule comprising at least one plant cell containing the recombinant RNA molecule will not contain or substantially contain plant cells lacking recombinant RNA. In certain embodiments, such isolated plant propagules substantially free of plant cells lacking recombinant RNA may include plant propagules in which at least 75%, 80%, 85%, 90%, 95%, 98% or 99% of the plant cells in the plant propagule contain recombinant DNA molecules. In an embodiment, a plant cell mixed population comprises a population of cells in a protoplast population or callus, explant, plant part or whole plant. In an embodiment, a plant cell mixed population may comprise such a plant cell population, wherein less than 70%, 60%, 50%, 40%, 30%, 20%, 10%, 5% or 1% of the plant cells in the population contain recombinant RNA molecules. In certain embodiments, a plant cell mixed population comprises a plant cell containing a somatic virus RDRP and a plant cell lacking a somatic virus RDRP. In certain embodiments, a plant cell lacking a somatic virus RDRP will also lack recombinant RNA. In other embodiments, a plant cell mixed population comprises a plant cell containing a somatic virus RDRP. In certain embodiments, a plant cell comprising a somatic virus RDRP may further comprise recombinant RNA. In certain embodiments, a cargo RNA sequence comprises an RNA encoding a selectable or scoreable marker. In an embodiment, a plant cell mixed population is screened or selected for the presence of a plant cell comprising a recombinant RNA molecule before separating plant propagules. In such screening, a mixed cell population or a portion thereof is subjected to a determination of a screenable marker for the presence of a recombinant RNA molecule (e.g., an RNA sequence that diagnoses the presence of a recombinant RNA molecule or a polypeptide encoded by the recombinant RNA molecule) and separated from plant cells lacking the recombinant RNA molecule. In certain embodiments, separation includes selecting plant cells that contain the recombinant RNA molecule before separating plant propagules.In the case where the recombinant RNA encodes a selectable marker (e.g., a protein that confers resistance to a selection agent such as a herbicide or antibiotic), examples of such selection can include exposing a mixed population of plant cells to a selection agent (e.g., a herbicide or antibiotic) and isolating plant cells that survive the exposure to the selection agent. Examples of selectable marker / selective agent combinations include glyphosate-resistant EPSPS enzymes and / or glyphosate oxidase / glyphosate, bialaphos resistance (bar) or glufosinate acyltransferase (pat) enzymes / phosphinothricin ammonium, or neomycin phosphotransferase (npt) / neomycin or kanamycin. In certain embodiments, the selectable or scorable marker is an RNA aptamer (e.g., a cauliflower aptamer) or a regulatory RNA (e.g., siRNA, siRNA precursor, miRNA, or miRNA precursor, or staged siRNA or staged siRNA precursor that downregulates the expression of endogenous genes in plants, thereby producing a detectable phenotype, e.g., bleaching caused by downregulation of pigment production genes). In an embodiment, the mixed population is located in a plant or plant part. In certain embodiments, before separating plant propagules, screen or select whether there is recombinant RNA molecule in plant or plant part.In other embodiments, before separating plant propagules, screen or select whether plant or plant part has systemic recombinant RNA molecule.In certain embodiments, plant cell, plant or plant part in mixed population or separation lacks DNA encoding recombinant RNA molecule.In an embodiment, plant propagules comprising recombinant RNA molecule are separated by: detecting RNA molecule in one or more plant cells comprising the recombinant RNA molecule, and separating one or more plant cells comprising the recombinant RNA molecule from plant cells lacking the recombinant DNA molecule.In certain embodiments, plant propagules are chimeras comprising plant cells containing recombinant RNA molecule and plant cells lacking recombinant RNA molecule.In other embodiments, modified plant propagules are chimeras comprising plant cells containing split virus RDRP and plant cells lacking split virus RDRP. In certain embodiments, at least 99%, 98%, 95%, 90%, 85%, 80%, 70%, 60%, 50%, 40%, 30%, 20%, 10%, 5% or 1% plant cells in the chimera can include recombinant RNA molecules. In certain embodiments particularly advantageous at least for regulatory reasons, plant propagules lack the DNA encoding recombinant RNA molecules. In an embodiment, modified plant propagules include cells containing recombinant RNA molecules, or include seeds, seedlings, ovules, embryos, pollen, roots, stems, leaves, buds, tubers, rhizomes, runners, bulbs, explants or callus containing cells containing recombinant RNA molecules. Plant propagules prepared by any of the aforementioned methods and / or in combination with any of the aforementioned features are also provided herein.

[0123] In certain embodiments, any of the aforementioned methods may further include propagation cells, seeds, seedlings, ovules, embryos, pollen, roots, stems, leaves, buds, tubers, rhizomes, runners, bulbs, explants or callus to obtain progeny, wherein the progeny includes recombinant RNA molecules. In other embodiments, the propagation of cells is composed of: cultivate multiple explants obtained from the cells, seeds, seedlings, ovules, embryos, pollen, roots, stems, leaves, buds, tubers, rhizomes, runners, bulbs, explants or callus. In other embodiments again, the propagator of separation includes cells, and the aforementioned methods may further include plants, seedlings, ovules, embryos, pollen, roots, stems, leaves, buds, tubers, rhizomes, runners, bulbs, explants or callus that include recombinant RNA from the cell regeneration. In still other embodiments, the isolated propagule comprises callus, and the aforementioned method may further comprise regenerating a plant, seedling, ovule, embryo, pollen, root, stem, leaf, bud, tuber, rhizome, runner, bulb, or explant comprising the recombinant RNA from the callus. In an embodiment, a plant is regenerated, and the aforementioned method may further comprise reclaiming an F1 seed or F1 progeny or clonal progeny comprising the recombinant RNA from the plant.

[0124] On the other hand, the present disclosure relates to a method for providing a synthetic somatic viral satellite RNA to a plant or plant part by grafting one plant part to another plant part. In certain embodiments, the method may include grafting a scion onto a stock, the stock comprising a recombinant DNA molecule and / or a recombinant RNA molecule (e.g., a recombinant RNA, which comprises a 5' replication element capable of being recognized by a somatic viral RNA-dependent RNA polymerase (RDRP) in a 5' to 3' order; a cargo RNA sequence; and a 3' replication element capable of being recognized by a somatic viral RDRP), wherein at least one cell of the stock and / or scion comprises a somatic viral RDRP. In certain embodiments, the scion may include a plant bud, an apex or other meristem, a leaf attached to a petiole, or other plant part, and the stock may include roots and an aerial part of the plant, including the main stem, secondary stems, leaves, and / or reproductive structures of the plant, in embodiments, the DNA encoding the recombinant RNA molecule is not present in the scion and / or stock. In embodiments, the scion lacks a recombinant RNA molecule prior to grafting. In embodiments, the stock comprises a somatic viral RDRP. In some embodiments, the mereovirus RDRP is provided by a mereovirus specific to the stock (e.g., a non-pathogenic and / or symbiotic mereovirus). In other embodiments, the mereovirus RDRP is provided exogenously to the stock (e.g., by a DNA expression cassette integrated into the chromosome or plastid DNA of the stock or by a recombinant viral vector comprising DNA or RNA encoding the RDRP). In an embodiment, the scion comprises a mereovirus RDRP. In some embodiments, the RDRP is provided by a mereovirus specific to the scion (e.g., a non-pathogenic and / or symbiotic mereovirus). In other embodiments, the RDRP is provided exogenously to the scion (e.g., by a DNA expression cassette integrated into the chromosome or plastid DNA of the scion or by a recombinant viral vector comprising DNA or RNA encoding the RDRP). In an embodiment, the mereovirus RDRP comprises a protein having at least 85%, 90%, 95%, 97% or 99% sequence identity to SEQ ID NO: 272, 290-384 or 390. In embodiments, the stock and / or scion comprises a heterologous viral coat protein that can encapsidate a recombinant RNA molecule. In some embodiments, the stock and / or scion comprises a recombinant RNA molecule encapsidated by a heterologous viral coat protein.

[0125] On the other hand, the present disclosure relates to a method for producing a grafted plant, the grafted plant comprising a recombinant RNA molecule, the recombinant RNA molecule comprising a 5' replication element capable of being recognized by a somatic virus RNA-dependent RNA polymerase (RDRP) in the order of 5' to 3'; a cargo RNA sequence; and a 3' replication element capable of being recognized by a somatic virus RDRP. In certain embodiments, the recombinant RNA molecule is provided by contacting the scion, the stock, or both the scion and the stock with a composition comprising the recombinant RNA molecule before the scion is grafted onto the stock to produce a grafted plant. In certain embodiments, before the scion, the stock, or both the scion and the stock are contacted with the composition, at least one cell of the stock and / or the scion comprises a somatic virus RDRP. In an embodiment, the stock comprises a somatic virus RDRP. In some embodiments, the somatic virus RDRP is provided by a somatic virus (e.g., a non-pathogenic and / or symbiotic somatic virus) specific to the stock. In other embodiments, the mereovirus RDRP is provided exogenously to the rootstock (e.g., by a DNA expression cassette integrated into the chromosome or plastid DNA of the rootstock or by a recombinant viral vector comprising DNA or RNA encoding the RDRP). In embodiments, the scion comprises a mereovirus RDRP. In some embodiments, the RDRP is provided by a mereovirus unique to the scion (e.g., a non-pathogenic and / or symbiotic mereovirus). In other embodiments, the RDRP is provided exogenously to the scion (e.g., by a DNA expression cassette integrated into the chromosome or plastid DNA of the scion or by a recombinant viral vector comprising DNA or RNA encoding the RDRP). In embodiments, the mereovirus RDRP comprises a protein having at least 85%, 90%, 95%, 97% or 99% sequence identity to SEQ ID NO: 272, 290-384 or 390. In embodiments, DNA encoding a recombinant RNA molecule is not present in the scion, the rootstock and / or the grafted plant. Compositions may be provided to the scion, the rootstock, or both the scion and the rootstock according to any formulation disclosed herein. In some embodiments, the formulation is a liquid, gel or powder. In some embodiments, the formulation is configured to be sprayed onto the scion, stock, or both the scion and stock; injected into the scion, stock, or both the scion and stock; immersed in the scion, stock, or both the scion and stock; or coated on the scion, stock, or both the scion and stock. In certain embodiments, contacting includes dipping the scion, stock, or both the scion and stock into the composition before grafting.

[0126] In another aspect, the disclosure relates to a method for producing a plant that transmits any of the foregoing or otherwise disclosed recombinant RNA molecules provided herein to progeny plants or seeds. In certain embodiments, the method comprises the steps of: obtaining from at least one parent plant containing the recombinant RNA molecule F 1A method of isolating a plant or seed population containing at least one cell containing a split viral RNA-dependent RNA polymerase (RDRP) and the recombinant RNA molecule. 1 The progeny plant or seed, wherein the recombinant RNA molecule comprises, in 5' to 3' order, a 5' replication element capable of being recognized by the RDRP of the split virus; a cargo RNA sequence; and a 3' replication element capable of being recognized by the RDRP of the split virus. 1 The parent plant or part thereof comprising said plant cell is screened or selected for the presence of the recombinant RNA molecule before the progeny plants or seeds are produced. 1 Before producing progeny plants, the parental plants or one or more parts thereof are screened for the systemic presence of the recombinant RNA molecule. In other embodiments, the floral tissue (e.g., whole flower or flower bud, sepal, calyx or petal), male reproductive tissue (e.g., stamen, anther or pollen) or female reproductive tissue (e.g., whole fruit, ovary, pericarp, ovule, seed coat, endosperm or embryo) of the parental plants are screened or selected for the presence of the recombinant RNA molecule. In embodiments, F1 seeds are obtained from parental plants selected for the presence of the recombinant RNA molecule in pericarp tissue. In embodiments, the F1 cells comprising the cells are selected for the presence of the recombinant RNA molecule. 1 Progeny plants or seeds are isolated by screening the F 1 The presence of the recombinant RNA molecule in a plant or seed population and the reproduction of F containing the recombinant RNA molecule 1 Progeny plants or seeds. In such screening, the progeny plants or their seeds are assayed for a screenable marker for the presence of the recombinant RNA (e.g., an RNA sequence that diagnoses the presence of a recombinant RNA molecule or a polypeptide encoded by the recombinant RNA molecule) and separated from progeny plants and seeds that lack the recombinant RNA. Such screening assays can be non-destructive assays, in which a portion of the progeny seeds or plants is removed and assayed without losing the viability or reproductive capacity of the seeds or plant tissues that contain the recombinant RNA. In some embodiments, the F of the parental plant is non-destructively screened for the presence of the recombinant RNA molecule. 1 In other embodiments, the F of the parental plants is non-destructively screened by assaying the presence of the recombinant RNA molecule in the maternal origin or endosperm tissue of the seeds. 1 Seeds. Methods for non-destructive assays of seeds or other plant tissues that may be suitable for such screening include, but are not limited to, those disclosed in U.S. Patent Applications US20220221377 and US20210259176, both of which are incorporated herein by reference in their entirety. In some embodiments, the cargo RNA sequence comprises RNA encoding a selectable or scorable marker. In some embodiments, the recombinant RNA molecule encodes a selectable marker and comprises an F1 Progeny plants or seeds are isolated by selecting for the presence or absence of the selectable marker comprising the recombinant RNA molecule. 1 Progeny plants or seeds. Where the recombinant RNA encodes a selectable marker (e.g., a protein that confers resistance to a selection agent such as a herbicide or antibiotic), examples of such selections may include exposing the progeny seeds or plants to a selection agent (e.g., a herbicide or antibiotic) and isolating the progeny seeds or plants that survive exposure to the selection agent. Examples of selectable marker / selective agent combinations include glyphosate-resistant EPSPS enzymes and / or glyphosate oxidase / glyphosate, bialaphos resistance (bar) or glufosinate acyltransferase (pat) enzymes / phosphinothricin, and neomycin phosphotransferase (npt) / neomycin or kanamycin. In certain embodiments, the selectable or scorable marker is an RNA aptamer or a regulatory RNA. In certain embodiments, F 1 The progeny plants or seeds lack the DNA encoding the recombinant RNA molecule. In other embodiments, the parental plants lack the DNA encoding the recombinant RNA molecule. In embodiments, the selected F1 progeny plants pass the recombinant RNA molecule to at least the F2 progeny. In some embodiments, the F1 progeny plant or seed population is obtained from the parental plant used as the pollen recipient. In other embodiments, the F1 progeny plant or seed population is obtained from the parental plant used as the pollen donor. In embodiments, the F1 progeny plant or seed population is obtained by selfing the parental plant. In other embodiments, the F1 progeny plant or seed population is obtained by selfing the parental plant. 1 Progeny plants or seed populations are obtained from the sexual cross of two parental plants. In some embodiments, the parental plant comprising the recombinant RNA molecule is a maternal plant. In other embodiments, the parental plant comprising the recombinant RNA molecule is a male plant, and the recombinant RNA molecule is transmitted in the pollen of the male plant.

[0127] In certain embodiments, the method may further include introducing a recombinant RNA molecule or a polynucleotide encoding the recombinant RNA molecule into a plant cell and obtaining a parent plant comprising the recombinant RNA molecule from the plant cell. In an embodiment, the recombinant RNA molecule further comprises at least one additional element selected from the group consisting of: (a) at least one RNA encoding a viral movement protein (MP); (b) at least one tRNA-like sequence; and c) an assembly origin sequence (OAS). In an embodiment, the parent and / or plant comprises a heterologous viral coat protein that can encapsidate the recombinant RNA molecule. In some embodiments, the parent and / or progeny plant comprises a recombinant RNA molecule encapsidated by a heterologous viral coat protein.

[0128] On the other hand, the present disclosure relates to a method for barcoding a plant, a plant cell, a progeny thereof, or a part thereof. The method includes providing any of the foregoing or otherwise disclosed recombinant RNA molecules provided herein to a plant or a plant cell, wherein the cargo RNA of the recombinant RNA molecule comprises a barcode RNA molecule, and wherein the plant or plant cell comprises a split virus RDRP. In an embodiment, the barcode RNA molecule comprises a sequence that uniquely identifies a plant, a plant cell, a progeny thereof, or a part thereof. In some embodiments, the barcode RNA can be a randomly generated sequence. In some embodiments, the barcode RNA molecule comprises a sequence that is not present in the genome and / or transcriptome of a wild-type plant of the same species, its pathogen, or its symbiont. In some embodiments, the barcode RNA molecule comprises a forward primer binding site and a reverse primer binding site for detecting the barcode RNA molecule. In an embodiment, the barcode RNA molecule comprises a non-protein coding sequence. In some embodiments, the length of the barcode RNA sequence is up to about 3.2 kb. In some embodiments, the barcode RNA has a length of 10 to 5000 nucleotides, 20 to 1000 nucleotides, or 50 to 500 nucleotides. In certain embodiments, the barcode RNA molecule is 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, 1000, 1500, 2000, 2500, 3000, 3500, 4000, 4500, or 5000 nucleotides in length. In embodiments, the plant transmits the recombinant RNA molecule comprising the barcode RNA to progeny. In some embodiments, the plant, plant cell, progeny thereof, or part thereof lacks DNA encoding the recombinant RNA molecule. In some embodiments, the method may further comprise isolating the F comprising at least one cell containing the split viral RDRP and the recombinant RNA molecule. 1 Progeny plants or seeds. In some embodiments, F 1 Progeny plants or seeds are obtained from the plant used as the pollen recipient. 1 Progeny plants or seeds are obtained from the plant used as the pollen donor. 1 The progeny plants or seeds are obtained by selfing the parent plants. In an embodiment, the method may further comprise propagating the plant or plant cell to obtain a plant part or plant propagule comprising the barcode RNA molecule.

[0129] In another aspect, the present disclosure relates to methods for identifying barcoded plants, plant parts or plant cells. The method comprises screening for the presence of barcode RNA molecules in plants, plant parts or plant cells, wherein the plants, plant parts or plant cells comprise any of the foregoing or otherwise disclosed recombinant RNA molecules provided herein, and wherein the cargo RNA of the recombinant RNA molecules comprises barcode RNA molecules. In certain embodiments, the method comprises obtaining a nucleic acid sample from a plant, plant part or plant cell; and detecting the presence of the barcode RNA molecules in the sample. Assays for detecting barcode RNA include RNA detection assays (e.g., RT-PCR assays) using nucleic acid probes and / or primers that can detect barcode RNA and / or sequencing barcode RNA. Such screening assays can be non-destructive assays, in which a portion of a seed or plant is removed and assayed without losing the viability or reproductive capacity of the seed or plant tissue containing the barcode RNA. Methods for non-destructive determination of seeds or other plant tissues applicable to such screening include, but are not limited to, those disclosed in U.S. Patent Applications US20220221377 and US20210259176, both of which are incorporated herein by reference in their entirety. In some embodiments, the seeds of plants are non-destructively screened for the presence or absence of barcode RNA molecules. In other embodiments, seedlings, ovules, embryos, pollen, roots, stems, leaves, buds, tubers, rhizomes, runners, bulbs, explants, or callus are screened for the presence or absence of barcode RNA molecules.

[0130] In some optional embodiments, the method disclosed herein is not a process for modifying the germline genetic identity of mankind. In some optional embodiments, the method disclosed herein is not a process for modifying the genetic identity of animals, which processes may cause them to suffer without any substantial medical benefit to humans or animals, and are not suitable for animals produced by such processes. In some optional embodiments, the method disclosed herein is not a method for treating human or animal bodies by surgery or therapy. In some optional embodiments, the cell disclosed herein is not a human embryo. In some optional embodiments, the cell disclosed herein is not a human body at different stages of its formation and development. In some optional embodiments provided herein, the plant cell, plant propagator (for example, seed, seedling, ovule, embryo, pollen, root, stem, leaf, bud, tuber, rhizome, runner, bulb, explant or callus) and plant provided herein are not just produced by biological processes. In certain optional embodiments provided herein, the methods provided herein for producing plant cells, plant propagules (e.g., seeds, seedlings, ovules, embryos, pollen, roots, stems, leaves, shoots, tubers, rhizomes, runners, bulbs, explants or callus) and plants are not merely biological processes. Example

[0131] Various embodiments of the compositions, systems, and methods described herein are shown in the following set of numbered examples.

[0132] 1. A recombinant DNA molecule comprising a first promoter, wherein the first promoter is operably linked to a DNA encoding an RNA molecule, wherein the RNA molecule comprises, from the 5' end to the 3' end: (a) a 5' RNA replication element recognized by a somatic viral RNA-dependent RNA polymerase (RDRP); (b) a cargo RNA molecule; and (c) a 3' RNA replication element recognized by the RDRP; wherein the 5' RNA replication element, the cargo RNA molecule and the 3' RNA replication element are operably linked, wherein the promoter and the cargo RNA molecule are heterologous to the 5' RNA replication element and the 3' RNA replication element.

[0133] 2. The recombinant DNA molecule of embodiment 1, wherein: (a) the 5' RNA replication element comprises at least one RNA secondary structure provided in Table 1, or at least one RNA secondary structure adopted by RNA encoded by SEQ ID NO: 1-34, 69-88, 372, 374, 376, 378, 380, 382 or 386; and / or (b) the 3' RNA replication element comprises at least one RNA secondary structure provided in Table 1, or at least one RNA secondary structure adopted by RNA encoded by SEQ ID NO: 35-68, 89-108, 373, 375, 377, 379, 381, 383 or 387.

[0134] 3. A recombinant DNA molecule as described in embodiment 1 or 2, wherein: (a) the 5' RNA replication element is encoded by: a DNA molecule comprising SEQ ID NO: 1-34, 69-88, 372, 374, 376, 378, 380, 382 or 386; a variant thereof comprising a DNA having at least 70%, 75%, 80%, 85%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO: 1-34, 69-88, 372, 374, 376, 378, 380, 382 or 386; or a variant thereof, wherein one or more nucleotides in the RNA secondary structure are replaced by different nucleotides that maintain the RNA secondary structure; and / or (b) the 3' RNA replication element is encoded by: a DNA molecule comprising SEQ ID NO: 1-34, 69-88, 372, 374, 376, 378, 380, 382 or 386. NO:35-68, 89-108, 373, 375, 377, 379, 381, 383 or 387; a variant thereof comprising a DNA having at least 70%, 75%, 80%, 85%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO:35-68, 89-108, 373, 375, 377, 379, 381, 383 or 387; or a variant thereof, wherein one or more residues in the RNA secondary structure are replaced by different nucleotides that maintain the RNA secondary structure.

[0135] 4. A recombinant DNA molecule as described in embodiment 1, 2 or 3, wherein the RNA secondary structure is maintained by replacing non-base paired nucleotides in the secondary structure with nucleotides that will not base pair and / or replacing base paired nucleotides in the secondary structure with nucleotides that will base pair.

[0136] 5. A recombinant DNA molecule as described in any one of embodiments 1 to 4, wherein: (a) the 5' RNA replication element comprises an RNA molecule containing at least one segment of the 5' untranslated region (UTR) of the somatic virus genome or a variant thereof having one or more nucleotide substitutions, insertions and / or deletions, wherein the variant is recognized by the RDRP, optionally wherein the 5' replicase replication element further comprises a genomic sequence of the somatic virus that is naturally located 3' to and adjacent to the 5'UTR sequence; and / or (b) the 3' RNA replication element comprises an RNA molecule containing at least one segment of the 3'UTR of the somatic virus genome or a variant thereof having one or more nucleotide substitutions, insertions and / or deletions, wherein the variant is recognized by the RDRP, optionally wherein the 3' replicase replication element further comprises a genomic sequence of the somatic virus that is naturally located 5' to and adjacent to the 3'UTR sequence.

[0137] 6. The recombinant DNA of any one of embodiments 1 to 5, wherein the 5' RNA replication element and the 3' RNA replication element are obtained from the same solitary viral genome or from related solitary viral genomes that have at least 85%, 90%, 95%, 98% or 99% sequence identity to each other, optionally wherein the 5' RNA replication element, the 3' RNA replication element and the RDRP are obtained from the same solitary viral genome or from related solitary viral genomes that have at least 85%, 90%, 95%, 98% or 99% sequence identity to each other, or optionally wherein the 5' RNA replication element, the 3' RNA replication element and / or the RDRP coding region are obtained from two solitary viral genomes, wherein the members of each pair of the 5' RNA replication element, the 3' RNA replication element and / or the RDRP coding region of the two solitary viral genomes have at least 85%, 90%, 95%, 98% or 99% sequence identity to each other.

[0138] 7. The recombinant DNA of embodiment 6, wherein the 5' RNA replication element of (a) and the 3' RNA replication element of (b) are obtained from different somatic viral genomes, optionally wherein the different somatic viral genomes have less than 85%, 80%, 75% or 70% sequence identity to each other or optionally wherein the different somatic viral genomes have any one of 50%, 60% or 65% to 70%, 75%, 80% or 84% sequence identity to each other.

[0139] 8. A recombinant DNA molecule as described in any one of embodiments 1 to 7, wherein the RNA molecule further comprises at least one of the following: (i) a tRNA-like element, optionally wherein the tRNA-like element provides for cell-to-cell movement of the RNA, and optionally wherein the cell-to-cell movement is mediated by a viral movement protein (MP); (ii) an encapsidation recognition element (ERE), optionally wherein the ERE provides for encapsidation of the RNA by a dichotomous viral capsid protein, or optionally wherein the ERE provides for encapsidation of the RNA by a non-dichotomous viral capsid protein; (iii) an RNA effector; and / or (iv) an RNA encoding a viral movement protein (MP), optionally wherein an internal ribosome entry site (IRES) is operably linked to the RNA encoding the MP.

[0140] 9. The recombinant DNA molecule of embodiment 8, wherein the encapsidation recognition element (ERE) comprises a viral origin of assembly sequence (OAS), optionally wherein the OAS is a tobacco mosaic virus OAS.

[0141] 10. The recombinant DNA molecule of embodiment 8, wherein the tRNA-like element comprises a tRNA-like molecule from Arabidopsis thaliana FT mRNA and / or the ERE is Tobacco Mosaic Virus (TMV) OAS.

[0142] 11. A recombinant DNA molecule as described in any one of embodiments 1 to 10, wherein the DNA molecule further comprises a second promoter, which is operably linked to the DNA encoding the RNA molecule, and the RNA molecule comprises from the 5' end to the 3' end: (i) a 5' RNA replication element recognized by a split viral RNA-dependent RNA polymerase (RDRP); (ii) an RNA encoding a viral movement protein (MP), optionally wherein an internal ribosome entry site (IRES) is operably linked to the RNA; and (iii) a 3' RNA replication element recognized by the RDRP, optionally wherein the RNA further comprises at least one of the following: (a) a tRNA-like element, optionally wherein the tRNA-like element provides for cell-to-cell movement of the RNA, and optionally wherein the cell-to-cell movement is mediated by the viral movement protein (MP); (b) an RNA effector; and / or (c) an encapsidation recognition element (ERE), optionally wherein the ERE provides for encapsidation of the RNA by a split viral capsid protein, or optionally wherein the ERE provides for encapsidation of the RNA by a non-split viral capsid protein.

[0143] 12. The recombinant DNA molecule of embodiment 11, wherein said RNA encoding viral MP is heterologous to said 5' RNA replication element and said 3' RNA replication element operably linked to said second promoter.

[0144] 13. A recombinant DNA molecule as described in embodiment 8 or 11, wherein the RNA effector provides RNA cleavage, protein binding or RNA synthesis, optionally wherein the RNA effector comprises a ribozyme, a ligand-responsive ribozyme (aptazyme), an RNA aptamer, or an RNA promoter recognized by an RNA promoter-dependent RNA polymerase (RPDRP), optionally wherein the RNA effector is operably linked to the RNA molecule, and / or optionally wherein the RNA effector is operably linked to: the 5' RNA replication element, the cargo RNA molecule; and / or the 3' RNA replication element.

[0145] 14. A recombinant DNA molecule as described in any one of Examples 1 to 13, wherein the DNA molecule further comprises: (i) a promoter operably linked to the DNA encoding the somatic virus RNA-dependent RNA polymerase (RDRP) and a terminator element operably linked; and / or (ii) a promoter operably linked to the DNA encoding the capsid protein that recognizes the ERE and a terminator element operably linked, optionally wherein the capsid protein is a somatic virus capsid protein.

[0146] 15. The recombinant DNA molecule of any one of embodiments 1 to 14, wherein the cargo RNA molecule has a length of up to about 3.2 kBp.

[0147] 16. The recombinant DNA molecule of any one of embodiments 1 to 15, wherein the cargo RNA molecule comprises: (a) at least one coding sequence, optionally wherein the cargo sequence encodes a selectable or scorable marker; (b) at least one non-coding sequence; or (c) both at least one coding sequence and at least one non-coding sequence.

[0148] 17. The recombinant DNA molecule of any one of embodiments 1 to 16, wherein the cargo RNA molecule comprises at least one coding sequence, and wherein the RNA molecule further comprises an internal ribosome entry site (IRES) operably linked to the at least one coding sequence, optionally wherein the operably linked IRES is located 5' of the coding sequence and immediately adjacent thereto.

[0149] 18. The recombinant DNA molecule of any one of embodiments 1 to 17, wherein the cargo RNA molecule comprises a plurality of coding sequences, and wherein the RNA molecule further comprises an IRES operably linked to each of the coding sequences, optionally wherein the operably linked IRES is located 5' of and immediately adjacent to the coding sequence in the cargo RNA molecule.

[0150] 19. The recombinant DNA molecule of any one of embodiments 1 to 17, wherein the cargo RNA molecule comprises at least one non-coding sequence, and wherein the at least one non-coding sequence is a hairpin RNA (hpRNA); an RNA that forms multiple stem loops; an RNA pseudoknot; an RNA molecule that forms at least a portion of a double-stranded RNA; a small interfering RNA (siRNA) or an siRNA precursor; a microRNA (miRNA) or an miRNA precursor; a phased RNA or a phased RNA precursor; a ribozyme; a ribozyme cleavage site; a ligand-responsive ribozyme (aptazyme); an RNA aptamer; or a long non-coding RNA (lncRNA).

[0151] 20. The recombinant DNA molecule of any one of embodiments 1 to 19, further comprising a DNA molecule encoding at least one ribozyme, optionally wherein the at least one ribozyme is located 5' to the 5' RNA replication element or 3' to the 3' RNA replication element.

[0152] 21. A recombinant DNA molecule as described in any one of embodiments 1 to 20, further comprising a DNA molecule encoding at least one ligand-responsive ribozyme (aptazyme), optionally wherein the at least one ligand-responsive ribozyme is located 5' of the 5' RNA replication element or 3' of the 3' RNA replication element.

[0153] 22. A recombinant DNA molecule as described in any one of embodiments 1 to 20, wherein the recombinant DNA molecule further comprises DNA encoding an intron, optionally wherein the DNA encoding the intron is located between: (i) the 3' end of the promoter and the 5' end of the DNA encoding the 5' RNA replication element; (ii) the 3' end of the 5' RNA replication element and the 5' end of the DNA encoding the cargo RNA molecule; or (iii) the 3' end of the DNA encoding the cargo RNA molecule and the 5' end of the 3' RNA replication element.

[0154] 23. A recombinant DNA molecule as described in any one of embodiments 1 to 22, wherein the recombinant DNA molecule further comprises at least one additional element comprising: a discrete expression cassette comprising a second promoter operably linked to the DNA molecule to be transcribed, and optionally a terminator element; an expression enhancing element operably linked to a promoter or an RNA coding sequence, wherein the expression enhancing element is optionally a transcription enhancer, a translation enhancer coding sequence, or an intron coding sequence; a DNA molecule encoding a selectable or scorable marker; a DNA aptamer; a DNA molecule encoding an RNA aptamer; Agrobacterium T-DNA left and right border DNA elements operably linked to the 5' and 3' ends of the recombinant DNA molecule; a spacer DNA molecule or a DNA encoding an RNA cleavage agent recognition site, optionally wherein the RNA cleavage agent comprises a guide RNA and a Cas nuclease, siRNA, ta-siRNA, ribozyme, aptazyme or miRNA; a DNA molecule encoding a transcription factor binding site operably linked to a promoter; a DNA molecule encoding a localization sequence operably linked to one or more coding sequences, optionally wherein the coding sequence comprises a cargo RNA; a DNA molecule encoding at least one sequence-specific recombinase recognition site (SSRRS), optionally wherein the SSRRS is operably linked to one or more of: (i) DNA encoding the cargo RNA; (ii) the coding sequence of the DNA molecule; (iii) the 5' and / or 3' end of the DNA molecule; and / or the 5' and / or 3' end of a segment of the DNA molecule encoding the RNA molecule; and / or a DNA molecule encoding a transcript stabilizing or transcript destabilizing RNA sequence, wherein the transcript stabilizing or transcript destabilizing RNA sequence is operably linked to the RNA molecule encoded by the DNA molecule.

[0155] 24. An RNA molecule encoded by the recombinant DNA molecule of any one of embodiments 1 to 23.

[0156] 25. A cell comprising the recombinant DNA molecule of any one of embodiments 1 to 23, optionally wherein the cell is a prokaryotic cell or a eukaryotic cell, and optionally wherein the eukaryotic cell is a plant cell.

[0157] 26. A vector for bacteria-mediated plant transformation, comprising the recombinant DNA molecule of any one of embodiments 1 to 23.

[0158] 27. The vector of embodiment 26, wherein the bacterium that mediates the plant transformation is an Agrobacterium species, a Sinorhizobium species, a Mesorhizobium species, a Bradyrhizobium species, a Rhizobium species, or a Xiphium species, and the vector is suitable for transformation with the bacterium.

[0159] 28. The vector of embodiment 26 or 27, wherein the bacterium mediating the plant transformation is an Agrobacterium species, and wherein the vector further comprises T-DNA flanking the DNA molecule encoding the recombinant RNA molecule.

[0160] 29. The vector of embodiment 26, 27 or 28, contained in a bacterium or a plant cell.

[0161] 30. An expression system comprising: (a) a recombinant DNA molecule as described in any one of embodiments 1 to 23; and (b) a cell containing the recombinant DNA molecule and a RDRP protein that recognizes 5' and 3' RNA replication elements encoded by the DNA molecule.

[0162] 31. An expression system as described in Example 30, wherein the recombinant DNA molecule further comprises at least one additional element containing the following: (i) DNA encoding at least one RNA, the RNA encoding a viral movement protein (MP); (ii) DNA encoding at least one tRNA-like molecule; (iii) DNA encoding an encapsidation recognition element (ERE); (iv) DNA encoding an RNA, the RNA comprising the following from 5' to 3' and operably linked: a 5' RNA replication element recognized by a split viral RNA-dependent RNA polymerase (RDRP), the RNA of (i) and optionally the operably linked RNA of (ii) and / or (iii), and a 3' RNA replication element; (v) DNA encoding an RNA promoter; (vi) DNA encoding an RNA promoter-dependent RNA polymerase (RPDRP); and / or (vii) a DNA molecule comprising a promoter, the promoter being operably linked to a DNA encoding at least one of (i), (ii), (iii), (iv), (v) or (vi).

[0163] 32. An expression system as described in Example 30 or 31, wherein the expression system further comprises a DNA molecule containing the following: (i) DNA encoding at least one RNA, the RNA encoding a viral movement protein (MP); (ii) DNA encoding at least one tRNA-like molecule; (iii) DNA encoding an encapsidation recognition element (ERE); (iv) DNA encoding an RNA, the RNA comprising the following from 5' to 3' and operably linked: a 5' RNA replication element recognized by a split viral RNA-dependent RNA polymerase (RDRP), the RNA of (i) and optionally the operably linked RNA of (ii) and / or (iii), and a 3' RNA replication element; (v) DNA encoding an RNA promoter; (vi) DNA encoding an RNA promoter-dependent RNA polymerase (RPDRP); and / or (vii) a DNA molecule comprising a promoter, the promoter being operably linked to a DNA encoding at least one of (i), (ii), (iii), (iv), (v) or (vi).

[0164] 33. An expression system as described in any one of embodiments 30 to 32, wherein the cell is a bacterial cell, a plant cell, a fungal cell, or an animal cell, optionally wherein the bacterial cell is an Agrobacterium species, a Sinorhizobium species, a Mesorhizobium species, a Bradyrhizobium species, a Rhizobium species, or a Xiphium species cell.

[0165] 34. An expression system as described in any one of Examples 30 to 33, further comprising: (i) a viral capsid protein that can encapsidate an RNA molecule comprising the encapsidation recognition element (ERE); (ii) an RNA binding protein (RBP) that can bind to the RNA molecule encoded by the DNA molecule, optionally wherein the RBP binds to an RNA effector; (iii) an RNA cleavage agent that cleaves the RNA molecule; and / or (iv) an RNA promoter-dependent RNA polymerase (RPDRP) protein that recognizes an RNA promoter in the RNA molecule.

[0166] 35. An expression system as described in Example 34, wherein the viral capsid protein: (a) is expressed by the recombinant DNA molecule in the cell, (b) is co-expressed by a second recombinant DNA molecule in the cell; (c) is exogenously provided to the cell; or (d) is expressed by a virus in the cell.

[0167] 36. An expression system as described in any of embodiments 30 to 35, wherein: (i) the capsid protein, viral movement protein (MP), RDRP protein and / or the RPDRP protein are heterologous to the cell, and / or (ii) wherein the RDRP protein or a polynucleotide encoding the RDRP protein is provided to the cell exogenously.

[0168] 37. The expression system of any one of embodiments 30 to 36, wherein the cell is a plant cell.

[0169] 38. The expression system of embodiment 37, wherein said plant cell contains a split virus that expresses said RDRP protein that recognizes said 5' RNA replication element and said 3' RNA replication element.

[0170] 39. The expression system of embodiment 38, wherein the split virus naturally exists in the plant cell.

[0171] 40. The expression system of any one of embodiments 30 to 39, wherein the recombinant DNA molecule further comprises at least one RNA encoding a viral MP, a tRNA-like molecule from Arabidopsis FT mRNA, and an encapsidation recognition element comprising TMV-OAS.

[0172] 41. An agricultural formulation comprising the expression system of any one of embodiments 30 to 40.

[0173] 42. The agricultural formulation of embodiment 41, wherein the formulation comprises the expression system and a carrier, excipient and / or adjuvant.

[0174] 43. An agricultural formulation comprising the recombinant DNA molecule of any one of embodiments 1 to 23.

[0175] 44. The agricultural formulation of embodiment 43, wherein the formulation comprises the recombinant DNA molecule and a carrier, excipient and / or adjuvant.

[0176] 45. A method of providing a synthetic split viral satellite RNA to a plant, the method comprising contacting the plant with the recombinant DNA molecule of any one of embodiments 1 to 23, the RNA of embodiment 24, the cell of embodiment 25, the vector of any one of embodiments 26 to 29, or the formulation of embodiment 43 or 44.

[0177] 46. ​​The method of embodiment 45, wherein contacting comprises spraying, dusting, injecting or soaking with the recombinant DNA molecule, the vector or the formulation.

[0178] 47. A recombinant RNA molecule comprising, from the 5' end to the 3' end: (a) a 5' RNA replication element recognized by a solitary viral RNA-dependent RNA polymerase (RDRP); (b) a cargo RNA molecule; and (c) a 3' RNA replication element recognized by the RDRP, wherein the 5' RNA replication element, the cargo RNA molecule and the 3' RNA replication element are operably linked, and wherein the cargo RNA molecule is heterologous to the 5' RNA replication element and the 3' RNA replication element, optionally wherein: (i) the 5' RNA replication element and the 3' RNA replication element are obtained from the same solitary viral genome or from solitary viral genomes that have at least 85%, 90%, 95%, (ii) the 5' RNA replication element, the 3' RNA replication element and the RDRP are obtained from the same solitary viral genome or from related solitary viral genomes that have at least 85%, 90%, 95%, 98% or 99% sequence identity to each other; or (iii) the 5' RNA replication element, the 3' RNA replication element and / or the RDRP coding region are obtained from two solitary viral genomes, wherein the members of each pair of the 5' RNA replication element, the 3' RNA replication element and / or the RDRP coding region in the two solitary viral genomes have at least 85%, 90%, 95%, 98% or 99% sequence identity to each other.

[0179] 48. A recombinant RNA molecule as described in embodiment 47, wherein: (a) the 5' RNA replication element comprises at least one RNA secondary structure provided in Table 1, or at least one RNA secondary structure adopted by an RNA molecule encoded by SEQ ID NO: 1-34, 69-88, 372, 374, 376, 378, 380, 382 or 386; and / or (b) the 3' RNA replication element comprises at least one RNA secondary structure provided in Table 1, or at least one RNA secondary structure adopted by an RNA molecule encoded by SEQ ID NO: 35-68, 89-108, 373, 375, 377, 379, 381, 383 or 387.

[0180] 49. A recombinant RNA molecule as described in embodiment 47 or 48, wherein: (a) the 5' RNA replication element comprises an RNA molecule encoded by SEQ ID NO: 1-34, 69-88, 372, 374, 376, 378, 380, 382 or 386; a variant thereof encoded by a DNA molecule having at least 70%, 75%, 80%, 85%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO: 1-34, 69-88, 372, 374, 376, 378, 380, 382 or 386; or a variant thereof, wherein one or more nucleotides in the RNA secondary structure are replaced by different nucleotides that maintain the RNA secondary structure; and / or (b) the 3' RNA replication element comprises an RNA molecule encoded by SEQ ID NO: 1-34, 69-88, 372, 374, 376, 378, 380, 382 or 386. NO:35-68, 89-108, 373, 375, 377, 379, 381, 383 or 387 encoded RNA; a variant thereof encoded by a DNA molecule having at least 70%, 75%, 80%, 85%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO:35-68, 89-108, 373, 375, 377, 379, 381, 383 or 387; and / or a variant thereof, wherein one or more base-paired residues in the RNA secondary structure are replaced by different nucleotides that maintain the RNA secondary structure.

[0181] 50. The recombinant RNA molecule of embodiment 49, wherein the RNA secondary structure is maintained by replacing non-base paired nucleotides in the secondary structure with nucleotides that will not base pair and / or replacing base paired nucleotides in the secondary structure with nucleotides that will base pair.

[0182] 51. A recombinant RNA molecule as described in any of Examples 47 to 50, wherein: (a) the 5' RNA replication element comprises at least one segment of the 5' untranslated region (UTR) of the somatic virus genome or a variant thereof having one or more nucleotide substitutions, insertions and / or deletions, wherein the variant is recognized by the RDRP, optionally wherein the 5' replicase replication element further comprises a genomic sequence of the somatic virus that is naturally located 3' to and adjacent to the 5'UTR sequence; and / or (b) the 3' RNA replication element comprises at least one segment of the 3'UTR of the somatic virus genome or a variant thereof having one or more nucleotide substitutions, insertions and / or deletions, wherein the variant is recognized by the RDRP, optionally wherein the 3' replicase replication element further comprises a genomic sequence of the somatic virus that is naturally located 5' to and adjacent to the 3'UTR sequence, and optionally wherein the somatic virus genomes of (a) and (b) are the same.

[0183] 52. A recombinant RNA molecule as described in Examples 47 to 51, wherein the RNA molecule further comprises at least one of the following: (i) a tRNA-like element, optionally wherein the tRNA-like element provides for cell-to-cell movement of the RNA, and optionally wherein the cell-to-cell movement is mediated by a viral movement protein (MP); (ii) an encapsidation recognition element (ERE), optionally wherein the ERE provides for encapsidation of the RNA by a dichotomous viral capsid protein, or optionally wherein the ERE provides for encapsidation of the RNA by a non-dichotomous viral capsid protein; (iii) an RNA effector; and / or (iv) an RNA encoding a viral movement protein (MP), optionally wherein an internal ribosome entry site (IRES) is operably linked to the RNA encoding the MP.

[0184] 53. A recombinant RNA molecule as described in embodiment 52, wherein the RNA effector provides RNA cleavage, protein binding or RNA synthesis, optionally wherein the RNA effector comprises a ribozyme, a ligand-responsive ribozyme (aptazyme), an RNA aptamer, or an RNA promoter recognized by an RNA promoter-dependent RNA polymerase (RPDRP), optionally wherein the RNA effector is operably linked to the RNA molecule, and / or optionally wherein the RNA effector is operably linked to: the 5' RNA replication element, the cargo RNA molecule; and / or the 3' RNA replication element.

[0185] 54. The recombinant RNA molecule of embodiment 52, wherein said encapsidation recognition element (ERE) comprises a viral origin of assembly sequence (OAS), optionally wherein said OAS is a tobacco mosaic virus OAS.

[0186] 55. The recombinant RNA molecule of embodiment 52, wherein the tRNA-like element comprises a tRNA-like molecule from Arabidopsis thaliana FTmRNA and / or the ERE is Tobacco Mosaic Virus (TMV) OAS.

[0187] 56. The recombinant RNA molecule of any one of embodiments 47 to 55, wherein the cargo RNA molecule has a length of up to about 3.2 kb.

[0188] 57. A recombinant RNA molecule as described in any one of embodiments 47 to 56, wherein the cargo RNA molecule comprises: (a) at least one coding sequence, optionally wherein the coding sequence encodes a selectable or scorable marker; (b) at least one non-coding sequence; or (c) both at least one coding sequence and at least one non-coding sequence.

[0189] 58. The recombinant RNA molecule of any one of embodiments 47 to 57, wherein the cargo RNA molecule comprises at least one coding sequence, and wherein the RNA molecule further comprises an internal ribosome entry site (IRES) operably linked to the at least one coding sequence, optionally wherein the operably linked IRES is located 5' of the coding sequence and is immediately adjacent thereto.

[0190] 59. The recombinant RNA molecule of any one of embodiments 47 to 58, wherein the cargo RNA molecule comprises a plurality of coding sequences, and wherein the RNA molecule further comprises an IRES operably connected to each of the coding sequences, optionally wherein the operably connected IRES is located 5' of the coding sequence in the cargo RNA molecule and is immediately adjacent thereto.

[0191] 60. A recombinant RNA molecule as described in any one of embodiments 47 to 57, wherein the cargo RNA molecule comprises at least one non-coding sequence, and wherein the at least one non-coding sequence is a hairpin RNA (hpRNA); an RNA that forms multiple stem loops; an RNA pseudoknot; an RNA molecule that forms at least partially double-stranded RNA; a small interfering RNA (siRNA) or an siRNA precursor; a microRNA (miRNA) or an miRNA precursor; a phased RNA or a phased RNA precursor; a ribozyme; a ligand-responsive ribozyme (aptazyme); an RNA aptamer; or a long non-coding RNA (lncRNA).

[0192] 61. The recombinant RNA molecule of any one of embodiments 47 to 60, further comprising RNA encoding at least one ribozyme, optionally wherein the at least one ribozyme is located 5' to the 5' RNA replication element or 3' to the 3' RNA replication element.

[0193] 62. The recombinant RNA molecule of any one of embodiments 47 to 61, further comprising an RNA molecule comprising at least one ligand-responsive ribozyme (aptazyme), optionally wherein the at least one ligand-responsive ribozyme is located 5' of the 5' RNA replication element or 3' of the 3' RNA replication element.

[0194] 63. A recombinant RNA molecule as described in any one of embodiments 47 to 62, further comprising an RNA encoding an intron, optionally wherein the RNA encoding the intron is located between the 3' end of the 5' RNA replication element and the RNA encoding the cargo RNA.

[0195] 64. A recombinant RNA molecule as described in any one of embodiments 47 to 63, further comprising at least one additional element comprising: an RNA aptamer; an RNA molecule encoding a positioning sequence operably linked to one or more coding sequences; an RNA cleavage agent recognition site, optionally wherein the RNA cleavage agent comprises a guide RNA and a Cas nuclease, a ribozyme, an aptamer, an siRNA, a ta-siRNA or a miRNA; and / or an RNA molecule encoding a transcript stabilizing or transcript destabilizing sequence operably linked to an RNA molecule encoded by a DNA molecule.

[0196] 65. The recombinant RNA molecule of any one of embodiments 47 to 64, wherein the RNA further comprises at least one segment of its reverse complementary RNA molecule.

[0197] 66. An agricultural formulation comprising the recombinant RNA molecule of any one of embodiments 47 to 65.

[0198] 67. The agricultural formulation of embodiment 66, wherein the recombinant RNA molecule is complexed with one or more RNA binding proteins or encapsidated by a viral capsid protein, optionally wherein the viral capsid protein is a meretricious viral capsid protein, and optionally wherein the RNA comprises an ERE that provides for encapsidation of the RNA by the meretricious viral capsid protein.

[0199] 68. The formulation of embodiment 66 or 67, wherein the RNA binding protein comprises an RNA recognition motif.

[0200] 69. The agricultural formulation of embodiment 66, 67 or 68, wherein the viral capsid protein is heterologous to the split virus.

[0201] 70. The agricultural formulation of any one of embodiments 66 to 69, wherein the formulation comprises the recombinant RNA molecule and a carrier, excipient, and / or adjuvant.

[0202] 71. A cell comprising the recombinant RNA molecule of any one of embodiments 47 to 65.

[0203] 72. The cell of embodiment 71, wherein the cell is a bacterial cell, a fungal cell, a plant cell or an animal cell.

[0204] 73. An expression system comprising: (a) an RNA molecule comprising the recombinant RNA molecule of any one of embodiments 47 to 65; and (b) a cell comprising the recombinant RNA molecule and a RDRP protein that recognizes the 5' and 3' RNA replication elements of the recombinant RNA molecule.

[0205] 74. An expression system as described in Example 73, wherein the recombinant RNA molecule comprises an operably linked encapsidation recognition element (ERE) recognized by a viral capsid protein, and the cell contains the viral capsid protein.

[0206] 75. An expression system as described in Example 74, wherein the encapsidation recognition element (ERE) is a split viral ERE, wherein the viral capsid protein in the cell is a split viral capsid protein, and wherein the RNA molecule is encapsidated by the split viral capsid protein.

[0207] 76. The expression system of any one of embodiments 73 to 75, further comprising a reverse complementary sequence of the recombinant RNA molecule.

[0208] 77. An expression system as described in any one of Examples 73 to 76, further comprising an RNA molecule, which comprises the following from 5' to 3' and is operably linked: (i) a 5' RNA replication element recognized by the split viral RNA-dependent RNA polymerase (RDRP); (ii) an RNA encoding a viral movement protein (MP); (iii) at least one tRNA-like molecule; and (iv) a 3' RNA replication element recognized by the split viral RNA-dependent RNA polymerase (RDRP).

[0209] 78. An expression system as described in any one of Examples 73 to 77, further comprising an RNA molecule, which comprises the following from 5' to 3' and is operably linked: (i) a 5' RNA replication element recognized by the split viral RNA-dependent RNA polymerase (RDRP); (ii) an RNA encoding a viral movement protein (MP); (iii) at least one tRNA-like molecule; and (iv) a 3' RNA replication element recognized by the split viral RNA-dependent RNA polymerase (RDRP).

[0210] 79. An expression system as described in any one of Examples 73 to 78, wherein the expression system further comprises an RNA molecule, which comprises the following from 5' to 3' and is operably linked: (i) a 5' RNA replication element recognized by the split viral RNA-dependent RNA polymerase (RDRP); (ii) RNA encoding a viral capsid protein (CP); (iii) at least one tRNA-like molecule; and (iv) a 3' RNA replication element recognized by the split viral RNA-dependent RNA polymerase (RDRP).

[0211] 80. An expression system as described in any one of embodiments 73 to 79, wherein any or all of the RNA molecules comprise an operably linked encapsidation recognition element (ERE), optionally wherein the ERE provides for encapsidation of a viral capsid protein encoded by the RNA molecule as described in embodiment 79.

[0212] 81. The expression system of any one of embodiments 73 to 80, wherein the cell is a bacterial cell, a plant cell, a fungal cell, or an animal cell.

[0213] 82. An expression system as described in Example 81, wherein the cell further comprises: (i) a viral capsid protein (CP); (ii) an RNA binding protein (RBP) that can bind to the RNA molecule, optionally wherein the RBP binds to an RNA effector; (iii) an RNA cleavage agent that cleaves the RNA molecule; (iv) an RNA promoter-dependent RNA polymerase (RPDRP) protein that recognizes an RNA promoter in the RNA molecule; and / or (iv) a viral movement protein (MP).

[0214] 83. An expression system as described in Example 82, wherein the CP, RBP, RPDRP and / or the MP: (a) are expressed by a recombinant DNA molecule in the cell, (b) are provided exogenously to the cell; (c) are expressed by a recombinant RNA molecule in the cell; or (d) are expressed by a virus in the cell.

[0215] 84. The expression system of any one of embodiments 73 to 83, wherein the RDRP, CP, RBP, RPDRP and / or the MP protein is heterologous to the cell.

[0216] 85. The expression system of any one of embodiments 73 to 84, wherein the RDRP protein or a polynucleotide encoding the RDRP protein is provided exogenously to the cell.

[0217] 86. The expression system of any one of embodiments 73 to 85, wherein the cell is a plant cell.

[0218] 87. An expression system as described in any one of embodiments 73 to 86, wherein the RNA molecule further comprises an RNA promoter recognized by an RNA promoter-dependent RNA polymerase (RPDRP) and operably linked to the RNA molecule.

[0219] 88. The expression system of embodiment 87, wherein the cell further comprises an RNA promoter-dependent RNA polymerase (RPDRP) that recognizes the RNA promoter and / or a polynucleotide encoding the RPDRP.

[0220] 89. The expression system of any one of embodiments 73 to 88, wherein the plant cell contains a split virus that expresses the RDRP protein that recognizes the 5' RNA replication element and the 3' RNA replication element.

[0221] 90. The expression system of embodiment 89, wherein the split virus naturally exists in the plant cell.

[0222] 91. A method of providing a synthetic split viral satellite RNA to a plant, the method comprising contacting the plant with the recombinant DNA molecule or formulation thereof of any one of embodiments 1-23, the cell or formulation thereof of embodiment 25, the vector or formulation thereof of any one of embodiments 26-29, the recombinant RNA molecule of any one of embodiments 47-65, or the formulation of any one of embodiments 66-69.

[0223] 92. The method of embodiment 91, wherein contacting comprises spraying, dusting, injecting or soaking with the recombinant DNA molecule, the cell, the vector, the recombinant RNA molecule or a formulation thereof.

[0224] 93. A method for establishing a synthetic split viral satellite RNA in a plant cell, the method comprising: providing a recombinant RNA molecule as described in any of Examples 47 to 64 to a plant cell, and wherein the plant cell contains a RDRP protein that recognizes the 5' RNA replication element and the 3' RNA replication element, whereby the RDRP protein catalyzes the synthesis of a synthetic split viral satellite RNA from the recombinant RNA molecule.

[0225] 94. The method of embodiment 93, wherein the plant cell comprises a split virus, and wherein the RDRP protein is provided to the plant cell by the split virus.

[0226] 95. A method as described in embodiment 93 or 94, wherein the recombinant RNA molecule comprises an operably linked encapsidation recognition element (ERE) recognized by a viral capsid protein.

[0227] 96. The method of embodiment 93, 94 or 95, wherein the plant cell comprises the viral capsid protein or a polynucleotide encoding the viral capsid protein.

[0228] 97. The method of embodiment 93, 94 or 95, wherein the capsid protein comprises a separate viral capsid protein and the ERE is recognized by the separate viral capsid protein.

[0229] 98. The method of any one of embodiments 93 to 97, wherein the mesomevirus is unique to the plant cell, optionally wherein the unique mesomevirus is non-pathogenic and / or symbiotic.

[0230] 99. A method for obtaining a phenotypic change in a plant or plant cell, the method comprising: providing a plant or plant cell with a recombinant DNA molecule or a formulation thereof as described in any one of embodiments 1 to 23, a cell or a formulation thereof as described in embodiment 25, a vector or a formulation thereof as described in any one of embodiments 26 to 29, a recombinant RNA molecule as described in any one of embodiments 47 to 64, or a formulation as described in any one of embodiments 66 to 69, wherein the cargo RNA molecule comprises RNA that achieves a phenotypic change in the plant or plant cell compared to a plant or plant cell lacking the recombinant RNA, wherein the plant or plant cell comprises a RDRP protein that recognizes the 5' RNA replication element and the 3' RNA replication element and catalyzes the synthesis of a synthesized split viral RNA from the recombinant RNA molecule, and the cargo RNA molecule achieves the phenotypic change.

[0231] 100. A method as described in embodiment 99, wherein the RNA that achieves a phenotypic change in the plant or plant cell includes RNA that regulates the expression of the target gene relative to the expression of the target gene in a control plant or plant cell not provided with the recombinant RNA molecule, and wherein the phenotypic change is the result of the regulation.

[0232] 101. The method of embodiment 99 or 100, wherein the modulation is (a) an increase in target gene expression; or (b) a decrease in target gene expression.

[0233] 102. The method of embodiment 99, 100 or 101, wherein the RNA that effects the phenotypic change in the plant or plant cell inhibits expression of the target gene.

[0234] 103. The method of any one of embodiments 99 to 102, wherein the RNA that effects a phenotypic change in the plant or plant cell comprises at least one RNA selected from siRNA or siRNA precursors, miRNA or miRNA precursors, and phased siRNA or phased siRNA precursors.

[0235] 104. The method of any one of embodiments 99 to 102, wherein the RNA that effects a phenotypic change in the plant or plant cell comprises a messenger RNA.

[0236] 105. The method of embodiment 104, wherein the messenger RNA comprises an RNA molecule that is not present in the genome of the plant or plant cell.

[0237] 106. The method of any one of embodiments 99 to 102, wherein the RNA that effects a phenotypic change in the plant or plant cell comprises RNA for modifying the genome of the plant or plant cell.

[0238] 107. The method of any one of embodiments 99 to 102, wherein the RNA that effects a phenotypic change in the plant or plant cell comprises RNA that modifies the transcriptome and / or epigenome of the plant or plant cell.

[0239] 108. The method of embodiment 107, wherein the RNA used to modify the transcriptome targets an endogenous RNA of the plant, the endogenous RNA encoding an mRNA or a non-coding RNA for degradation.

[0240] 109. A method as described in Example 108, wherein the RNA used to modify the transcriptome comprises a hairpin RNA (hpRNA); an RNA that forms multiple stem loops; an RNA pseudoknot; an RNA molecule that forms at least partially double-stranded RNA; a small interfering RNA (siRNA) or an siRNA precursor; a microRNA (miRNA) or an miRNA precursor; a phased RNA or a phased RNA precursor; a ribozyme; a ligand-responsive ribozyme (aptazyme); an RNA aptamer; or a long noncoding RNA (lncRNA).

[0241] 110. The method of embodiment 107, wherein the RNA used to modify the epigenome targets an endogenous plant gene for RNA-induced transcriptional silencing.

[0242] 111. A method of increasing resistance of a plant to a pest or pathogen, the method comprising providing to a plant a recombinant DNA molecule or formulation thereof as described in any one of embodiments 1-23, a cell or formulation thereof as described in embodiment 25, a vector or formulation thereof as described in any one of embodiments 26-29, a recombinant RNA molecule as described in any one of embodiments 47-64, or a formulation as described in any one of embodiments 66-69, wherein the cargo RNA molecule effects an increase in resistance of the plant to the pest or pathogen compared to a plant lacking the recombinant RNA molecule, and wherein the plant or plant cell comprises a RDRP protein that recognizes the 5' RNA replication element and the 3' RNA replication element of the recombinant RNA and catalyzes the synthesis of a synthesized split viral satellite RNA from the recombinant RNA molecule.

[0243] 112. The method of embodiment 111, wherein the pest or pathogen is selected from the group consisting of bacteria, viruses other than mycoviruses, fungi, oomycetes, and invertebrates.

[0244] 113. The method of embodiment 111 or 112, wherein the cargo RNA molecule comprises RNA that inhibits gene expression of the pest or pathogen and / or inhibits genome replication of the pest or pathogen.

[0245] 114. The method of embodiment 111 or 112, wherein the cargo targets endogenous RNA of the pest or pathogen for degradation.

[0246] 115. The method of any one of embodiments 111 to 114, wherein the cargo RNA comprises a hairpin RNA (hpRNA); an RNA that forms multiple stem loops; an RNA pseudoknot; an RNA molecule that forms at least partially double-stranded RNA; a small interfering RNA (siRNA) or an siRNA precursor; a microRNA (miRNA) or an miRNA precursor; a phased RNA or a phased RNA precursor; a ribozyme; a ligand-responsive ribozyme (aptazyme); an RNA aptamer; or a long noncoding RNA (lncRNA).

[0247] 116. The method of any one of embodiments 111 to 115, wherein the cargo RNA targets an endogenous pest or pathogen gene for RNA-induced transcriptional silencing.

[0248] 117. A method of increasing resistance to stress in a plant, the method comprising: providing to a plant a recombinant DNA molecule or formulation thereof as described in any one of embodiments 1-23, a cell or formulation thereof as described in embodiment 25, a vector or formulation thereof as described in any one of embodiments 26-29, a recombinant RNA molecule as described in any one of embodiments 47-64, or a formulation as described in any one of embodiments 66-69, wherein the plant comprises a RDRP protein that recognizes the 5' RNA replication element and the 3' RNA replication element of the recombinant RNA and catalyzes the synthesis of a synthetic split viral satellite RNA from the recombinant RNA molecule, and wherein the cargo RNA molecule effects an increase in the resistance of the plant to stress compared to a plant lacking the recombinant RNA molecule.

[0249] 118. The method of embodiment 117, wherein the stress comprises at least one abiotic stress comprising nutrient stress, light stress, water stress, heat stress and / or cold stress.

[0250] 119. The method of embodiment 117, wherein the stress comprises at least one biotic stress comprising crowding, shading, or allelopathy.

[0251] 120. The method of embodiment 117, 118 or 119, wherein the cargo RNA molecule that achieves increased resistance of the plant to stress comprises RNA for modifying the transcriptome and / or epigenome of the plant or plant cell.

[0252] 121. The method of embodiment 120, wherein the RNA used to modify the transcriptome targets an endogenous RNA of the plant, the endogenous RNA encoding an mRNA or a non-coding RNA for degradation.

[0253] 122. A method as described in embodiment 120 or 121, wherein the RNA used to modify the transcriptome comprises a hairpin RNA (hpRNA); an RNA that forms multiple stem loops; an RNA pseudoknot; an RNA molecule that forms at least partially double-stranded RNA; a small interfering RNA (siRNA) or an siRNA precursor; a microRNA (miRNA) or an miRNA precursor; a phased RNA or a phased RNA precursor; a ribozyme; a ligand-responsive ribozyme (aptazyme); an RNA aptamer; or a long noncoding RNA (lncRNA).

[0254] 123. The method of embodiment 120, wherein the RNA used to modify the epigenome targets an endogenous plant gene for RNA-induced transcriptional silencing.

[0255] 124. The method of any one of embodiments 93 to 123, wherein the recombinant RNA molecule is provided to the plant or plant cell in the form of RNA, encapsidated RNA, or a formulation thereof.

[0256] 125. A method as described in Example 124, wherein the encapsidated RNA comprises a synthetic split viral satellite particle.

[0257] 126. The method of any one of embodiments 93 to 125, wherein the providing comprises contacting the plant or plant cell with the RNA, encapsidated RNA, or a formulation thereof, optionally wherein contacting comprises spraying, dusting, injecting, or soaking the plant or plant cell with the RNA, encapsidated RNA, or a formulation thereof.

[0258] 127. The method of any one of embodiments 93 to 126, wherein the recombinant RNA further comprises a reverse complementary RNA molecule or a segment thereof.

[0259] 128. A method for producing an exogenous polypeptide in a plant or plant cell, the method comprising: providing a plant or plant cell comprising a recombinant DNA molecule as described in any one of embodiments 1 to 18 or 20 to 23, wherein the cargo RNA molecule encoded by the DNA molecule comprises a translatable messenger RNA encoding the exogenous polypeptide, wherein the plant or plant cell comprises a RDRP protein that recognizes the 5' RNA replication element and the 3' RNA replication element of the recombinant RNA and catalyzes the synthesis of a synthesized split viral satellite RNA from the recombinant RNA molecule, and wherein the exogenous polypeptide is translated from the translatable messenger.

[0260] 129. The method of any one of embodiments 91 to 127, further comprising the following first step: providing a plant population comprising the plant cells, the plant cells comprising a split virus providing the RDRP protein; and then providing the recombinant DNA molecule, the cell, the vector, the recombinant RNA molecule, or a formulation thereof, to the plant comprising the plant cells.

[0261] 130. The method of embodiment 129, wherein the split virus is provided exogenously to the plant cell.

[0262] 131. The method of embodiment 129, wherein the RDRP protein or a recombinant polynucleotide encoding the RDRP is provided exogenously to the plant cell.

[0263] 132. The method of embodiment 129, 130 or 131, further comprising the following first step: providing a plant population comprising the plant cells, the plant cells comprising the RDRP protein or a recombinant polynucleotide encoding the RDRP; and then providing the recombinant RNA molecule to the plants comprising the plant cells.

[0264] 133. The method of any one of embodiments 129 to 132, wherein the recombinant RNA molecule has been produced in a fermentation system.

[0265] 134. The method of any one of embodiments 91 to 133, further comprising the step of determining whether the plant cell comprises a split virus that can provide the RDRP.

[0266] 135. The method of embodiment 134, wherein the plant cell is determined to contain a somatic virus that can provide the RDRP, optionally wherein the somatic virus is not exogenously provided to the plant cell, the RDRP protein or a recombinant polynucleotide encoding the RDRP is not exogenously provided to the plant cell, or optionally wherein any combination of the somatic virus, the RDRP protein, or a polynucleotide encoding the RDRP is not exogenously provided to the plant cell.

[0267] 136. A method as described in embodiment 134 or 135, wherein the plant cell is determined to not contain a split virus that can provide the RDRP, and the split virus is provided to the cell exogenously, the RDRP protein or a recombinant polynucleotide encoding the RDRP is provided to the plant cell exogenously, or a combination of the split virus, the RDRP protein, or the polynucleotide encoding the RDRP is provided to the plant cell exogenously.

[0268] 137. The method of any one of embodiments 91 to 136, wherein the recombinant RNA molecule comprises an operably linked encapsidation recognition element (ERE) recognized by a viral capsid protein.

[0269] 138. The method of embodiment 137, wherein the plant cell comprises the viral capsid protein or a polynucleotide encoding the viral capsid protein.

[0270] 139. The method of embodiment 138, wherein the capsid protein comprises a separate viral capsid protein, and the ERE is recognized by the separate viral capsid protein.

[0271] 140. A method for making a synthetic split viral satellite particle, the method comprising: (a) providing a recombinant RNA molecule as described in any of Examples 47 to 64 to a plant cell, wherein the recombinant RNA molecule comprises an encapsidation recognition element (ERE), and wherein the plant cell comprises a RDRP protein and a viral capsid protein, the RDRP protein recognizes the 5' RNA replication element and the 3' RNA replication element and catalyzes the synthesis of a synthetic split viral satellite RNA from the recombinant RNA molecule, wherein the ERE provides encapsidation of the RNA by the viral capsid protein; and optionally (b) isolating the synthetic split viral satellite particle from the plant cell, a plant comprising the plant cell, or from a culture medium in which the plant cell or the plant is grown.

[0272] 141. A method as described in Example 140, wherein the RDRP and / or the viral capsid protein: (a) is expressed by a recombinant DNA molecule in the cell, (b) is provided to the cell exogenously; (c) is expressed by a recombinant RNA molecule in the cell; or (d) is expressed by a virus in the cell.

[0273] 142. The method of embodiment 140, wherein the plant cell comprises a split virus expressing the RDRP protein and / or the viral capsid protein.

[0274] 143. The method of embodiment 142, wherein the split virus naturally exists in the plant cell.

[0275] 144. The method of embodiment 140, 142 or 143, wherein the split virus is provided to the plant cell.

[0276] 145. methods as described in any one of embodiments 140 to 144, wherein said recombinant RNA molecule is provided to said plant cell by a recombinant DNA construct, said recombinant DNA construct is included in a promoter functional in said plant cell and operably connected to a DNA molecule encoding said recombinant RNA molecule, optionally wherein said recombinant DNA construct further comprises a DNA molecule encoding said RDRP and / or a viral capsid protein.

[0277] 146. The method of any one of embodiments 140 to 145, further comprising a step of purifying the synthetic split viral satellite particles.

[0278] 147. The method of any one of embodiments 140 to 146, further comprising the step of formulating the synthetic split viral satellite particles.

[0279] 148. The method of embodiment 147, wherein the formulation comprises combining the synthetic split viral satellite particles with a carrier, excipient and / or adjuvant.

[0280] 149. A method for producing synthetic split viral satellite particles, the method comprising combining a recombinant RNA molecule as described in any one of Examples 47 to 64 with a viral capsid protein in a container, wherein the recombinant RNA molecule comprises an encapsidation recognition element (ERE), and wherein the ERE provides encapsidation of the RNA by the viral capsid protein in the container; optionally wherein the method further comprises separating the synthetic split viral satellite particles from uncombined RNA and / or viral capsid protein in the container.

[0281] 150. The method of embodiment 149 further comprises the following steps: separating the synthetic split viral satellite particles from the uncombined RNA and / or viral capsid protein in the container and purifying the separated synthetic split viral satellite particles.

[0282] 151. The method of embodiment 149 or 150, further comprising the step of purifying the isolated synthetic split viral satellite particles.

[0283] 152. The method of embodiment 149, 150 or 151, further comprising the step of formulating the synthetic split viral satellite particles.

[0284] 153. The method of embodiment 152, wherein the formulation comprises combining the synthetic split viral satellite particles with a carrier, excipient and / or adjuvant.

[0285] 154. The method of any one of embodiments 149 to 153, wherein the recombinant RNA further comprises a reverse complementary RNA molecule thereof or at least a segment thereof.

[0286] 155. A synthetic split viral satellite particle prepared by the method of any one of embodiments 140 to 153.

[0287] 156. An agricultural formulation comprising a synthetic split viral satellite particle prepared by the method of any one of embodiments 140 to 153.

[0288] 157. A method of providing a synthetic split viral satellite particle to a plant, the method comprising contacting the plant with the synthetic split viral satellite particle of embodiment 155 or the formulation of embodiment 156.

[0289] 158. The method of embodiment 157, wherein contacting comprises spraying, dusting, injecting or soaking with the synthetic split viral satellite particles or the formulation.

[0290] 159. A plant propagule comprising the recombinant RNA molecule of any one of embodiments 47 to 65 and a partiviral RDRP.

[0291] 160. The plant propagule of embodiment 159, wherein the plant propagule is a seed.

[0292] 161. The plant propagule of embodiment 159, wherein the plant propagule comprises a seedling, a root, a stem, a leaf, a bud, a tuber, a rhizome, a runner, a bulb, an explant, an embryo, or a callus.

[0293] 162. A plant propagule comprising at least one plant cell of embodiment 72 and a split viral RDRP.

[0294] 163. The plant propagule of embodiment 162, wherein the plant propagule comprises cells, or seeds, seedlings, ovules, embryos, pollen, roots, stems, leaves, buds, tubers, rhizomes, runners, bulbs, explants or callus containing the cells.

[0295] 164. The plant propagule of embodiment 162, wherein the plant propagule is a seed.

[0296] 165. The plant propagule of embodiment 162, 163 or 164, wherein the propagule is a chimera comprising a plant cell containing the split viral RDRP and a plant cell lacking the split viral RDRP.

[0297] 166. The plant propagule of any one of embodiments 162 to 165, wherein the plant propagule is a chimera comprising a plant cell containing the recombinant RNA molecule and a plant cell lacking the recombinant RNA molecule.

[0298] 167. The plant propagule of any one of embodiments 162 to 166, wherein the plant propagule lacks DNA encoding the recombinant RNA molecule.

[0299] 168. A method for producing a modified plant propagule, the plant propagule comprising at least one plant cell containing a recombinant RNA molecule as described in embodiments 47 to 65, the method comprising isolating a plant propagule comprising at least one plant cell containing the recombinant RNA molecule and a split viral RNA-dependent RNA polymerase (RDRP) from a mixed population of plant cells comprising plant cells containing the recombinant RNA molecule and plant cells lacking the recombinant RNA molecule.

[0300] 169. The method of embodiment 168, wherein the mixed population of plant cells comprises a population of protoplasts or a population of cells in callus or explants.

[0301] 170. The method of embodiment 168 or 169, wherein the mixed population of plant cells comprises plant cells containing the mereoviral RDRP and plant cells lacking the mereoviral RDRP.

[0302] 171. The method of embodiment 168 or 169, wherein the mixed population of plant cells comprises plant cells containing the split virus RDRP.

[0303] 172. The method of any one of embodiments 168 to 171, wherein the mixed population of plant cells is screened or selected for the presence of plant cells comprising the recombinant RNA molecule prior to isolating the plant propagules.

[0304] 173. The method of any one of embodiments 168 to 172, wherein said isolating comprises selecting a plant cell comprising said recombinant RNA molecule prior to isolating said plant propagule.

[0305] 174. The method of any one of embodiments 168 to 173, wherein the mixed population is within a plant or plant part.

[0306] 175. The method of embodiment 174, wherein the plant or plant part is screened or selected for the presence of the recombinant RNA molecule prior to isolating the plant propagules.

[0307] 176. The method of embodiment 174, wherein the plants or plant parts are screened or selected for the systemic presence of the recombinant RNA molecule prior to isolating the plant propagules.

[0308] 177. The method of any one of embodiments 168 to 176, wherein said recombinant RNA molecule encodes a selectable marker, and plant propagules comprising said recombinant RNA molecule are isolated by selecting for the presence of said selectable marker.

[0309] 178. The method of embodiment 177, further comprising selecting plant propagules comprising the recombinant RNA molecule, wherein the selectable marker has been removed.

[0310] 179. The method of any one of embodiments 168 to 176, wherein the plant propagule comprising the recombinant RNA molecule is isolated by detecting the RNA molecule in one or more plant cells comprising the recombinant RNA molecule, and separating the one or more plant cells comprising the recombinant RNA molecule from plant cells lacking the recombinant DNA molecule.

[0311] 180. The method of any one of embodiments 168 to 179, wherein the plant propagule is a chimera comprising a plant cell containing the recombinant RNA molecule and a plant cell lacking the recombinant RNA molecule.

[0312] 181. The method of any one of embodiments 168 to 180, wherein the plant propagule is a chimera comprising a plant cell containing the split viral RDRP and a plant cell lacking the split viral RDRP.

[0313] 182. The method of any one of embodiments 168 to 181, wherein said plant propagules lack DNA encoding said recombinant RNA molecule.

[0314] 183. The method of embodiment 174, wherein the plant or plant part lacks DNA encoding the recombinant RNA molecule.

[0315] 184. The method of any one of embodiments 168 to 183, wherein the plant propagule comprises the cell, or a seed, seedling, root, stem, leaf, bud, tuber, rhizome, runner, bulb, explant, or callus containing the cell.

[0316] 185. The method of embodiment 184, further comprising propagating the cell, seed, seedling, root, stem, leaf, bud, tuber, rhizome, runner, bulb, explant or callus to obtain progeny, wherein the progeny comprises the recombinant RNA molecule.

[0317] 186. The method of embodiment 185, wherein the propagating comprises culturing a plurality of explants obtained from the cell, seed, seedling, root, stem, leaf, bud, tuber, rhizome, runner, bulb, explant, or callus.

[0318] 187. methods as described in any one of embodiments 168 to 186, wherein said isolated propagule comprises said cell, and said method further comprises regenerating a plant, seedling, root, stem, leaf, bud, tuber, rhizome, runner, bulb, explant or callus comprising said recombinant RNA from said cell.

[0319] 188. The method of any one of embodiments 168 to 186, wherein the isolated propagule comprises callus, and the method further comprises regenerating a plant, seedling, root, stem, leaf, bud, tuber, rhizome, runner, bulb or explant comprising the recombinant RNA from the callus.

[0320] 189. The method of embodiment 187 or 188, wherein a plant is regenerated, and wherein the method further comprises recovering an F1 seed or F1 progeny comprising the recombinant RNA from the plant.

[0321] 190. A method for providing a synthetic split virus satellite RNA to a plant, the method comprising: grafting a scion onto a rootstock comprising a recombinant RNA molecule as described in any one of Embodiments 47 to 65, wherein at least one cell in the rootstock and / or the scion comprises a split virus RDRP.

[0322] 191. The method of embodiment 190, wherein the scion lacks the recombinant RNA molecule prior to grafting.

[0323] 192. The method of embodiment 190 or 191, wherein the rootstock comprises the split virus RDRP.

[0324] 193. The method of any one of embodiments 190 to 192, wherein the RDRP is provided by a rootstock-specific mereovirus, optionally wherein the rootstock-specific mereovirus is non-pathogenic and / or symbiotic.

[0325] 194. The method of any one of embodiments 190 to 192, wherein the RDRP is provided exogenously to the rootstock.

[0326] 195. The method of any one of embodiments 190 to 194, wherein the scion comprises the split virus RDRP.

[0327] 196. The method of any one of embodiments 190 to 194, wherein the RDRP is provided by a scion-specific mereovirus and / or wherein the RDRP is provided exogenously to the scion, optionally wherein the scion-specific mereovirus is non-pathogenic and / or commensal.

[0328] 197. A method for producing a plant that transmits a recombinant RNA molecule to a progeny plant or seed, the method comprising obtaining from a parent plant comprising a recombinant RNA molecule as described in any one of embodiments 47 to 65 an F 1 A method of isolating a plant or seed population containing at least one cell containing a split viral RNA-dependent RNA polymerase (RDRP) and the recombinant RNA molecule. 1 Progeny plants or seeds.

[0329] 198. The method of embodiment 197, wherein the F 1 Progeny plants or seeds are isolated by screening the F 1 Whether the recombinant RNA molecule is present in a plant or seed population, and whether ... 1 Progeny plants or seeds.

[0330] 199. A method as described in embodiment 197, wherein the recombinant RNA molecule encodes a selectable marker and comprises the F of the recombinant RNA molecule. 1 Progeny plants or seeds are isolated by selecting for the presence or absence of the selectable marker and comprising the recombinant RNA molecule. 1 Progeny plants or seeds.

[0331] 200. The method of any one of embodiments 197 to 199, wherein the F 1 Progeny plants or seeds lack the DNA encoding the recombinant RNA molecule.

[0332] 201. The method of any one of embodiments 197 to 200, wherein the parent plant lacks DNA encoding the recombinant RNA molecule.

[0333] 202. The method of embodiment 199, wherein the selected F 1 The progeny plants transmit the recombinant RNA molecule to at least F 2 Offspring.

[0334] 203. The method of any one of embodiments 197 to 202, wherein the F 1 Progeny plants or seed populations are obtained from the parent plant that served as the pollen recipient.

[0335] 204. The method of any one of embodiments 197 to 202, wherein the F 1 Progeny plants or seed populations are obtained from the parent plant that served as the pollen donor.

[0336] 205. The method of any one of embodiments 197 to 202, wherein the F 1 Progeny plants or seed populations are obtained by selfing the parent plants.

[0337] 206. The method of any one of embodiments 197 to 205, wherein in separating the F 1 Progeny plants or seeds are previously screened or selected for the presence of the recombinant RNA molecule from the parent plant or part thereof comprising the plant cell.

[0338] 207. The method of any one of embodiments 197 to 205, wherein in isolating the F 1 Progeny plants are previously screened for the systemic presence of the recombinant RNA molecule from the parent plant or one or more parts thereof, optionally wherein the parts comprise floral tissue or male or female reproductive tissue.

[0339] 208. The method of any one of embodiments 197 to 207, wherein the pericarp of the parent plant is screened or selected for the presence of the recombinant RNA molecule.

[0340] 209. The method of any one of embodiments 197 to 207, wherein F 1 Seeds are obtained from parent plants selected for the presence of the recombinant RNA molecule in pericarp tissue.

[0341] 210. The method of any one of embodiments 197 to 209, wherein the F of the parent plant is non-destructively screened for the presence of the recombinant RNA molecule. 1 seed.

[0342] 211. The method of embodiment 210, wherein the F of the parental plant is non-destructively screened by determining the presence of the recombinant RNA molecule in maternal origin or endosperm tissue of the seed. 1 seed.

[0343] 212. The method of any one of embodiments 197 to 211, further comprising introducing the recombinant RNA molecule or a polynucleotide encoding the recombinant RNA molecule into a plant cell and obtaining a parent plant comprising the recombinant RNA molecule from the plant cell.

[0344] 213. The method of any one of embodiments 168-212, wherein the propagule, plant, plant part, scion and / or stock comprises a heterologous viral coat protein that can encapsidate the recombinant RNA molecule and / or comprises the recombinant RNA molecule encapsidated by a heterologous viral coat protein.

[0345] 214. A method for barcoding a plant, a plant cell, a progeny thereof, or a part thereof, the method comprising providing to the plant or plant cell a recombinant RNA molecule as described in any one of embodiments 47 to 65, wherein the cargo RNA of the recombinant RNA molecule comprises a barcode RNA molecule, and wherein the plant or plant cell comprises a split viral RNA-dependent RNA polymerase (RDRP).

[0346] 215. The method of embodiment 214, wherein the barcode RNA molecule comprises a sequence that uniquely identifies the plant, plant cell, progeny thereof, or a part thereof.

[0347] 216. The method of embodiment 214 or 215, wherein the barcode RNA molecule comprises a sequence that is not present in the genome and / or transcriptome of a wild-type plant of the same species, its pathogen, or its symbiont.

[0348] 217. The method of any one of embodiments 214-216, wherein the barcode RNA molecule comprises a random sequence.

[0349] 218. The method of any one of embodiments 214-217, wherein the barcode RNA molecule comprises a forward primer binding site and a reverse primer binding site that are not present in the genome and / or transcriptome of a wild-type plant of the same species, its pathogen, or its symbiont.

[0350] 219. The method of any one of embodiments 214-217, wherein the barcode RNA molecule is up to about 3.2 kb in length.

[0351] 220. The method of any one of embodiments 214-219, wherein the barcode RNA molecule has a length of 10 to 3200 nucleotides, 20 to 1000 nucleotides, or 50 to 500 nucleotides, optionally wherein the barcode RNA molecule has a length of 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, 1000, 1500, 2000, 2500, 3000, or 3200 nucleotides.

[0352] 221. The method of any one of embodiments 214-220, wherein the barcode RNA molecule comprises a non-protein coding sequence.

[0353] 222. The method of any one of embodiments 214-221, wherein said plant transmits said recombinant RNA molecule to progeny.

[0354] 223. The method of any one of embodiments 214-222, wherein the plant, plant cell, progeny thereof, or part thereof lacks DNA encoding the recombinant RNA molecule.

[0355] 224. The method of any one of embodiments 214-223, further comprising isolating an F comprising at least one cell 1 A progeny plant or seed, wherein at least one cell comprises the split viral RDRP and the recombinant RNA molecule.

[0356] 225. The method of embodiment 224, wherein the F 1 Progeny plants or seeds are obtained from the plants used as pollen recipients.

[0357] 226. The method of embodiment 224, wherein the F 1 Progeny plants or seeds are obtained from the plant used as the pollen donor.

[0358] 227. The method of any one of embodiments 224-227, wherein the F 1 Progeny plants or seeds are obtained by selfing said plants.

[0359] 228. The method of any one of embodiments 214-227, further comprising propagating the plant or plant cell to obtain a plant part or plant propagule comprising the barcode RNA molecule, optionally wherein the propagule comprises callus, tuber and / or rootstock.

[0360] 229. A method of identifying a barcoded plant, plant part, or plant cell, the method comprising screening the plant, plant part, or plant cell for the presence of a barcode RNA molecule, wherein the plant, plant part, or plant cell comprises the recombinant RNA molecule of any one of embodiments 47 to 65, wherein a cargo RNA of the recombinant RNA molecule comprises the barcode RNA molecule.

[0361] 230. The method of embodiment 229, wherein the barcode RNA molecule comprises a sequence that uniquely identifies the plant, plant part, or plant cell.

[0362] 231. The method of embodiment 229 or 230, wherein the barcode RNA molecule comprises a sequence that is not present in the genome and / or transcriptome of a wild-type plant of the same species, its pathogen, or its symbiont.

[0363] 232. The method of any one of embodiments 229-231, wherein the barcode RNA molecule comprises a random sequence.

[0364] 233. The method of any one of embodiments 229-232, wherein the barcode RNA molecule comprises a forward primer binding site and a reverse primer binding site that are not present in the genome and / or transcriptome of a wild-type plant of the same species, its pathogen, or its symbiont.

[0365] 234. The method of any one of embodiments 229-233, wherein the barcode RNA molecule is up to about 3.2 kb in length.

[0366] 235. The method of any one of embodiments 229-233, wherein the barcode RNA molecule has a length of 10 to 5000 nucleotides, 20 to 1000 nucleotides, or 50 to 500 nucleotides, optionally wherein the barcode RNA molecule has a length of 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, 1000, 1500, 2000, 2500, 3000, 3500, 4000, 4500, or 5000 nucleotides.

[0367] 236. The method of any one of embodiments 229-235, wherein the barcode RNA molecule comprises a non-protein coding sequence.

[0368] 237. The method of any one of embodiments 229-236, wherein the method comprises obtaining a nucleic acid sample from the plant, plant part, or plant cell; and detecting the presence of the barcode RNA molecule in the sample.

[0369] 238. The method of any one of embodiments 229-237, wherein the screening comprises amplification and / or sequencing of the barcode RNA molecules.

[0370] 239. The method of any one of embodiments 229-238, wherein the screening comprises detecting the barcode RNA molecule with a hybridization probe that hybridizes to at least a portion of the barcode RNA molecule.

[0371] 240. A method as described in Example 239, wherein the hybridization probe comprises a detectable label.

[0372] 241. The method of any one of embodiments 229-240, wherein the plant part comprises a seed, a seedling, an ovule, an embryo, pollen, a root, a stem, a leaf, a bud, a tuber, a rhizome, a runner, a bulb, an explant, or a callus.

[0373] 242. The method of embodiment 241, wherein the seeds are non-destructively screened for the presence of the barcode RNA molecule.

[0374] 243. The method of any one of embodiments 229-242, wherein the plant, plant part, or plant cell comprises a split viral RDRP.

[0375] 244. A plant comprising the recombinant RNA molecule of any one of embodiments 47-65 and a partiviral RDRP.

[0376] 245. The plant of embodiment 244, wherein said plant is a monocot or a dicot.

[0377] 246. The plant of embodiment 244 or 245, wherein the plant is of the family Asteraceae, Cucurbitaceae, Leguminosae, Poaceae, or Solanaceae.

[0378] 247. The plant of any one of embodiments 244-246, wherein said plant lacks DNA encoding said recombinant RNA molecule.

[0379] 248. The plant of any one of embodiments 244-247, wherein the plant comprises a mereovirus, and wherein the mereovirus RDRP is provided to the plant cells by the mereovirus, optionally wherein the mereovirus RDRP comprises a protein having at least 85%, 90%, 95%, 97% or 99% sequence identity to SEQ ID NOs: 272-290, 384 or 390.

[0380] 249. The plant of any one of embodiments 244-248, wherein the mesomevirus is unique to the plant, optionally wherein the unique mesomevirus is non-pathogenic and / or symbiotic.

[0381] 250. The plant of any one of embodiments 244-249, wherein said splitiviral RDRP, said 5' replication element and / or said 3' replication element are derived from a splitivirus comprising one or both of said splitiviral RDRP, said 5' replication element and / or said 3' replication element.

[0382] 251. The plant of any one of embodiments 244-250, wherein the RDRP is at least 85%, 90%, 95%, 97%, 98% or 99% identical to SEQ ID NOs: 272-290, 384 or 390, wherein the 5' replication element is at least 85%, 90%, 95%, 97%, 98% or 99% identical to an RNA encoded by SEQ ID NOs: 2-34, 70-88, 372, 374, 376, 378, 380, 382 or 386, and / or wherein the 3' replication element is at least 85%, 90%, 95%, 97%, 98% or 99% identical to an RNA encoded by SEQ ID NOs: 35-68, 89-108, 373, 375, 377, 379, 381, 383 or 387.

[0383] 252. The plant of any one of embodiments 244-251, wherein the plant is a grafted plant, and wherein the rootstock and / or scion of the grafted plant comprises at least one cell containing the recombinant RNA and the split viral RDRP.

[0384] 253. The plant of any one of embodiments 244-252, wherein said plant is not produced by a substantially biological process.

[0385] 254. A split virus satellite system that can self-replicate when introduced into a plant or plant cell, the split virus satellite system comprising: (1) a recombinant split virus satellite RNA, which comprises, from the 5' end to the 3' end: (a) a 5' RNA replication element recognized by a split virus RNA-dependent RNA polymerase (RDRP); (b) a cargo RNA molecule; and (c) a 3' RNA replication element recognized by the RDRP; wherein the 5' RNA replication element, the cargo RNA molecule, and the 3' RNA replication element are operably linked, and wherein the promoter and the cargo RNA molecule are heterologous to the 5' RNA replication element and the 3' RNA replication element; and (2) an exogenous split virus that is capable of replicating in the plant or plant cell and encodes the split virus RDRP that recognizes the 5' and 3' replicase recognition sequences in the recombinant split virus satellite RNA.

[0386] 255. The self-replicating split virus satellite system of embodiment 254, wherein the exogenous split virus is unique or native to a different species, variety or germplasm of the plant.

[0387] 266. The plant propagule of any one of embodiments 159-167, wherein the plant propagule is not produced by an essentially biological process. Summary of the table Table 1. DNA coding sequences of 5' and 3' replication elements of the mitotic virus 1The descriptor "NC_XXXXXX" refers to the National Center for Biotechnology Information database accession number for an entry in the World Wide Web Internet database "ncbi.nlm.nih.gov / nuccore". 2 DNA sequences encoding the corresponding RNA molecules of the replication elements are provided. Table 2. Virus capsid protein and assembly origin sequences 1 The descriptor "NC_XXXXXX.1" refers to the National Center for Biotechnology Information database accession number for an entry in the World Wide Web Internet database "ncbi.nlm.nih.gov / nuccore". 2 RNA equivalents of the DNA sequences are also provided. Table 3. Mobile proteins. 1 The descriptor "NC_XXXXXX.1" refers to the National Center for Biotechnology Information database accession number for an entry in the World Wide Web Internet database "ncbi.nlm.nih.gov / nuccore". Table 4. tRNA-like sequences 1 The descriptor "ATXXXXXXX.X" refers to the Arabidopsis Information Resource (TAIR) database accession number for an entry in the World Wide Web Internet database "arabidopsis.org". Table 5. IRES sequences IRES Name <![CDATA[Sequence 1 > EMCV IRES SEQ ID NO:232 CrTMV IRES SEQ ID NO:233 HCRSV IRES SEQ ID NO:234 ZmHSP101IRES SEQ ID NO:235 1 DNA equivalents of the RNA sequences are also provided. Table 6. Intron sequences Table 7: Split virus CP genome and CP sequence Table 8. Sequences of the RDRP of the splice virus Table 9. 5' and 3' replication element pairs of the splice virus capsid genome Table 10 5' and 3' replication element pairs of RdRP genomes of the split viruses and RdRP Examples Example 1. Replication of PCV1 and SCV1 in Nicotiana benthamiana plants.

[0388] T-DNA encoding the expression cassette containing the intronic RDRP and CP genomes of pepper latent virus 1 (PCV1) and spinach latent virus 1 (SCV1) was constructed. The vector containing the T-DNA encoding the PCV1 RDRP genome was Figure 8 The vector comprising the T-DNA encoding the PCV1 CP genome is shown in SEQ ID NO: 255 (Table 11). Fig. 9 The vector containing the T-DNA encoding the SCV1 RDRP genome is shown in SEQ ID NO: 256 (Table 12). Fig.10 The vector comprising the T-DNA encoding the SCV1 CP genome is shown in SEQ ID NO: 257 (Table 13). Fig.12 , and the sequence of the vector is provided in SEQ ID NO: 259 (Table 14). These T-DNA-containing vectors were transformed into Agrobacterium. The strains with T-DNA encoding the RDRP and CP of the specific split virus were infiltrated into Nicotiana benthamiana leaves. Six days later, RNA was collected from the infiltration site and cDNA was generated using negative strand specific primers. RT-PCR was then used to assay the cDNA for the presence of correctly spliced ​​RNA genomes, which are only produced when the transcribed RNA has been replicated by the delivered viral RDRP, indicating that the construct is able to reproduce in vivo viral replication. The results of the experiment are shown in Figure 4 and Figure 5 Primers that hybridize to the negative strands of the PCV1 and SCV1 genomes each produce products indicative of viral replication mediated by RDRP. Table 11 Table 12 Table 13 Table 14 Example 2. Systemic movement of SCV1 in spinach plants with the support of movement proteins.

[0389] Figure 6 The experiment shown in was performed as follows. A T-DNA encoding an expression cassette for a symbiotic satellite RNA ("comsat") of Spinach latent virus 1 (SCV1) with a cargo RNA encoding a TMV movement protein (MP) and a tRNA-like element was constructed. A vector containing this T-DNA was constructed in Fig.11 The T-DNA was transformed into Agrobacterium. The resulting strain was used to infiltrate leaves on Bloomsdale spinach plants infected with SCV1 and producing SCV1 RDRP. After 58 days, RNA was collected from non-infiltrated leaves of the system and RT-PCR was performed for TMV MP cargo. The mobility and persistence of SCV1 comsat was observed in several plants, such as Figure 7 This result was replicated in a second set of experiments. Table 15 Example 3. Vertical transmission of cargo RNA in plants

[0390] This example demonstrates how a symbiotic satellite RNA of a split virus can be used to generate plants with satellite RNA without the need for transgenesis.

[0391] Plants (e.g., N. benthamiana, spinach, pepper, or tomato) containing the SCV1 or PCV1 genomes shown in Example 1, spinach plants containing the SCV comsat shown in Example 2, or other symbiotic satellite RNAs ("comsat") provided herein (e.g., comsat containing a scorable or selectable marker) were generated. The systemic mobility and persistence of these molecules in these plants were demonstrated in systemic tissues using RT-PCR. The plants were then grown to maturity and the fruits were harvested. Plant tissues (e.g., the peel of the fruit) were screened for the presence of the delivered symbiotic virus comsat using RT-PCR, selectable markers, or scorable markers, and the assayed fruits containing comsat were identified.

[0392] From the ripe fruit of these plants, collect seeds, carry out vernalization if necessary, and then plant in the soil.Then collect the cotyledons or other tissues from these seedlings, and independently extract RNA.Can use merged screening strategy, wherein will combine from the RNA of seedling, and use RT-PCR to find whether there is the comsat of sending or the product (for example, cargo RNA or protein) of coding in these tissues.In merged group, observe positive signal.Measure each individual in positive merged group, and identify one or more positive individuals in each merge.Therefore, obtain thus the result of the vertical transmission of indication split virus comsat.

[0393] Then make the plant growth of successful vertical propagation to maturity.At this, it is expected that the cargo RNA in comsat or the protein encoded by comsat is expressed.Such expression can be confirmed by PT-PCR determination (for RNA), protein determination (immunity and / or for enzyme activity in the applicable case) and / or phenotypic determination (for example, for the proterties given by the coded RNA or protein). Example 4. Replication of PCV1 in bell pepper plants.

[0394] An Agrobacterium strain harboring T-DNA encoding the RDRP and CP genomes of PCV1 shown in Example 1 (SEQ ID NOs: 255 and 256) was infiltrated into bell pepper ( Capsicum annuum ) leaves. Five days later, RNA was collected from the infiltration site. cDNA was generated and RT-PCR was used to determine the presence of correctly spliced ​​RNA. The primers produced products corresponding to amplification of cDNA synthesized from both the (+) and (-) strands of the spliced ​​RNA, which were independent of the presence of the T-DNA encoding the PCV1 RDRP. Example 5. Systemic movement of PCV1 in Nicotiana benthamiana plants.

[0395] An Agrobacterium strain harboring T-DNA encoding the RDRP and CP genomes of PCV1 shown in Example 1 (SEQ ID NOs: 255 and 256) was infiltrated into N. benthamiana leaves. After 28 days, RNA was collected from tissues at the infiltration site, surrounding tissues, and apical leaf tissues to detect systemic movement. cDNA was generated from the RNA, and RT-PCR was used to assay for the presence of spliced ​​RNA. Spliced ​​RNA was detected in local leaf tissues as well as apical leaf tissues, indicating that at least PCV1 RNA moves systemically in N. benthamiana despite the lack of movement proteins. Sequencing of the PCR product from the apical leaf tissue confirmed that the signal was from PCV1 RNA. Example 6. Replication and systemic movement of SCV1 in Nicotiana benthamiana plants.

[0396] An Agrobacterium strain having T-DNA encoding the RDRP and CP genomes of SCV1 shown in Example 1 (SEQ ID NOs: 257 and 259) and T-DNA encoding SCV1 comsat having cargo RNA encoding TMV MP shown in Example 2 (SEQ ID NO: 258) was infiltrated into Nicotiana benthamiana leaves.

[0397] After 5 days, RNA was collected from infiltrated leaves and distal leaves (above infiltrated leaves). cDNA was generated from RNA and the presence of spliced ​​RNA was determined using RT-PCR. Spliced ​​RNA was detected in both sense and antisense RNA from infiltrated leaf tissue. No movement to distal leaves was detected 5 days after inoculation.

[0398] After 14 days, RNA was collected from infiltrated and distal leaves. cDNA was generated from the RNA and the presence of spliced ​​RNA was determined using RT-PCR. Spliced ​​RNA was detected in both sense and antisense RNA from infiltrated leaf tissue, indicating that SCV1 RNA persists in N. benthamiana (a non-host plant) for up to two weeks.

[0399] After 28 days, RNA was collected from infiltrated leaves, distal leaves, and apical leaves. cDNA was generated from the RNA, and RT-PCR was used to determine the presence of spliced ​​RNA. As expected, spliced ​​RNA was detected in both sense and antisense RNA from infiltrated leaf tissue. Spliced ​​RNA was also detected in distal and apical leaf tissue, indicating that SCV1 RNA is systemically moved in N. benthamiana with the support of mobile proteins. Sequencing of PCR products from distal and apical leaf tissues confirmed that the signal was from SCV1 RNA.

[0400] At 5, 14, and 28 dpi, the presence of both positive- and negative-strand SCV1 spliced ​​RNAs was independent of the presence of the SCV1 RdRP encoded by the T-DNA. Other embodiments

[0401] Although the foregoing disclosure has been described in some detail by way of illustration and example for purposes of clarity of understanding, the descriptions and examples should not be construed as limiting the scope of the disclosure.

[0402] Other embodiments are within the claims.

Claims

1. A recombinant RNA molecule comprising, from the 5' end to the 3' end: (a) 5' RNA replication element recognized by the mitotic viral RNA-dependent RNA polymerase (RDRP); (b) cargo RNA molecules; and (c) a 3' RNA replication element recognized by the RDRP; wherein the 5' RNA replication element, the cargo RNA molecule and the 3' RNA replication element are operably linked, and wherein the cargo RNA molecule is heterologous to the 5' RNA replication element and the 3' RNA replication element, optionally in: (i) the 5' RNA replication element and the 3' RNA replication element are obtained from the same mereoviral genome or from related mereoviral genomes that have at least 85%, 90%, 95%, 98% or 99% sequence identity to each other; (ii) the 5' RNA replication element, the 3' RNA replication element and the RDRP are obtained from the same mereoviral genome or from related mereoviral genomes that have at least 85%, 90%, 95%, 98% or 99% sequence identity to each other; or (iii) wherein the 5' RNA replication element, the 3' RNA replication element and / or the RDRP coding region are obtained from two separate viral genomes, wherein the members of each pair of the 5' RNA replication element, the 3' RNA replication element and / or the RDRP coding region have at least 85%, 90%, 95%, 98% or 99% sequence identity with each other.

2. The recombinant RNA molecule according to claim 1, in: (a) the 5' RNA replication element comprises at least one RNA secondary structure provided in Table 1, or at least one RNA secondary structure adopted by an RNA molecule encoded by SEQ ID NO: 1-34, 69-87, or 88, 372, 374, 376, 378, 380, 382 or 386; and / or (b) the 3' RNA replication element comprises at least one RNA secondary structure provided in Table 1, or at least one RNA secondary structure adopted by an RNA molecule encoded by SEQ ID NO: 35-68, 89-107, or 108, 373, 375, 377, 379, 381, 383 or 387.

3. The recombinant RNA molecule according to claim 1, in: (a) the 5' RNA replication element comprises an RNA molecule encoded by SEQ ID NO: 1-34, 69-87, or 88, 372, 374, 376, 378, 380, 382 or 386; or a variant thereof encoded by a DNA molecule having at least 70%, 75%, 80%, 85%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO: 1-34, 69-87, or 88, 372, 374, 376, 378, 380, 382 or 386; or a variant thereof, wherein one or more nucleotides in the RNA secondary structure are replaced by different nucleotides that maintain the RNA secondary structure; and / or (b) the 3' RNA replication element comprises an RNA molecule encoded by SEQ ID NO: 35-68, 89-107, or 108, 373, 375, 377, 379, 381, 383 or 387; or a variant thereof encoded by a DNA molecule having at least 70%, 75%, 80%, 85%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO: 35-68, 89-107, or 108, 373, 375, 377, 379, 381, 383 or 387; or a variant thereof, wherein one or more base-paired residues in the RNA secondary structure are substituted by different nucleotides that maintain the RNA secondary structure.

4. The recombinant RNA molecule of claim 3, wherein the RNA secondary structure is maintained by replacing non-base paired nucleotides in the secondary structure with nucleotides that will not base pair and / or replacing base paired nucleotides in the secondary structure with nucleotides that will base pair.

5. The recombinant RNA molecule according to claim 1, in: (a) the 5' RNA replication element comprises at least a segment of the 5' untranslated region (UTR) of the solivirus genome or a variant thereof having one or more nucleotide substitutions, insertions and / or deletions, wherein the variant is recognized by the RDRP, optionally wherein the 5' replicase replication element further comprises a genomic sequence of the solivirus that is naturally located 3' to and adjacent to the 5'UTR sequence; and / or (b) the 3' RNA replication element comprises at least a segment of the 3'UTR of the solivirus genome or a variant thereof having one or more nucleotide substitutions, insertions and / or deletions, wherein the variant is recognized by the RDRP, optionally wherein the 3' replicase replication element further comprises a genomic sequence of the solivirus that is naturally located 5' to and adjacent to the 3'UTR sequence, and optionally wherein the solivirus genomes of (a) and (b) are identical.

6. A recombinant RNA molecule as described in claim 1, wherein the RNA molecule further comprises at least one of the following: (i) a tRNA-like element, optionally wherein the tRNA-like element provides for cell-to-cell movement of the RNA, and optionally wherein the cell-to-cell movement is mediated by a viral movement protein (MP); (ii) an encapsidation recognition element (ERE), optionally wherein the ERE provides for encapsidation of the RNA by a dichotomous viral capsid protein, or optionally wherein the ERE provides for encapsidation of the RNA by a non-dichotomous viral capsid protein; (iii) an RNA effector; and / or (iv) an RNA encoding a viral movement protein (MP), optionally wherein an internal ribosome entry site (IRES) is operably linked to the RNA encoding the MP.

7. A recombinant RNA molecule according to claim 6, wherein the tRNA-like element comprises a tRNA-like molecule from Arabidopsis FT mRNA, or a tRNA-like sequence selected from SEQ ID NOs: 184-231, or a modified tRNA-like sequence having at least 90% sequence identity with a scaffold tRNA-like sequence selected from the group consisting of SEQ ID NOs: 184-231 and maintaining the secondary structure of the scaffold tRNA-like sequence, and / or wherein the ERE is Tobacco Mosaic Virus (TMV) OAS.

8. The recombinant RNA molecule of claim 1, wherein the cargo RNA molecule has a length of up to about 3.2 kb.

9. The recombinant RNA molecule of claim 1, wherein the cargo RNA molecule comprises: (a) at least one coding sequence, optionally wherein the coding sequence encodes a selectable or scorable marker; (b) at least one non-coding sequence; or (c) both at least one coding sequence and at least one non-coding sequence.

10. The recombinant RNA molecule of claim 24, wherein the cargo RNA molecule comprises at least one coding sequence, and wherein the RNA molecule further comprises an internal ribosome entry site (IRES) operably linked to the at least one coding sequence, optionally wherein the operably linked IRES is located 5' and immediately adjacent to the coding sequence.

11. The recombinant RNA molecule of claim 24, wherein the cargo RNA molecule comprises at least one non-coding sequence, and wherein the at least one non-coding sequence is a hairpin RNA (hpRNA); an RNA that forms multiple stem-loops; an RNA pseudoknot; an RNA molecule that forms at least partially double-stranded RNA; a small interfering RNA (siRNA) or an siRNA precursor; a microRNA (miRNA) or an miRNA precursor; a phased RNA or a phased RNA precursor; a ribozyme; a ligand-responsive ribozyme (aptazyme); an RNA aptamer; or a long non-coding RNA (lncRNA).

12. The recombinant RNA molecule of claim 1, further comprising RNA encoding at least one ribozyme, optionally wherein the at least one ribozyme is located 5' to the 5' RNA replication element or 3' to the 3' RNA replication element.

13. The recombinant RNA molecule of claim 1, further comprising an RNA molecule containing at least one ligand-responsive ribozyme (aptazyme), optionally wherein the at least one ligand-responsive ribozyme is located 5' to the 5' RNA replication element or 3' to the 3' RNA replication element.

14. The recombinant RNA molecule according to claim 1, in: (i) the RNA further comprises at least one segment of its reverse complementary RNA molecule; and / or (ii) the recombinant RNA molecule is complexed with one or more RNA binding proteins or is encapsidated by a viral capsid protein, optionally wherein the viral capsid protein is a separate viral capsid protein, optionally wherein the RNA comprises an ERE that provides for encapsidation of the RNA by the separate viral capsid protein, and / or optionally wherein the RNA binding protein comprises an RNA recognition motif.

15. An agricultural formulation comprising the recombinant RNA molecule of any one of claims 1 to 14.

16. The agricultural formulation of claim 15, wherein the recombinant RNA molecule is complexed with one or more RNA binding proteins or is encapsidated by a viral capsid protein, optionally wherein the viral capsid protein is a meretricious viral capsid protein, and optionally wherein the RNA comprises an ERE that provides for encapsidation of the RNA by the meretricious viral capsid protein.

17. The agricultural formulation of claim 15, wherein the RNA binding protein comprises an RNA recognition motif.

18. The agricultural formulation of claim 15, wherein the viral capsid protein is heterologous to the partivirus.

19. The agricultural formulation of claim 15, wherein the formulation comprises the recombinant RNA molecule and a carrier, excipient and / or adjuvant.

20. A cell comprising the recombinant RNA molecule of any one of claims 1 to 14.

21. The cell of claim 20, wherein the cell is a bacterial cell, a fungal cell, a plant cell or an animal cell.

22. The cell of claim 20, wherein the cell comprises a recombinant DNA molecule encoding the recombinant RNA molecule.

23. An expression system comprising: (a) an RNA molecule comprising the recombinant RNA molecule according to any one of claims 1 to 14; and (b) a cell containing the recombinant RNA molecule and the RDRP protein that recognizes the 5' and 3' RNA replication elements of the recombinant RNA molecule.

24. The expression system of claim 23, wherein the recombinant RNA molecule comprises an operably linked encapsidation recognition element (ERE) that is recognized by a viral capsid protein, and wherein the cell contains the viral capsid protein.

25. The expression system of claim 23, wherein the encapsidation recognition element (ERE) is a split viral ERE, wherein the viral capsid protein in the cell is a split viral capsid protein, and wherein the RNA molecule is encapsidated by the split viral capsid protein.

26. The expression system of claim 23, further comprising a reverse complement sequence of the recombinant RNA molecule.

27. The expression system of claim 23, wherein the cell is a bacterial cell, a plant cell, a fungal cell, or an animal cell.

28. An expression system as described in claim 23, wherein the cell further comprises: (i) a viral capsid protein (CP); (ii) an RNA binding protein (RBP) that can bind to the RNA molecule, optionally wherein the RBP binds to an RNA effector; (iii) an RNA cleavage agent that cleaves the RNA molecule; (iv) an RNA promoter-dependent RNA polymerase (RPDRP) protein that recognizes an RNA promoter in the RNA molecule; and / or (iv) a viral movement protein (MP).

29. An expression system as described in claim 28, wherein the CP, RBP, RPDRP and / or the MP: (a) is expressed by a recombinant DNA molecule in the cell; (b) is provided to the cell exogenously; (c) is expressed by a recombinant RNA molecule in the cell; or (d) is expressed by a virus in the cell.

30. The expression system of claim 28, wherein the RDRP, CP, RBP, RPDRP and / or the MP protein is heterologous to the cell.

31. An expression system as described in claim 23, wherein the RDRP protein or a polynucleotide encoding the RDRP protein is (a) expressed by a recombinant DNA molecule in the cell; (b) provided exogenously to the cell; (c) expressed by a recombinant RNA molecule in the cell; or (d) expressed by a virus in the cell.

32. The expression system of claim 23, wherein the cell is a plant cell.

33. The expression system of claim 32, wherein the plant cell contains a split virus that expresses the RDRP protein that recognizes the 5' RNA replication element and the 3' RNA replication element.

34. The expression system of claim 33, wherein the partivirus naturally occurs in the plant cell.

35. A method of providing a synthetic split viral satellite RNA to a plant, the method comprising contacting the plant with a recombinant RNA molecule as claimed in any one of claims 1 to 14.

36. The method of claim 35, wherein contacting comprises spraying, dusting, injecting or soaking with the recombinant RNA molecule or the formulation.

37. A method for establishing synthetic split viral satellite RNA in plant cells, the method include: Providing a recombinant RNA molecule according to any one of claims 1 to 14 to a plant cell; wherein the plant cell comprises a RDRP protein that recognizes the 5' RNA replication element and the 3' RNA replication element, The RDRP protein thereby catalyzes the synthesis of the synthetic split viral satellite RNA from the recombinant RNA molecule.

38. The method of claim 37, wherein the plant cell comprises a split virus, and wherein the RDRP protein is provided to the plant cell by the split virus.

39. The method of claim 38, wherein the split virus is specific to the plant cell, optionally wherein the split virus specific to the plant cell is non-pathogenic and / or commensal.

40. The method of claim 37, wherein the capsid protein comprises a particulate viral capsid protein and the ERE is recognized by the particulate viral capsid protein, optionally wherein the recombinant RNA molecule comprises an operably linked encapsidation recognition element (ERE) that is recognized by the viral capsid protein.

41. A method for obtaining a phenotypic change in a plant or plant cell, the method include: Providing a recombinant RNA molecule as described in any one of claims 1 to 14 to a plant or plant cell, wherein the cargo RNA molecule comprises RNA that achieves a phenotypic change in the plant or plant cell compared to a plant or plant cell lacking the recombinant RNA, wherein the plant or plant cell comprises a RDRP protein that recognizes the 5' RNA replication element and the 3' RNA replication element and catalyzes the synthesis of a synthetic split viral RNA from the recombinant RNA molecule, and the cargo RNA molecule achieves the phenotypic change.

42. The method of claim 41, wherein the RNA that effects a phenotypic change in the plant or plant cell comprises at least one RNA selected from siRNA or siRNA precursor, miRNA or miRNA precursor, and phased siRNA or phased siRNA precursor.

43. The method of claim 41, wherein the RNA that effects a phenotypic change in the plant or plant cell comprises messenger RNA.

44. The method of claim 43, wherein the messenger RNA comprises an RNA molecule that is not present in the genome of the plant or plant cell.

45. The method of claim 41, wherein the RNA that effects a phenotypic change in the plant or plant cell comprises RNA for modifying the genome of the plant or plant cell.

46. ​​The method of claim 41, wherein the RNA that effects a phenotypic change in the plant or plant cell comprises RNA for modifying the transcriptome and / or epigenome of the plant or plant cell, optionally wherein the RNA for modifying the epigenome targets an endogenous plant gene for RNA-induced transcriptional silencing.

47. The method of claim 41, wherein the phenotypic change comprises an increase in the plant's resistance to a pest or pathogen, optionally wherein the pest or pathogen is selected from the group comprising bacteria, viruses other than schizoviruses, fungi, oomycetes, and invertebrates.

48. The method of claim 41, wherein the phenotypic change comprises an increase in the plant's resistance to stress, optionally wherein the stress comprises at least one abiotic stress comprising nutrient stress, light stress, water stress, heat stress and / or cold stress, or optionally wherein the stress comprises at least one biotic stress comprising crowding, shading or allelopathy.

49. The method of any one of claims 41 to 48, wherein the recombinant RNA molecule is provided to the plant or plant cell in the form of RNA, encapsidated RNA or a formulation thereof.

50. The method of claim 49, wherein the encapsidated RNA comprises a synthetic split viral satellite particle.

51. The method of any one of claims 41 to 48, wherein the providing comprises contacting the plant or plant cell with the RNA, encapsidated RNA, or a formulation thereof, optionally wherein contacting comprises spraying, dusting, injecting, or soaking the plant or plant cell with the RNA, encapsidated RNA, or a formulation thereof.

52. The method of any one of claims 41 to 48, wherein the recombinant RNA further comprises a reverse complementary RNA molecule thereof.

53. A method for making synthetic split viral satellite particles, the method comprising combining a recombinant RNA molecule as described in any one of claims 1 to 14 with a viral capsid protein, wherein the recombinant RNA molecule comprises an encapsidation recognition element (ERE), and wherein the ERE provides encapsidation of the RNA by the viral capsid protein.

54. The method of claim 53, wherein the recombinant RNA molecule is combined with a viral capsid protein in a container.

55. The method of claim 53, wherein the combination comprises (a) providing the recombinant RNA molecule to a plant cell, wherein the recombinant RNA molecule comprises an encapsidation recognition element (ERE), and wherein the plant cell comprises a RDRP protein and a viral capsid protein, wherein the RDRP protein recognizes the 5' RNA replication element and the 3' RNA replication element and catalyzes the synthesis of a synthetic split viral satellite RNA from the recombinant RNA molecule, wherein the ERE provides encapsidation of the RNA by the viral capsid protein; and optionally (b) isolating the synthetic split viral satellite particle from the plant cell, the plant comprising the plant cell, or from the culture medium in which the plant cell or the plant is grown.

56. The method of claim 53, further comprising the step of formulating the synthetic split viral satellite particle, wherein the formulating comprises combining the synthetic split viral satellite particle with a carrier, excipient and / or adjuvant.

57. A plant propagule comprising the recombinant RNA molecule of any one of claims 1 to 14 and a split viral RDRP.

58. The plant propagule of claim 57, wherein the plant propagule is a seed, seedling, root, stem, leaf, bud, tuber, rhizome, runner, bulb, explant, embryo or callus.

59. The plant propagule of claim 57, wherein the plant propagule is a chimera comprising a plant cell containing the recombinant RNA molecule and a plant cell lacking the recombinant RNA molecule.

60. The plant propagule of claim 57, wherein the plant propagule lacks DNA encoding the recombinant RNA molecule.

61. A plant comprising the recombinant RNA molecule of any one of claims 1 to 14 and a partiviral RDRP.

62. The plant of claim 61, wherein the plant is a monocot or a dicot.

63. The plant of claim 61, wherein the plant belongs to the family Asteraceae, Cucurbitaceae, Leguminosae, Poaceae or Solanaceae.

64. The plant of claim 61, wherein said plant lacks DNA encoding said recombinant RNA molecule.

65. The plant of claim 61, wherein the plant comprises a mereovirus, and wherein the mereovirus RDRP is provided to the plant cells by the mereovirus, optionally wherein the mereovirus RDRP comprises a protein having at least 85%, 90%, 95%, 97% or 99% sequence identity to SEQ ID NO: 272-275 or 276 to 290, 384 or 390.

66. The plant of claim 61, wherein the mesomevirus is endemic to the plant, optionally wherein the endemic mesomevirus is non-pathogenic and / or commensal.

67. The plant of claim 61, wherein said splitiviral RDRP, said 5' replication element and / or said 3' replication element are derived from a splitivirus comprising one or both of said splitiviral RDRP, 5' replication element and / or 3' replication element.

68. The plant of claim 61, wherein the RDRP is at least 85%, 90%, 95%, 97%, 98% or 99% identical to SEQ ID NOs: 272-275 or 276 to 290, 384 or 390, wherein the 5' replication element is at least 85%, 90%, 95%, 97%, 98% or 99% identical to the RNA encoded by SEQ ID NOs: 2-34, 70-88, 372, 374, 376, 378, 380, 382 or 386, and / or wherein the 3' replication element is at least 85%, 90%, 95%, 97%, 98% or 99% identical to the RNA encoded by SEQ ID NOs: 2-34, 70-88, 372, 374, 376, 378, 380, 382 or 386.

69. The plant of claim 61, wherein the plant is a grafted plant, and wherein the rootstock and / or scion of the grafted plant comprises at least one cell containing the recombinant RNA and the split viral RDRP.

70. The plant of claim 62, wherein the plant is not produced by a substantially biological process.

71. A split virus satellite system that can self-replicate when introduced into a plant or plant cell, the split virus satellite system comprising: (1) a recombinant split virus satellite RNA, which comprises, from the 5' end to the 3' end: (a) a 5' RNA replication element recognized by a split virus RNA-dependent RNA polymerase (RDRP); (b) a cargo RNA molecule; and (c) a 3' RNA replication element recognized by the RDRP; wherein the 5' RNA replication element, the cargo RNA molecule, and the 3' RNA replication element are operably linked, and wherein the promoter and the cargo RNA molecule are heterologous to the 5' RNA replication element and the 3' RNA replication element; and (2) an exogenous split virus that is capable of replicating in the plant or plant cell and encodes the split virus RDRP that recognizes the 5' and 3' replicase recognition sequences in the recombinant split virus satellite RNA.

72. The self-replicating partiviral satellite system of claim 71, wherein the exogenous partiviral virus is unique or native to a different species, variety or germplasm of the plant.